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SUMMARY
There is a lack of information about structural requirements 
for a functional transmembrane domain in eukaryotic membrane 
proteins. This led me to design a eukaryotic system to bring 
more information about this structure and the role of the 
positively charged residues situated at the cytoplasmic side 
of a transmembrane region. The CD2 molecule was chosen as a 
model for an integral membrane protein. I deleted the 
transmembrane domain (26 amino acids) by oligonucleotide site- 
directed mutagenesis and overlap extension using PCR 
mutagenesis. Truncated forms with transmembrane regions 14, 
12, 10 and 8 amino acids long were created. The common
positive cluster (Lys-Arg-Lys-Lys) at the cytoplasmic domain 
was disrupted by substituting it for polar residues (Gln-Gln- 
Gln-Gln).
The effects of such mutagenesis was examined after expression 
of the mutant proteins in eukaryotic cells (COS-7 and CHO). 
Cellular localization was determined by panning and 
immunostaining experiments. The functional state of the 
mutant proteins expressed on the cell surface was verified by 
rosetting experiments and immunostaining with antibodies 
against different epitopes of the CD2 extracellular domain. 
The interaction of the molecule with the lipid bilayer was 
determined by lateral diffusion studies, using photobleaching 
analysis.
It was demonstrated that a transmembrane domain at least 12 
amino acids long is necessary for the CD2 protein to be
expressed on the cell surface as an integral membrane protein. 
Proteins with shorter transmembrane domains (10 and 8 amino 
acids respectively) were localized intracellularly as verified 
by immunostaining. This finding is in agreement with previous 
work on the VSV G protein (Adams and Rose, 1985b) . Lateral 
diffusion studies revealed that even large deletions in the 
transm’embrane domain of CD2 do not interfere with its lateral 
mobility in the lipid bilayer. Although the fraction of the 
free molecules for diffusion was higher in the CD2 protein 
with transmembrane region 12 amino acids long. This implies 
that deletions in the transmembrane domain can interfere with 
the stability of the protein within the lipid bilayer.
The disruption of the positively charged cluster of the CD2 
cytoplasmic domain did not alter the orientation and stability 
of the molecule within the cell membrane. This suggests that 
the topology of a membrane protein with only one span domain 
is not influenced by this positively charged sequence. The 
orientation within the membrane should be determined in the 
early stages of translocation by interaction of the signal 
sequence and the hydrophobic domain with the protein- 
conducting pore in the endoplasmic reticulum membrane.
Chapter 1 Introduction
CHAPTER 1
INTRODUCTION
1. Insertion of membrane protein into the Endoplasmic 
Reticulum
The cell has specific transport mechanisms for the targeting 
of newly synthesized proteins to their site of function. The 
amino acid sequence of nascent polypeptides have the necessary 
information for intracellular protein targeting, to control 
the timing and location of protein folding and to determine 
the final three dimensional structure of the protein. Newly 
synthesized proteins can reach the cell membrane (integral
membrane proteins), the lumen (secreted proteins) or enter 
other intracellular organelles. The first two have to be
transported by the secretory pathway before they reach their 
targets. In eukaryotic cells, nascent polypeptides enter the 
secretory pathway at the rough endoplasmic reticulum membrane 
(RERM) and they travel through the Golgi complex either to
cell surface or to secretory granules, as lysosomes or
vacuoles, in order to be secreted from the cell or anchored to 
the cell surface.
1.1 Membrane proteins
Blobel (1980) proposed that discrete segments of the 
polypeptide chain act as topogenic determinants of protein 
structure and he called them topogenic sequences. These 
sequences can either start or stop the translocation of the 
polypeptide chain through the ER membrane. Stop-transfer
1
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sequences can interrupt the chain translocation that was 
initiated by a start transfer sequence and they are effective 
means for asymmetric integration of membrane proteins.
Integral membrane proteins anchor to the cell surface and span
the lipid bilayer at least once. They were classified on the 
tKe. , chain
basis of number of times the polypeptide crosses the membrane
(Blobel, 1980) and of their orientation in the membrane (von
Heijne and Gavel, 1988) (Fig 1.1). Class I proteins present a
cleavable signal peptide, their terminus is oriented towards
the ER lumen and their C-terminus to cytoplasmic side. Human
glycophorin A (Siebert and Fukuda, 1986), HLA antigens of
human cells (Lopez de Castro et al., 1983), viral spike
glycoprotein (Wiley and Skehel, 1987/ Rose et al., 1980) are
some examples of class I membrane proteins. In class II
membrane proteins, the signal peptide is not cleaved, it can
be internal and may overlap with the membrane spanning domain:
as observed in human liver transferrin receptor (Zerial et
al., 1986). They exhibit the C-terminus in the ER lumen and
the N-terminus in the cytoplasm, for example, like influenza A
neuraminidase (Block and Air, 1982), human HLA-DR invariant
gamma chain (Strubin et al., 1984), human liver transferrin
receptor (Schneider et al., 1984/ Zerial et al., 1986). In
class III membrane proteins the signal peptide may remain in
the mature protein functioning as a start transfer sequence
and it was also postulated that these polypeptides contain an
internal stop sequence that interrupts the cotranslocation
through the ER membrane, leaving the C-terminus exposed on the
cytoplasmic surface, assuming an orientation as class I
proteins. Rat cytochrome P450 (DeLemos-Chiarandini et al.,
1987), human cytochrome P450 (Beaune et al., 1986), influenza
A M2 protein (Lamb et al,1985) can be included in class III of
membrane proteins. Some proteins can span the membrane several
times, they are classified as polytopic membrane proteins.
They contain multiple hydrophilic domains on both sides of the
membrane, such topology could be because a succession of
2
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Figure 1.1 - Diagram showing the different classes of membrane 
proteins. The horizontal shaded lines represents the cell 
membrane/ the black vertical rectangles represent 
transmembrane region of proteins. Classes I, II, III and IV 
are integral membrane proteins. GLYP represents those membrane 
proteins that are anchored by glypiation tails. For class I 
integral membrane protein, the N-terminal leader sequence 
(open box) is shown cleaved (dotted line) from the N terminus 
of the mature protein. The number of transmembrane seqeunces 
of class IV proteins need not be seven, and the orientation of 
their N and C termini not be as shown.
Chapter 1 Introduction
alternating internal signal and stop transfer sequences^human 
asialoglycoprotein ( Wessel and Spiess, 1988), glucose 
transporter (Mueckler et al.,1985) and rhodopsins (Schobert et 
al.,1988)}.
An alternative mechanism to anchor proteins to the plasma 
membrane was first found in the Thy-1 antigen of rodent 
thymocytes and neurons (Williams and Gagnon, 1982) and in the 
variant surface glycoprotein (VSG) of Trypanosoma brucei
(Allen et al.., 1982). Both molecules have properties of a
membrane protein that bind the lipid bilayer but no
hydrophobic properties or sequences were observed in their 
structure. This alternative anchoring mechanism involves the 
covalent attachment of a complex structure of phosphatidyl 
inositol, carbohydrate and ethanolamine to the C-terminus of a 
protein. Structurally, these proteins are glycoproteins
composed of a single domain which is anchored to the membrane 
via a covalent linkage to a glycophospholipid-glycosyl
phosphatidyl inositol (GPI)(Fig 1.1). The C-terminal amino 
acid of the extracellular protein moiety is linked via an 
ethanolamine residue to an oligosaccharide composed of
mannose, a variable number of galactose residues and
glucosamine (non N-acylated). This oligosaccharide is in turn 
attached to the inositol portion of PI (phosphatidyl
inositol). The diacylglycerol portion of PI provided is the 
only site for membrane attachment in these proteins (Ferguson 
and Williams, 1988) . Translocation mechanism of these proteins 
into the lumen of the ER is initiated through a conventional 
N-terminal signal sequence. A second cleavable hydrophobic 
sequence at the C-terminal end of the protein is also present 
and it serves as a signal for GPI attachment. This sequence is 
cleaved cotranslationally in the lumen of the ER, and GPI is 
added as a' block by a set of enzymes (Caras et al., 1987,
Caras et al.., 1989).
3
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The ras family of proteins are members of a small guanine 
nucleotide binding proteins which were initially detected by 
their ability to transform cells, to function they have to 
bind GTP and be localized at the plasma membrane, as mature 
forms of polypeptide chain. Their localization involves two 
posttranslational modifications, polyisoprenylation and 
palmitoylation at the Cysl86-AAX motif and 181/4 Cys, 
respectively, localized at the C-terminus (Hancock et al. , 
1989/1991). The heterotrimeric G proteins, signal transducers 
from the superfamily of GTPases, are localized to the inner 
surface of the plasma membrane. They are composed of three 
subunits and none of them have hydrophobic membrane spanning 
domains, two types of posttranslational modifications, 
myristoylation and isoprenylation, play a role in their 
membrane association (Spiegel et al. , 1991).
Signal sequences
The signal sequence or signal peptide is the first topogenic 
sequence involved in protein targeting . Gething and Sambrook 
(1982) showed that the signal peptide act as a targeting 
signal, by deleting the entire signal peptide region of
influenza virus hemagglutin, after expressing the mutants in 
Cos cells, it was found that instead of it being glycosylated 
and transported to cell surface, the mutant form was
unglycosylated and located intracellularly. Lingappa and cols 
(1984), studied a fusion protein of coding sequence for 
chimpanzee a-globin ( a cytoplasmic protein) and portion of 
/3-lactamase gene coding for the 28 aa • , including the
25 aa signal peptide. The protein was translocated across the
ER and cleaved at normal P lactamase signal peptide.
Signal sequences do not exhibit primary sequence homology, 
their function depends more on general physical properties, like 
the hydrophobic character, than on specific residue
4
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recognition (Landry and Gierasch, 1991). Some properties 
differ between prokaryotes and eukaryotes (von Heijne, 1985/ 
Duffaud et al., 1985). The amino terminal region in eukaryotes 
carry a net positive charge, .where in prokaryotes one to three 
positively charged amino acid residues will be present. Akita 
and colleagues (1990) suggested that basic residues in the 
signal sequence possibly interact with acidic residues in 
components of the secretion apparatus. The hydrophobic core 
in prokaryotes is longer than eukaryotes, and ttie presence of 
a serine and /or threonine in the former one, divides this 
hydrophobic domain into two regions of different degrees of 
hydrophobicity. The cleavage site seems to be preferentially 
negatively charged and it follows the motif AXA in prokaryotes 
and in eukaryotes it is preceded by six to eight residues.
Transmembrane domains
Most integral membrane proteins share a similar structural
motif, a hydrophobic transmembrane stretch of 17-30 amino 
acids (Sabatini et al., 1982) that functions as' a stop
transfer sequence. Several experiments show that the 
hydrophobic character in such segments is important to
membrane anchor properties as this hydrophobic segment may act 
as a anchor (von Heijne and Blomberg, 1979/ Engelman and
Steitz, 1981) . von Heijne (1981) compared the overall amino
acid composition of 10 transmembrane segments. The residues 
seemed to be selected only for their . hydrophobicity, thus 
the amino acid composition of those segments are conserved. 
Davis and Hunter (1987) observed that this hydrophobic 
character is important not only to anchor the protein to the 
cell membrane, but also for intracellular transport. By 
introducing two point mutations into the transmembrane region 
of the Rous Sarcoma virus, they converted a hydrophobic 
leucine to an arginine. The mutant exhibited reduction on cell 
surface expression because it appeared to be transported 
normally through the cell until the trans-Golgi compartment,
5
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where instead of being transported to the cell surface, it was 
transported to the lysosome and degraded. Adams and Rose 
(1985a) did a similar experiment with vesicular stomatitis 
virus G protein, and the mutant could be seen localizing in 
the Golgi. Davis and Model (1985), in order to prove that the 
hydrophobicity itself is responsible to membrane anchoring 
process, created an artificial anchor domain by inserting 
repeats of hydrophobic amino acids into the genes encoding a 
secreted version of coliphage fl gene III protein (Davis et 
al.., 1985); the mutant spanned the membrane assuming a
membrane topology.
Effect of positively charged amino acids
Another important feature of integral transmembrane protein is 
the location of positively charged amino acids stretches, in 
the cytoplasmic domain adjacent to transmembrane segments By 
analysing the sequences of known membrane proteins from
prokaryotes and eukaryotes (von Heijne, 1986/ von Heijne and 
Gavel, 1988) it was found that lysine and arginine residues 
are four times more prevalent in the cytoplasmic domain than
in periplasmic loops and this proportion is more than
would be expected at random. The "positive inside" rule
suggested that membrane proteins orientate themselves with the 
most positively charged end in the cytoplasm and the function 
of the charged residues is more related /to
orientation of the protein in the lipid bilayer than to
insertion (von Heijne, 1986).
There is some experimental support for the idea that
positively charged residues can act as topological
determinants. The membrane topology of leader peptidase,
which spans the membrane twice with Nout-Cout pattern, can be 
&
inverted to Nin-Cin pattern, by changing the charge distribution 
of the hydrophilic domains (von Heijne, 1989). Positively
6
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charged amino acids were found to be important in anchoring 
cytoplasmic domains of MalF, when this was fused to alkaline 
phosphatase (Boyd and Beckwith, 1989) and various domains of 
the fusion proteins were deleted (McGovern et al.., 1991).
Studies on the topology of hemaglutinin-neuraminidase proteins 
of paramyxovirus simian virus 5 (HN), a class II protein, 
support the positive inside rule, since removal of positively 
charged residues on the N-terminus side of the transmembrane
region, causes an inverted topology, from Nin-c°ut to Nout-cin 
(Parks and Lamb,1991).
Nilsson and von Heijne (1990) demonstrated that addition or 
removal of a single positively charged lysine residue in the 
N-terminal side of the first spanning domain of leader 
peptidase, can be sufficient to reverse the topology of a 
polytopic membrane protein, these results provide a good 
support for the "positive inside" rule. It was also observed 
that a sufficient number of negatively charged residues can 
affect the topology, j
McGovern and colleagues (1991) compared the charged residue 
composition of MalF/alkaline phosphatase fusion deleted 
mutants and found that the strength of cytoplasmic domains as 
topogenic signals varies and is correlated with the density 
of positively charged amino acids within them. This difference 
may be related to the potential to form stable ion pairs 
between charged residues, making the domain more readily 
exportable (Traxler et al., 1993). This MalF deletion system 
suggested that in the case of polytopic membrane proteins with 
various cytoplasmic domains, the rule for the effect of basic 
amino acids does not follow a sequence of events initiated by 
topological signals at the N-terminal of the protein. A more 
C-terminal cytoplasmic signal can compete with other signals 
that occur amino terminal to it and establish the protein 
orientation in the membrane.
7
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Hartmann and cols (198 9) proposed the charge difference 
hypothesis, in which the sum of the flanking charges of the 
signal/anchor domain is important for directing the topology 
of the protein, and it is not the absolute number of positive 
or negative charges surrounding this segment. This hypothesis 
is based on a comparison of sequences from eukaryotic type II 
and III membrane protein* and a strong correlation between 
the sum of the charges surrounding the signal/anchor domain 
and its membrane topology was identified.
The way this interaction occurs is still unclear. One 
possibility is that the basic residues adjacent to the apolar 
segment interact with the acidic lipid head groups exposed on 
the cytoplasmic surface of the membrane, this is according to 
the loop model (Inouye and Halegoua, 1980). Another 
possibility is concern«iwith the eletrochemical gradient across 
the bacterial membrane, which is more negative on the 
cytoplasmic side, that seems to be suitable for hydrophobic 
sequences to insert with their positively charged ends on the 
inner face of the membrane ( Li et al, 1988; Yamane and 
Mizushima,1988). Although in eukaryotes no general membrane 
potential exists across the rough endoplasmic reticulum 
membrane, where protein translocation initiates, the 
possibility of local membrane potential has not been excluded 
(Boyd and Beckwith, 1990).
The positively charged segment is also required to localize 
p21ras to the inner face of the plasma membrane. The ras 
proteins, p21H”ras, p21N_ras and p21^_ras^  have sites of 
palmitoylation (C-terminal CAAX motifs), that target this 
protein to cell membrane (Hancock et al, 1989). It was 
demonstrated that p21K“ras B^ ,^ which is not palmitoylated, 
requires the combination of the C-terminal motif and a
8
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polybasic domain -for- plasma membrane localization (Hancock et 
al, 1990/ Hancock et al, 1991).
1.2 Insertion mechanisms
The endoplasmic reticulum (ER) is the place of topogenesis of 
most newly synthesized membrane and secreted proteins, it is 
also where many posttranslational modifications and assembly 
events occur. The orientation of a membrane protein into the 
phospholipid bilayer is likely to be determined by the 
mechanism of its insertion, for which there are several
models. The main difference between the models is the 
participation or not of membrane receptors of the ER in the 
translocation process.
von Heijne and Blomberg (1979) proposed that the transfer of a 
nascent chain is directly through the lipophilic core of the 
ER membrane, and the driving force is provided by direct 
interaction between ribosome and membrane, this hypothesis 
was denominated "The direct tranfer model". The signal peptide 
assume an a-helical conformation and binds to the lipophilic 
core of any membrane, resulting in the binding of the ribosome 
to the ER membrane, forcing even strongly hydrophobic residues 
into the lipid bilayer.
Wickner (1979, 1980) proposed the membrane triggered folding
hypothesis, which emphasizes the self assembly and folding 
properties of protein as they pass from cytoplasm to membrane. 
It is based on the assumption that assembly of proteins can 
be initiated during or shortly after the polypeptide synthesis 
and that it is an integral part of the folding pathway, as 
protein encounter an amphipathic surface. Larger proteins may 
assemble during synthesis, others after synthesis is
9
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completed. Once they encounter a membrane, they may triggered 
to refold by the availability of the hydrocarbon core of the 
bilayer. During this assembly event, polar portions of the 
protein are protected from the fatty acyl chains by more 
apolar residues. The hypothesis is supported by examples of 
proteins that can exist in alternate conformation, compatible 
with aqueous or apolar environments like fumarase (Clarke, 
1975), diphteria toxin (Bouquet et al,1976), adenyl cyclase 
(Homey et al, 1978) and protein II of the E.coli (Schweizer et 
al, 1978).
Engelman and Steitz (1981) proposed the helical hairpin
hypothesis, in which the translocation and insertion of 
membrane proteins are spontaneous processes, driven by 
hydrophobic forces. There is no need of additional specific 
membrane receptors or transport proteins, because of the
distribution of polar and nonpolar sequences in the 
polypeptide chain. It was postulated that the nascent 
polypeptide chain will fold to form an antiparallel pair of 
helices, the hairpin structure, which should contain the
signal peptide. This helical hairpin structure will insert 
spontaneously into the hydrophobic region of the bilayer. If 
the second helix is polar, secretion will initiate and it will 
continue until a hydrophobic segment is encountered. In the 
case of secreted proteins, after insertion of the helical 
hairpin structure, the synthesis will continue. When the 
translocation is completed and the C-terminus passes through 
the membrane, the signal sequence is cleaved and the protein 
released into the ER lumen. However, the insertion and
orientation of membrane proteins will depend on the presence 
of a hydrophobic domain, which will halt the translocation. 
The insertion of membrane proteins from class II, where the C- 
terminus is found on the exterior side of the membrane, like 
sucrase-isomaltase dimer (Frank et al.,1978; Brunner et 
al.,197 9) and Cytochrome bs (Jagow and Sebol, 1980) which is 
anchored to the ER and synthesized without a leader sequence
10
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on free cytoplasmic ribosomes (Krieter and Shires, 1980), the 
insertion might be posttranslationally, either by a helical 
hairpin or a single hydrophobic helix. In the case of proteins 
with several transmembrane segments, like bacteriorhodopsin, 
several hairpin insertions may be involved.
Blobel and Dobberstein (1975) in studies on the presence of
proteolytically processed and unprocessed nascent
immunoglobulin light chains on membrane-bound ribosomes of 
cells
murine myeloma, observed that the processing of nascent chains 
in vitro by rough microsome is dependent on ribosome binding 
to the membrane and on the basis of these results the signal 
hypothesis idea was described. The essence of this hypothesis 
is that specific factors, membrane or cytoplasmic proteins, 
bind to the growing polypeptide chain and conduct it into the 
bilayer during its synthesis. According to this hypothesis the 
insertion of the nascent polypeptide chain is directed by a 
unique sequence of codons, the signal sequence , present 
immediately to the right of the initiation codon only in those 
mRNAs whose translational product are to be transferred across 
the cytoplasmic membrane (in prokaryotes) or the ER membrane 
(in eukaryotes), this sequence will collaborate with ribosome 
attachment to the membrane, that facilitates the 
translocation. The whole process consists of a series of 
events, involving distinct complex components. First, the 
signal recognition particle (SRP) binds the signal sequence of 
a nascent polypeptide chain, regulates translational 
elongation and initiates translocation across the membrahe. An 
SRP receptor, found in the ER membrane, associates the 
SRP/nascent polypeptide complex with the membrane. The signal 
sequence receptor, also an integral ER membrane protein, 
interacts with the signal sequence once it has reached the 
membrane. The ribosome binds to the ribosome receptor, also 
located in the ER membrane, and after the translocation of the 
protein across the membrane, the signal peptidase cleaves the 
signal sequence, producing the mature form of the protein.
11
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Class I and II of membrane protein, orientation in 
the cell membrane is, in a way, easy to explain according to 
this hypothesis. On the other hand, class III membrane 
protein orientation is contradictory with the signal
sequence/membrane interaction, crucial to the signal 
hypothesis. Sabatini and colleagues (1982), postulated the 
existence of a N-terminus interior uncleavable
cotranslational signal peptide to explain the orientation of 
these membrane proteins . It interacts with the
membrane, in a loop conformation, in order to promote 
cotranslation of the nascent polypeptide, until it is 
interrupted by a stop transfer sequence near the C-terminus 
region. This loop model shares similarities with the helical 
hairpin one, the difference is that in the former polypeptides 
are synthesized on bound ribosomes. The insertion mechanism of 
membrane proteins with multiple spanning domains (polytopic 
membrane protein), could be explained by a sucession of 
alternating internal signal and stop transfer sequences. 
Wessel and Spiess (1988) constructed artificial polytopic 
proteins spanning the membrane up to four-fold by tandemly 
repeating portions of the cDNA encoding the human 
asialoglycoprotein (ASGP) receptor HI. By in vitro
translation in the presence of microsomes, it was observed 
that the first hydrophobic domain functioned as a signal 
peptide and together with SRP initiates a first translocation 
process. The second domain acts as a stop transfer, while the 
third initiates a second translocation process up to the next 
apolar domain that halts the translocation.
The three first hypotheses are quite related in the way that 
membrane receptors are not necessary for translocation, and 
existing evidence for posttranslationally insertion of
membrane proteins provide support for them. Mueckler and
Lodish (1986) described a cotranslational and
12
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posttranslational mechanism of membrane integration of a 
multispanning membrane transport protein, the human 
facilitated diffusion glucose transporter (GT) (Fig 1.4C). RNA 
transcripts encoding the complete GT or fragments
corresponding to the N-terminus (GT-N) and C-terminus (GT-C) 
were synthesized in reticulocyte or wheat germ cell-free 
systems and their insertion into pancreatic micrdsomes were 
assayed by endoglycosidase H and trypsin digestion or alkaline 
extraction of membranes. It was assumed, for illustrative 
purposes that GT possesses at least two distinct signal 
sequences, positioned arbitrary in the two halves of the 
protein and that the ribosomes engaged in the synthesis never 
interact directly with the ER membrane which functions during 
the cotranslational insertion. Elongation of the polypeptide 
chain continues until the first signal sequence emerges from 
the ribosome. SRP binds to this sequence facilitating the 
insertion of the N-terminal fragment into the membrane as a 
loop structure through interaction of the complex with the SRP 
receptor, without the ribosome being brought in direct contact 
with the membrane. The polypeptide chain elongation continues 
until the other signal sequences emerges and the cycle repeats 
as before. This mechanism can be considered as
cotranslational insertion in a way that the polypeptide chain 
is still being synthesized while the N-terminus is inserted 
into the membrane via SRP/SRP receptor integration, where SRP 
may be required for targetting and initiation of the insertion 
process. On the other hand, it can be a posttranslational 
event because the polypetide chain folds into the membrane 
■may be driven by the free energy change resulting from 
hydrophobic interactions with the lipid bilayer and the 
ribosome is not in contact with the ER membrane, driving the 
nascent polypeptide chain through an aqu^fes pore.
The cytochrome b5, a class II membrane protein located on the 
outer surface of the ER, is considered to be synthesized on 
free ribosomes and to be inserted into the ER membrane
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posttranslationaly. Kutay and colleagues (1993) point out 
that because the hydrophobic segment of cytochrome b5 ( and 
other class II membrane proteins) is to close to the C- 
terminal fragment, it could not have emerged from the ribosome 
before termination of translation, which corroborates the
idea of a SRP independent insertion pahtway. Although it 
follows a SRP/SRP receptor independent pathway, Mitoma and Ito 
(1992), by doing deletions in the C-terminal domain and 
fusions with 106 amino acids fragment of the mature adrenoxin 
and to artificial hydrophobic peptides 20 amino acids long, 
observed that the last 10 amino acids from the C-terminus 
contain the necessary information to target the cytochrome b5 
specifically into the ER membrane, so the mode of insertion 
was classified as receptor mediated pathway.
1.3 Function and components as the membrane supporter signal 
sequence hypothesis
Signal peptidase
The signal sequence or signal peptide is the only segment that 
keeps the translational complex bound to membrane after 
translocation. This hydrophobic segment can be either cleaved 
off and the protein released into the lumen of the ER, or it
14
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can act as a stop transfer signal, as described before. In the 
first case, the signal peptidase will be responsible by the 
cleavage of the signal peptide. It is a special class of 
endopeptidases with a well-defined substrate specificities. 
The eukaryotic signal peptidase has been isolated from canine 
pancreatic rough microsomes (Evans et al, 1986). It was found 
to contain six polypeptides (25, 23,22,21,18 and 12 KDa),
these polypeptides exhibited sensitivity to endoglycosidase H 
and ability to bind concanavalin A, so they were considered 
glycoproteins. It seems that only one subunit of the complex 
is responsible for signal peptide cleavage, maybe the other 
subunits are involved in other enzymatic processes. Each of 
the polypeptide chains is more abundant than either SRP or SRP 
receptor and is roughly equivalent in amount to the membrane 
bound ribosomes (Evans et al, 1986) . The catalytic site is 
located on the noncytoplasmic face of the membrane.
Signal recognition particle
In order that translocation of nascent polypeptide chain 
occurs, it is necessary that the polysome binds to the ER 
membrane. This process is mediated by a ribonucleoprotein 
complex, the signal recognition particle, SRP (Walter and 
Blobel, 1981).It is a cytoplasmic ribonucleoprotein composed 
of six non identical polypeptide chains and a 300 nucleotide 
RNA molecule, 7SL RNA (Walter and Blobel, 1982) . The complex 
functions as an adapter between protein synthesis in the 
cytoplasm and protein translocation in the ER membrane. It was 
first recognized by its ability to restore the translocation 
activity of salt-extracted microsomes in vitro (Warren and 
Dobberstein, 1978). The four polypeptide chains are 
noncovalently bound, these subunits are two monomers, a 19 
plus 14 KDa and a 68 plus 72 KDa.
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Signal recognition starts when SRP binds an inactive ribosome 
with relative low affinity, which increases with synthesis and 
exposure on the ribosomal surface of the signal sequence as 
part of the nascent polypeptide. This signal recognition gives 
rise to translational arrest and the SRP-ribosome-n^cent chain 
complex will target the ER membrane via interaction with SRP 
receptor or docking protein, while the signal sequence
interacts with signal sequence receptor. This last event is
accompanied by SRP/SRP receptor complex detachment from the 
ribosome, ribosome/nascent chain complex associates with ER
membrane, possibly involving a ribosome receptor and the
translocation mechanism proceeds (Walter and Lingappa, 1986) .
The different functions of SRP in the targetting process are 
specific to the different structural units of the particle 
(Siegel and Walter, 1988) . Crosslinking experiments 
demonstrated that there is an interaction of signal sequence 
and SRP, and the 54 KDa subunit was responsible for this 
(Krieg et al, 1986/ Kurzchalia et al,1986 and Wiedmann et al,
1987) . Analysis of its amino acid sequence shows that it has 
two domains, a N-terminal one, with typical features of a GTP 
binding protein (G domain), and a C-terminal domain,
methionine rich (M domain) . This last one has been implicated
in signal sequence binding (Bernstein et al, 1989/ Romisch et
al, 1989). The G domain plays a essential role in SRP-mediated 
targeting of nascent chain-ribosome complexes to the ER 
membrane and also influences signal sequence recognition,
possibly by promoting a tighter association between signal
-%■
sequences and M domain (Zopf et al., 1993). The 19 KDa binds 
directly to the RNA (Lingelbach et al, 1986) . The 9/14 KDa
dimer is necessary for elongation arrest (Siegel and
Walter,1988/ Scoulica et al,1987). The 68/72 KDa* serves to 
bind the complex to the SRP receptor and promote transmembrane 
translocation (Siegel and Walter, 1988). Walter and Blobel
(1982) pointed out that 7SLRNA is a constitutive and
indispensable part of the SRP, it is thought to have a
polypeptide
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structural role, serving as a "core" or "matrix" on which the 
SRP proteins assemble.
Signal recognition particle receptor
As mentioned before, the SRP/ribosome complex interacts with 
an integral membrane protein, the SRP receptor. It is a 
heterodimeric protein with an a-subunit, the 69 KDa
polypeptide, that comprises a 18 KDa anchor and a 52 KDa
so U nit
cytoplasmic domain, and a p, the 30 KDa popypeptide (Hortsch, 
et al 1988/ Lauffer et al, 1985) . The a-subunit it is also 
call docking protein (Meyer et al,1982) and it resembles 
nucleic acid binding proteins, which suggests that SRP receptor 
may interact with 7SLRNA in SRP, and this interaction could be 
mediated by protein-nucleic acid interaction.
The ER has on its membrane some integral membrane proteins 
that interact in order to form a multicomponent translocation 
apparatus, the translocon. Its function is to mediate the
binding of ribosomes engaged in the synthesis of secretory or 
membrane proteins, that have been targeted o the ER membrane by
SRP/SRP receptor complex. The translocon components can be
also responsible by protection of the aqueous pore, needed for 
translocation of the nascent polypeptide through the 
hydrophobic core of the membrane. It also can promote
integration of signal anchor sequences in a proper orientation 
to give rise to the different types of membrane protein 
(Walter, 1992) .
Translocon (signal sequence receptor and ribosome receptor)
The signal sequence receptor is one of the components of the 
translocon. Wiedman and cols (1987) used a crosslinking 
approach to identify an integral glycosylated protein (35
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KDa) , called SSR, that interacts with the signal sequence 
during the process of protein translocation. However, Krieg 
and cols (1989) , observed that not only the signal sequence 
could be crosslinked to the membrane glycoprotein but also to 
distant parts of the translocation nascent chains, suggesting 
that SSR can interact with various components of membrane 
proteins and not only with signal sequences. Migliaccio and 
cols (1992) also demonstrated that reconstituted ER vesicles, 
immunodepleted of SSR and associated subunits, were still able 
to translocate secretory and membrane proteins substrates. 
Gorlich and cols (1992) purified, cloned and sequenced a 
different ER membrane glycoprotein that participates in 
protein translocation. It was called TRAM (for translocating 
chain-associating membrane protein), its amino acid sequence 
indicates that it probably crosses the membrane eight times 
and it is as abundant as ER membrane bound ribosomes. In order 
to prove its functional significance, TRAM was depleted from 
ER vesicles. Translocation of two secretory proteins p- 
lactamase and prepro-a-factor was blocked in TRAM depleted 
vesicles, on the other hand, translocation of preprolactin was 
still observed, but with low efficiency, perhaps due to 
residual TRAM probably present in the vesicles. Readdition 
of purified TRAM to the extract restore the translocation 
activity of the two secretory proteins.
The other component of the translocon is the ribosome 
receptor. The large number of ribosomes attached to the RER, 
gives to it this rough appearance. It seems to be such a tight 
attachment that persists even during fragmentation of the ER 
and sucrose gradient centrifugation. Ribophorins I and II were 
the first membrane proteins described as characteristic of 
the rough endoplasmic reticulum. Although they copurify with 
the ribosomes and other components of the translocon, they do 
not show protease sensivity, exhibited by the ribosome binding 
activity of ER membranes (Hortsch et al, 1986) . Also when a 
fraction enriched in ribophorins I and II was incorporated
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into liposomes and binding assays were performed, only a
marginal capacity for ribosomal binding was shown (Savitz and
Meyer, 1990). Another candidate for a possible binding factor
was identified by Savitz and Meyer (1990,), to bo. isolated,
purified and characterized a large integral membrane protein
(180 KDa), with a large cytosolic domain (160 KDa). When this
protein is proteolytically detached from the membrane, it can 
ti .
competively inhibit the binding of ribosomes to intact
membranes. This ribosome receptor was denominated pl80. it
was showed to be essential for both ribosome binding and
+V\roo^V\ -V^e
protein translocation depletion of pl80 with monoclonal
antibodies from detergent extracts of the RER used in the
preparation of translocation-competent proteoliposomes. 
Proteoliposomes from pl80-depleted extracts were unable to 
bind ribosomes and lost the ability to cotranslationally
translocate two secretory protein precursors. Re-addition of 
purified pl80 to depleted extracts, restored ribosome binding 
and translocation activity (Savitz and Meyer, 1993) . Yoshida 
and cols (1987) isolated a protein fraction from rat liver 
microsomes, and separated it into two fractions on a Con-A 
sepharose column. A glycoprotein fraction, including major 
part of ribophorins, and a non glycoprotein fraction were 
obtained. Both were reconstituted into liposomes and had their 
ribosome binding activities compared. The non glycoprotein 
fraction showed 90% of recovered binding capacity. Tazawa and 
cols (1991) separated the non-glycoprotein fraction, by 
affinity chromatography on a chelating-Sepharose column, into 
two fractions. Ribosome binding activity was observed at the 
flow-through fraction (chelate FT fraction),which one was 
treated with trypsin, and a parallel decrease in ribosome 
binding activity and the amount of a 34 KDa band was observed. 
By photocrosslinking studies, it was found that the 34 KDa 
component crosslinked with the 60S ribosome subunit and it was 
in proportion to the amount of 60S subunit added to the 
system. This 34 KDa polypeptide was called p34, and it appears 
to be another candidate for a ribosome receptor.
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The signal hypothesis emphasizes that the newly synthesized 
polypeptide has to be conducted through an aqueous 
proteinaceous channel, and interactions that will determine 
topology will occur between the translocating protein and the 
components of the channel (Fig 1.2). Simon and Blobel (1991) 
described and characterized a protein conducting channel in 
the ER membrane by electrophysiological techniques, using 
puromycin to release nascent from ribosomes, membranes to 
induce protein conducting channel of 220 pS and high salt 
concentrations to detach ribossomes from the membrane. The 
results suggest a role for the attached ribosome in keeping an 
open channel.
Either the signal sequence itself opens the channel and binds 
to a stop tranfer receptor in the protein-conducting channel, 
or the SRP receptor, or the ribosome, serves as the ligand. In 
order to translocate secreted proteins the protein-conducting 
channel would need to open only perpendicularly to the 
bilayer. However, in the case of integral transmembrane 
proteins, it would need to open in two dimensions, 
perpendicularly to the membrane, so the domain of the protein 
can pass through and. into the plane of the membrane, to allow 
another domain, the possible transmembrane one, to move 
laterally into the lipid bilayer (Simon and Blobel,1991) . 
Blobel (1980) suggested that the protein conducting channel is 
formed by subunits that dissociate after translocation of the 
polypeptide, leaving the transmembrane segment embedded in the 
bilayer. Another possibility is suggested by Singer and 
colleagues (1987), where the channel structure remains intact 
and allows the transmembrane segment to slip between two of 
its subunits.
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Figure 1.2 - Schematic representation of a mechanism for
translocation of a soluble polypeptide across the protein- 
conducting pore in the ER membrane. The transition from a to b  
represents the translocation of a nonhydrophobic sequence 
vertically across the pore to the opposite side of the 
membrane (secreted proteins). The transition from c to d 
represents the translocation of a hydrophobic sequence 
horizontally into the lipid bilayer (integral membrane 
proteins) (From Singer and Yaffe, 1990) .
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1.4 The length of the transmembrane region
As mentioned before the transmembrane region is one of the 
stop transfer sequences of a polypeptide chain; the
orientation of a membrane protein within the membrane would 
depend on a direct interaction of the protein with the lipid 
bilayer. Blobel (1980) characterized these segments as at 
least 20 uncharged amino acids with a largely hydrophobic 
character. Tanford (1978) and von Heijne (1981) pointed out 
that a 20 residue long segment in an a-helix gives a peptide 
30 nm long, which is a sufficient length to penetrate the 
hydrophobic core of a membrane 3nm thickness. However, when 
transmembrane sequences of several membrane proteins are 
examined this length varies from 17 amino acids like HLA-B7 
(Sood et al., 1985) and the p subunit of the T cell receptor 
(Hedrick et al., 1984), to 26 amino acids, like CD2 (Sayre and 
Reinherz, 1988).
Truncate forms of membrane proteins with short TM segments, 
showed different anchoring properties related to the 
different lengths. The bacteriophage fl gene III protein 
(pill) has a TM 23 amino acids long, deletions in this segment 
produced mutants with TM sequences of 4,6,11,12,13,16,17,20 
and 22 amino acids long (Davis et al., 1985; Davis and Model,
1985) . A loss of anchor function was observed -fo-^  the
mutant 4 amino acids long, mutants 6 to 13 showed a residual 
membrane association , and mutants 16 to 22 were still able 
to anchor the protein as the wild type. Adams and Rose (1985b) 
in a similar experiment, shortened the TM region of the VSV 
glycoprotein from 20 amino acids long (wild type) to 18, 16,
14, 12 and 8 amino acids. By indirect immunofluorescence it
was observed that the mutants 18 to 14 were transported to 
cell surface and the others (12 and 8) seemed to span 
intracellular membranes, because they showed a Golgi-like 
region stainning pattern. From these two deletion experiments 
it was concluded that a TM consisting of 14 residues is able
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to stabilize a protein membrane interaction and it is also 
possible to postulate that if the membrane has fixed 
dimensions, the shorter TM domains have a more extended 
structure than a a-helix (Adams and Rose, 1985b), on the other 
hand, the membrane could be locally deformed to accomodate a 
shortened hydrophobic core (Davis et al., 1985).
2. Processing of polypeptide chain into the ER
2.1 Protein folding
To be transported and to become functional, most of the 
proteins have to acquire a mature form, and a series of events 
are responsible * for cleavage, folding, oligomerization
and covalent modifications. Most of the oligomeric proteins 
have to oligomerize to become "transportation competent" to be 
correctly transported through the secretory pathway. Anfinsen 
(1973) demonstrated the spontaneous refolding of ribonuclease 
in vitro, and established that amino acid sequence dictates the 
final conformation of a protein. Several studies of refolding 
in vitro suggests that this process is initiated by collapse 
of hydrophobic regions into the interior of the molecule, 
forming the prefolded state, formation of stable secondary 
structure,and formation of covalent interactions, the 
disulphide bo nds, which stabilize the polypeptide in 
particular conformation. These events result in an 
intermediate state, with significant secondary structure, but 
it lacking the well defined tertiary structure. Although, there 
is some evidence to support this mechanism, it is important to 
notice that in vitro experiments do not reflect the real 
folding process of a nascent polypeptide chain in a cell. In 
comparison to folding in vivo, refolding in vitro is very 
inefficient, it requires different protein concentrations and 
physicochemical conditions involving the whole polypeptide 
chain.
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A s  d i s c u s s e d  b e f o r e ,  t h e  t r a n s l a t i o n  o f  m o s t  p r o t e i n s  o f  t h e  
s e c r e t o r y  p a t h w a y  i n  m a m m a l i a n  c e l l s  o c c u r s  o n  m e m b r a n e  b o u n d  
r i b o s o m e s .  A c c o r d i n g  t o  t h e  s i g n a l  h y p o t h e s i s ,  t h e  f o l d i n g  
p r o c e s s ,  i n  m o s t  o f  t h e  p r o t e i n s ,  s h o u l d  o c c u r  
p o s t t r a n s l a t i o n a l l y . It  i s  p o s t u l a t e d  t h a t  t h e  f o l d i n g  o f  a 
p r o t e i n  c a n  n o t  o c c u r  s e q u e n t i a l l y  a s  t h e  a m i n o  a c i d  r e s i d u e s  
e m e r g e  f r o m  t h e  r i b o s o m e ,  b u t  o n l y  w h e n  t h e  c o m p l e t e  p r o t e i n  
is a v a i l a b l e .  T h i s  a p p l i e s  t o  s o m e  p r o t e i n s  s u c h  a s  i n  r a t  
s e r u m  a l b u m i n  a n d  m o u s e  l i g h t  c h a i n ,  w h e r e  i n t r a c h a i n  o r  
i n t e r c h a i n  d i s u l f i d e  b o n d s  w e r e  s h o w n  t o  b e  f o r m e d  w h e n  
f o l d i n g  is n e a r  c o m p l e t i o n  ( B e r g m a n  a n d  K u e h l ,  1979; P e t e r  a n d  
D a v i d s o n ,  1982). H o w e v e r ,  i n  t h e  c a s e  o f  l a r g e r  p r o t e i n s ,  w h e n  
t h e  c a r b o x y - t e r m i n a l  is s t i l l  b e i n g  s y n t h e s i z e d ,  t h e  a m i n o  
t e r m i n a l  d o m a i n  m a y  h a v e  a l r e a d y  s t a r t  t h e  f o l d i n g  p r o c e s s  
( B r a c k m a n  e t  al, 1991; W e t t l a u f e r  a n d  R i s t o w ,  1973).
An efficient folding process requires an antifolding activity, 
that prevents folding during synthesis and before 
translocation. There are a series of polypeptide chain binding 
proteins, also called molecular chaperones (Ellis, 1987; 
Ellis et al, 1989) that have a wide range of functions like 
stabilization of unfolded polypeptide chains before 
translocation, rearragement of protein oligomers, dissolution 
of protein aggregates and degradation of rapidly turned-over 
cytosolic proteins. They can be divided into three families, 
hsp70, hsp90 and chaperonin (groEL/hsp60), all of them are 
found both in eukaryotes and prokaryotes (Gething and 
Sambrook,1992)
The hsp70 family, in mammalian cells, consists of cytosolic 
proteins hsp70, hsc70 (p73, clathrin uncoating ATPase), prp73 
(peptide recognition protein 73) and the ER protein BiP (grp 
78) . They are strongly inducible by heat shock and they 
contain typical amino-terminal targeting sequences that
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directs their sorting to the correct membrane compartment. 
They exhibit a conserved mechanism of action, in the way that 
they present a differential recognition of targeting 
polypeptides, modulating either their conformation or state 
of assembly, they imply an ATP binding and/or hydrolysis 
interaction, when it is the case, they require other heat 
shock proteins or cellular factors and depending cnrx. the 
cellular compartment, the accumulation of unfolded proteins 
can cause induction of synthesis.
The Hsp70 proteins present in the lumen of the ER, interact 
with nascent polypeptide chain, maintaining them in a loose 
conformation. This was confirmed by Beckman and colleagues 
(1990) who found , using antibodies direct against hsp70, that 
newly synthesized chains associated with expressed hsp70 in 
the cytosol of HeLa cells. That it also maintains protein 
precursors in a translocating-competent conformation, destined 
for translocation across the ER membrane (Chirico et aL, 1988/ 
Deshaies et al, 1988/ Zimmerman et al., 1988) .
The lumen of the ER contains an hsp70 protein type which was 
firstly identified by its association with immunoglobulin 
heavy chain in pre-B cells. It is known as BiP, for binding 
protein (Haas and Wahl, 1983) and as grp78, because it is
induced by glucose starvation (Munro and Pelham, 1986). It is
■ • • , a
r e t a i n e d  m  t h e  E R  a g a i n s t  s e c r e t i o n  b e c u s e  o f  t h e  K D E L  m o t i f
in the C-terminal sequence (Munro and Pelham, 1987). It has an
important function in oligomeric assembly of proteins in the
ER, proteins incompletely folded, modified or nonassembled in
the ER are found as complexes with BiP. The accumulation of
misfolded or mutants proteins in the ER induces synthesis of
BiP (Kozutsumi et al, 1988, Normington et al, 1989/ Rose et
al, 1989) . As a rule in the secretory pathway, proteins must
fold and assemble before leaving the ER. So, the main function
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of BiP could be either to retain normal proteins until 
assembly with other subunits is complete, as's the case of 
immunoglobulin heavy chains ujWh. remain bound to BiP 
awaiting the synthesis of light chain necessary for assembly 
(Bole et al, 1986) or to prevent abnormal proteins from
leaving the ER by channeling them into the ER degradation 
system. There is also another protein that can act like a 
assembly factor, i.e., it is found associated with partially 
assembled oligomeric proteins in the ER and not in the final
oligomeric structure. It is a 28 Kd polypeptide, TRAP, which
interacts transiently with assembly intermediates of the T-
cell receptor (Bonifacino et al, 1988) .
Most of the members of Hsp70 family do not interact with 
defined sequences motifs, they present a broad pattern of 
polypeptide recognition, which allows them to participate in 
many cellular processes. Rothman (1989) suggested that Hsp70 
proteins interact with chain segments only if they are part 
of unfolded structures, or if they extended as loops from 
folded proteins; they do not associate, with native protein 
structures. Pelham (1986, 1988) proposed an interaction of
Hsp7 0 with hydrophobic residues exposed by unfolded or 
partially denatured polypeptides, Flynn and colleagues (1991) 
point out that charged residues and prolines were excluded 
from the binding site. So the cytosolic hsp70 should bind to 
segments of nascent chain, preventing or delaying misfolding 
and aggregation during synthesis and maintaining the emerging 
sequences from the ribosome in an extended conformation, in 
order to produce after synthesis a ~ stable—  loose 
conformation equivalent of the translocation-competent state.
Hsp 70 family members do not require ATP for binding, but 
their release from unfolded proteins or peptides is dependent 
on ATP hydrolysis (Flynn et al, 1989, 1991). Addition of ATP
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to cell extracts causes dissolution of complexes between hsp70 
proteins and polypeptide substrates, as demonstrated in hsp70 
and heat-shocked nuclei (Lewis and Pelham, 1985), hsc70 and 
mutant forms of the cellular p53 protein (Clarke et al.,
1988), and BiP and immunoglobulin heavy chain (Munro and 
Pelham, 1986).
Once the polypeptide chain has translocated the ER membrane, 
the folding process occurs quite immediately, it proceeds 
vectorially domain by domain from the amino terminal to the 
C-terminal. Assembly of most of the protein is essential to 
their exit from the ER, incorrectly folded proteins tend to 
aggregate. Sorting signals, that are involved with right 
transport of the proteins through the secretory pathway, maybe 
encoded in sequences that are only recognized in the final 
dimensional structure of the molecule. A sequence of events 
involving enzymes and protein factors, will take place in the 
ER lumen.
First of all, removal of the signal sequence by signal 
peptidase, as it was discussed before, may help in a correct 
and rapid folding (Randall and Hardy, 1986). Protein 
disulphide isomerase (PDI) is also an important enzyme in the 
folding process, because it facilitates formation of 
disulphide bounds (Freedman, 1987) . This was observed by 
Bulleid and Freedman (1988) that restored cotranslational 
formation of disulphide bonds, in synthesized proteins using a 
cell free system, by reintroducing purified PDI into 
microsomes that have been evacuated of their lumen content by 
alkali or detergent treatment. The highly abundant and widely 
distributed proteins with peptidyl prolyl cis-trans isomerase 
(PPIase) activity, acts as "conformases", catalysing slow 
isomerization of X-P peptide bonds and can accelerate the 
refolding of proline containing polypeptides (Fischer and
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Schmid, 1990). Addition of asparagine-linked (N-linked) 
carbohydrate side chain by oligosacharide transferase, a 
process known by glycosylation, allows correct folding of many 
proteins (Schlesinger and Schlesinger, 1987). The acceptor 
peptide (Asn-X-Ser) is glycosylated by addition of a 
(Glucose) 3-(Mannose) 9-(N-acetylglucosamine) 2 complex onto Asn 
residue^. It seems to occur while the polypeptide is in 
an unfolded state, once the acceptor sites can be inacessible 
with the folding process. The glucose and manose residues can 
be trimmed later on in the Golgi, by glucosidases I and II, 
and a-mannosidase, respectively (Kornfeld and Kornefeld,
1985).
2.2 Protein oligomerization
Many secretory and membrane proteins consist of multiple 
subunits,i.e., they are oligomeric proteins. The efficiency of 
subunit assembly is an essential feature of the 
oligomerization reaction and subunit polypeptides must fold 
correctly to bind specifically and stably. VSV G protein is 
composed of three subunits and mutations in the external and 
transmembrane domains of it prevent correct folding of the 
monomers, resulting in accumulation of large aggregates in the 
ER (Adams and Rose, 1985b; Dorns et al, 1988). Other mutant G- 
proteins show that trimerization is necessary, but not 
sufficient for exit from the ER. Amino acid substituitions in 
the cytoplasmic domain, result in subunit assembly in trimers. 
However, the trimers were transported slowly and inefficiently 
from the ER, indicating that both domains must be correctly 
structured for efficient transport.
The T-cell receptor complex is composed by seven subunits, 
consisting of the disulphide-linked a-p heterodimer, the 
homodimer and the three noncovalently associated chains,
CD3^y, -8, and -e, all transmembrane polypeptides. In mature T
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cells, these chains are expressed on cell surface as a complex 
with a minimum stoichiometry of apySe^. PrW assembly is 
required for its expression on the cell surface and it occurs 
through a series of intermediates in the ER, which are 
associated with TRAP, an assembly factor, prior to assembly 
(Samelson et al, 1985/ Clevers et al, 1988) . Only heptameric 
TCR complexes are correctly transported efficiently from the 
ER to the medial Golgi of T cells and targeted to the cell
i
surface , the other partial complexes are degraded before 
reaching the cell surface (Sussman et al, 1988/ Minami et al,
1987).
Class I MHC antigens are dimers, formed by a transmembrane 
heavy chain and a peripheral subunit, p2-microglobulin. The 
secretion of the heavy chain depends on its assembly with p2-M 
(Krangel et al, 197 9/ Owen et al, 1980) . On the other hand, 
soluble p2-M can be secreted in the absence of heavy chain 
expression. An example supporting this observation was the 
constructed mutants of heavy chain, without cytoplasmic tail 
and transmembrane domain, (Zuniga and colleagues, 1983). 
These could assemble with P2-M and be secreted, indicating that 
the transmembrane domain is not important for the conformation 
of the extracellular domain. Miyazaki (1986a,b) analysed 
mutants of class I without heavy chain glycosylation sites or 
an internal disulphide bond. The assembly with p2-M 
intracellularly was observed in both cases, but secretion was 
inhibited. So assembly is required, but not sufficient for the 
transport of the heavy chains. A subunit can act as an 
assembly factor, but not be part of the final complex. This is 
the case of class II MHC antigens, that form a trimer in the 
ER consisting of a, p and invariant chains. The invariant chain 
is produced in excess and retained in the ER until assembly of 
a and p are completed, after transport to the trans-Golgi, it
the
will be removed from a P  complex (Owen et al, 1981) .
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In membrane proteins with a single membrane spanning sequence, 
extracellular and cytoplasmic domains fold independently of
each other and remain structurally independent. Although a 
notable diversity is observed in the primary and secondary 
structures of extracellular and cytoplasmic domains, 
transmembrane segments show some similarity in length and 
hydrophobicity. Transmembrane proteins are folded in a stable 
state independent of the mechanism of insertion into the 
bilayer, and has an important role in mediating
oligomerization, as it was demonstrated by Manolios and
colleagues (1990) in studies with T cell receptor. It was
observed that the association of the CD3 8-chain subunit of 
the T-cell receptor with the a-chain is influenced by the 
transmembrane sequence of the l a t t e r  one. In the case of 
multihelix transmembrane proteins, first each a-helix is 
folded in a stable conformation, influenced by hydrophobic 
effects and hydrogen bonding, then they assemble in a 
tertiary structure, whicW requires other factors like polar 
interactions, links between helices and to extra-membrane 
domains or other cytoskeletal proteins, interaction with 
prosthetic groups and packing effects (Bormann and Engelman, 
1992) .
2.3 Degradation system of the ER
I . vx.
Misfolded and misassembled proteins are produced continuosly; 
the more complex the structure, the larger the fraction of 
misfolded and incompletely assembled side products. Cells have 
developed mechanisms that prevent mistaken structures from 
reaching the cell surface or surviving within the cells. These 
mechanisms are regulated either by retention of newly 
synthesized proteins within the ER or selective degradation of 
abnormal proteins. From these observations, the presence of a 
degradation system in connection with the ER was postulated.
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The a-chain of the membrane protein nicotinic acetylcholine 
receptor was one of the earliest ER degradation system 
reported ( Merlie et al., 1982). The degradation of the
subunits of the TCR is much affected by their state of 
assembly, it seems that a selective degradation of unassembled 
or incompletely assembled TCR complexes ensures that only 
correct complexes reach the cell surface of T cells. Whereas 
the y chain is rapidly degraded when expressed alone, the CD3 e 
seems to be not suscetfble to such degradation. However, when 
they are expressed together in fibroblasts, in ati assembled 
way, they are quite stable and are retained in or close to the 
ER before their transport to the cell surface. (Bonifacino et 
al., 1989). On the other hand, when a, |3 and CD 3 5 chains of 
human TCR receptor are expressed in fibroblasts, they are 
rapidly degraded by a pre Golgi degradative pathway, but when 
these subunits assemble with the e and y chains, their 
degradation is inhibited (Wileman et al., 1990) . These 
observations suggests that two mechanisms exist to prevent 
transport of incomplete complexes to the cell surface: 
delivery of incomplete complexes to lysosomes and retention in 
the ER.
Lippincot-Schwartz and colleagues (1988) demonstrated the
existence of an independent proteolytic system for rapid 
degradation in studies with a and |3 chains of T cell antigen 
receptor (TCR), which is insensitive to drugs that block
it
lysosomal proteolysis. It was denominated nonlysosomal
M
degradative pathway, and serves as a more direct route for
disposing of newly synthesized TCR chains,* in this pathway 
proteins are degraded from the ER without transit through the 
Golgi. The site of this degradation system is uncertain, but
should be either within or closely related to the ER, in a
pre- Golgi compartment. Other systems of ER degradation ^>ere 
described, like H2 subunit of the asialoglycoprotein (Amara et 
al, 1989) and CD3-5 subunit in a cell hybridoma lacking the p
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chain (Chen et al., 1988), that share the same characteristics 
of this pre-Golgi, nonlysosomal degradation pathway.
HMG-CoA reductase is a example of a ER membrane whose
degradation can be regulated. Because it is the rate limiting 
enzyme for cholesterol biosynthesis, when the cholesterol
levels are high, the proteinlS rapidly degraded, iJhen. the
cholesterol levels fall, the stability of this protein is
recovered (Jingami et al., 1987). Apoliprotein B, also
degraded in the ER in a regulated way, depending on the
nutrients conditions, is either secreted as a lumenal
protein assembled into very low density lipoprotein particles 
or retained and degraded in the ER (Davis et al, 1990) .
2.4 Retention of proteins in the ER
The mechanism of retention of proteins in the ER has been 
shown to be mediated by a linear stretch of amino acids which
acts by binding to a specific receptor. This was firt
demonstrated by Poruchynsky and colleagues (1985) in one of 
the two SA11 rotavirus glycoprotein^ it was assumed that the 
second hydrophobic domain should contain a retention signal. 
Although later Stirzaker and colleagues (1987) found out
that the retention signal was in the hydrophilic portion of 
the N-terminal sequence. The transmembrane domain also can 
contain retention signals, Machamer and Rose (1987) observed 
that IBV El glycoprotein is targeted to the Golgi membranes. 
It has three transmembrane segments and it was found by 
deletion experiments that the first domain has a retention
signal. The cytoplasmic domain of an adenovirus E19 
glycoprotein, a transmembrane glycoprotein retained in the ER, 
had 9 amino acids deleted. The mutant form was shown to be 
expressed on the cell surface. So it was assumed that this 
protein also had a retention signal at its cytoplasmic domain, 
although it was not shown to be transferable to other protein
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(Paabo et al.,1987). None of these examples mentioned above 
exhibit an amino acid sequence that can be potentially 
recognized as a retention signal sequence. Munro and Pelham 
(1986) identified a C-terminal sequence KDEL on three lumenal 
resident ER proteins, grp78 (BiP), grp94 and PDI. When this 
sequence was deleted from BiP, a slow secretion of the protein 
from COS cells was observed and when it was transferred to the 
C-terminus of lysozyme, a secretory protein, the retention of 
this mutant in the ER of COS cells was verified. Proteins 
carrying this signal leave the ER, but they are retrieved from 
the Golgi or a pre- Golgi compartment. This sequence is both 
necessary and sufficient for retention. In yeast, this signal 
is modified to HDEL, proteins containing this signal, leave 
the ER, receive Golgi-specific carbohydrate modifications and 
are retrieved to the ER (Pelham et al., 1988). A receptor, 
encoded by the ERD-2 gene , mediate this recycling pathway 
(Semenza et al., 1990; Lewis et al., 1990). A mammalian ERD-2
homologue was identified by PCR ( Lewis and Pelham, 1990). 
Jackson and colleagues (1990, 1993) described an ER targeting 
motif in some ER type I transmembrane protein (adenoviral 
protein E3/19K). Mutational analyses . of the cytoplasmic tail 
of other membrane bound proteins demonstrated that two 
lysines positioned three and four or five residues from the C- 
terminus represent the retention motif. Arginines and 
histidines cannot replace lysines, suggesting that simple 
charge interactions are not sufficient to explain the 
retention.
A less specific mechanism appears to contribute to the
retention of proteins that lack this linear signal. It was 
demonstrated that conformation of newly synthesized proteins
determine whether they are transported or not out of the ER.
As it was described before in the ER degradation section, 
misfolded and misassembled proteins normally are retained in 
the ER prior to degradation associated with BiP ( binding
protein).
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2.5 Transport of proteins from ER, through Golgi to the cell 
surface
At any given time, the ER exhibits a large variety of newly 
synthesized proteins, some will remain retained in the ER, but 
the most of them will move to the Golgi. The transport of 
proteins through the secretory pathway seems to be a 
nonselective event, no specific transport signal has yet been 
identified. Palade (1975) proposed two mechanisms to explain 
both the specificity of protein export from the ER and the 
concentration of protein along the pathway. The
presence of receptors, in the regions where vesicles form, 
vjjWtcA recognize positive sorting signals in the proteins to be
"Ti l -^5 61 , ■ • i texported, !he other regulation process via negative sorting signal, 
so proteins necessary to the ER are retained. There are 
evidences that both mechanisms direct the rate of protein exit 
from the ER. Probably, proteins that exit the ER at high rates 
are concetrated at sites of vesicle formation, while others may 
move at a slower, bulk flow rate.
Fitting and Kabat (1982) studying expression on cell surface 
of two viral glycoproteins, Lodish and colleagues (1983) 
studying rates of secretion of five proteins by rat hepatoma 
cells and Scheele and Tartakoff (1985) studying the exit of
12 proteins from the ER in the exocrine pancreas, found that 
different proteins exit from the ER at different rates. This 
could be explained by different affinities for cisternal 
surfaces of the ER, and also because one or more "receptors" 
localized in the ER bind proteins and concentrate them in 
specialized regions where transport vesicles form.
Wiedland and colleagues (1987) measured the rate of bulk flow, 
by adding tripetides, 125I-labeled containing the acceptor
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sequence for Asn-linked glycosylation, to CHO and HepG2 cells. 
It was found out that the half time for secretion was faster 
then that of known proteins transported through the same 
pathway and no signal is necessary for rapid and efficient 
transport from the ER to the Golgi, or from the Golgi to the 
cell surface, once this transport occurs by default. This 
argument against retention signals was criticized by Rose and 
Dorns (1988), first because the glycosylated tripefcide might 
not be neutral, as required for bulk flow measurements, once 
it can interact with glycosidases. Also, because glycosylation 
affects protein folding and enhances the movement of
proteins from the ER.
Ectoplasmic, transmembrane and cytoplasmic domains of membrane 
proteins should contain transport signals, so their correct 
folding should allow correct transport from the ER. There are 
some studies that give good examples of this events. 
Cytoplasmic domains are important in promoting transport of 
some but not all proteins. Rose and Bergman (1983) deleted 
residues from cytoplasmic domain of the VSV G protein and 
observed a large reduction on half-time for exit from the ER, 
although this was not completely blocked. However, deletion of 
almost all cytoplasmic domain of the Semliki Forest Virus E2 
(Garoff et al., 1983), of the cellular H-2 protein (Zuniga et 
al.,1983), of the influenza HA (Doyle et al ,1986) or the Rous 
sarcoma virus glycoprotein (Perez et al., 1987) did not affect 
their expression on the cell surface. So it seems that there 
is no transport signal at the cytoplasmic domain , but because 
the deletion can reduce the half-time of exit from the ER, it 
probably can accelerate exit. But when the cytoplasmic domain 
is deleted and substituted by other amino acid sequence, a 
reduction on the transport rate to the ER is observed ( Wills 
et al., 1984; Doyle et al., 1985; Shida, 1986; Gething et al.,
1986), this suggests that an alteration on the sequence can 
affect the folding more than a deletion, resulting in a 
reduced transport rate.
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Once the protein has assumed its right conformation, it is 
packaged into vesicles and transported to the Golgi apparatus, 
where further maturation, recognition and sorting of the 
protein will occur. The rate of protein transport through the 
secretory pathway varies. It was found that most of the delay 
is between the ER and Golgi, maybe because proteins need to 
interact with specific receptors in the ER, and carbohydrates 
might form part of the recognition signal. Also because 
proteins can only be transported from the ER when they fold 
and oligomerize in a transport-competent conformation, 
different time of folding and oligomerization^reflected in 
different times of transport.
The Golgi apparatus is composed by membrane stacks, which are 
arranged in three distinct cisternae, designated cis, medial 
and trans, according to their orientation with respect to the 
ER. Secretory proteins migrate from one end of the cisternae 
to the other, and this intra-Golgi movement depends on a 
"competent state for transport". Vesicle movement within 
the cisternaes is vectorial. Receptors on the surface are
present to recognize vesicles budding from the preceding 
cisternae in the chain and vesicle fusion with the membrane of 
the acceptor cisternae occurs in order to release the contents 
into the lumen of the receptor cisternae. The cis-Golgi 
cisternae are where recognition and recycling of escaped ER 
proteins occurs. The proteins reach the trans-Golgi cisternae, 
from where different branches (constitutive, lysosomal, 
regulated, apical and basolateral) of the secretory pathway 
are formed, and the sorting events take place. This sorting of 
proteins is dependent on sorting signals, that also do not 
exhibit consensus sequence shared by proteins sorted in the 
same pathway, so again, these signals are provided either by 
secondary structures or conformational motifs instead of 
amino acids sequences (Pryer et al., 1992).
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Transport of proteins between membranes can be either by the 
biosynthetic pathway (regulated and constitutive secretion) or 
by the endocytic pathway (lysosomal secretion), in both the 
formation of vesicles is required. Vesicle formation can be 
mediated by a protein coat, as clathrin coat (Brodsky, 1988)/ 
by cargo molecules (Roman and Garoff,1985) and by changes in 
the membrane organization (Sheetz and Singer, 1974) . Newly 
synthesized lysosomal proteins carrying, lysosomal sorting 
signals, determined by mannose-6-phosphate (M6P) residues on 
N-linked core oligosaccharides, will be recognized by a 
specific receptor, packaged into clathrin-coated vesicles, 
divertecLfrom the constitutive pathway and enter the endocytic 
pathway for further delivery to the lysosome ( Kornfeld and 
Mellman, 1987). The constitutive pathway has default sorting 
and involves the secretion of proteins that lack sorting 
signals, accumulated in transport vesicles without protein 
coats (Guiard, 1985; Orci et al., 1986).
Membrane protein sorting into vesicles is also dependent on 
signals, which are usually found in the cytoplasmic domain
and they can be recognized by specific receptors of the
sorting machinery, ujVtigVi. guarantee their inclusion in the
membrane of a budding vesicle. The inclusion of single-
spanning transmembrane receptors into clathrin coated
endocytic vesicles is dependent on recognition of a
sorting signal by the cytoplasmic domain receptor. This was
theconfirmed by deletion experiments on cytoplasmic domain of 
transmembrane receptors that affected their endocytic uptake*
Ejca nuclei
are.' LDL receptor (Lehrman et al., 1985), polymeric IgG receptor 
(Mostov et al., 1986), transferrin receptor ( Rothenberger et 
al., 1987) and Fc receptor (Mieteinen et al., 1989).
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3. The focus of the project
As reviewed above, many properties of a polypeptide chain and 
mature form of a protein are involved in the mechanism in 
which an integral membrane protein is inserted into the 
membrane, translocated and transported to the cell surface. 
This project will focus on the two classes of topological 
determinants in membrane proteins, the transmembrane segment 
and the adjacent positively charged hydrophilic segment.
Previous work showed by immunostaining that viral membrane 
proteins with short TM segments are still able to span the 
membrane.(Davis et al, 1985/ Adams and Rose, 1985b; Doyle et 
al., 1986). It was pointed out that either the a-helix would 
extend its structure or the lipid bilayer would deformed to 
accomodate the hydrophobic core. However^little is known about 
the membrane anchoring properties of eukaryotic membrane 
proteins with short transmembrane domains. In particular, the 
ability of the protein to diffuse laterally in the lipid 
bilayer. This should contribute for the knowledge about 
associations of the a-helix and the lipid bilayer.
A second area of uncertanty concerns the role, if any, of the 
positively charged amino acid segment adjacent to the 
transmembrane region at the begining of the cytoplasmic 
domain. Some claim that this charge influences in the 
orientation of membrane proteins into the cell membrane by 
directing their own cytoplasmic localizaton. In proteins with 
one spanning domain, the signal sequence and hydrophobic 
segment, acting as start and stop-transfer signals, could 
already determined the orientation of the molecule into the 
cell membrane. Thus the positively charged segment could only 
be involved in the stabilization of the protein into the 
membrane. Most of the data presented until now is based on 
deletions and insertions of positive charges in critical
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locations. The substitution of this positive charged 
residues for something less positive, would help to clarify 
the importance of this charged segment in membrane protein 
orientation.
It was proposed for this project, that a series of mutants in 
the transmembrane and cytoplasmic region of an eukaryotic 
membrane protein woiad-'o&created. Deletions on the transmembrane 
domain and substitution of the positively charged amino acids 
adjacent to the C-terminal of the transmembrane sequence for 
something less positive woulcLbecarried out. The purpose of such 
experimentsvouictteto obtain more information about the minimal 
length of a transmembrane region and the role of the positive 
charged segment in a eukaryotic system.
As the CD2 system was already established in the laboratory 
where the project took place, the CD2 molecule was chosen as a 
model to study membrane protein structure. The strategy 
devised to develop this project was to create by mutagenesis 
truncate forms of CD2, shortening gradually its transmembrane 
region and substituting the positively charged segment. The 
localization of the mutant protein would be assayed by 
panning, to verify surface expression. Indirect
immunostaining with a panel of antibodies against different 
regions of CD2 external domain yj'oiiLk bring information about 
surface and intracellular localization. The interaction and 
mobility of the mutant protein in the lipid bilayer would. be 
investigated by photobleaching analysis. To determine if th^e 
mutant proteins will reach the cell surface in a functional 
state, rosetting experiments and immunostaining using 
antibodies to different CD2 extracellular domain epitopes 
would be carried out to check the integrity of such domain.
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4. CD2 as a model structure
CD2, the T-lymphocyte adhesion receptor, is a non polymorphic 
glycoprotein, also known as Til, LFA-2 and E rosetting 
receptor. It was originally denominated the sheep red blood 
cell receptor by its ability to form spontaneous aggregates 
(rosettes) with sheep erythrocytes (Brain et al., 1970/ Coombs 
et al., 1970/ Lay et al., 1971). Human CD2 enconding cDNAs 
were isolated by screening a expression library with antiserum 
against the purified, denatured CD2 antigen (Sewell et al.,
1986), by selection of CD2 epitope bearing COS cells 
transfected with pools from a plasmid expression library (Seed 
and Aruffo, 1987) and through the use of oligonucleotide 
probes based on NH2-terminal protein sequence (Sayre et 
al.,1987). Murine (Sewell et al., 1987) and rat (Williams et 
al., 1987) CD2 have also been cloned and sequenced. After 
removal of the signal peptide that is 24 amino acids long, 
their sequences predict proteins of 327 amino acids for human 
CD2 and 322 amino acids for murine and rat CD2. The CD2 gene 
is located on human chromosome 1 and murine chromosome 3 
(Richardson et al.,1988/ Ruddle et al.,1988). It is composed 
of five exons separated by four introns, spanning 15 Kb of 
the genome (Lang et al.,1988/ Diamond et al.,1988)
In human CD2, the 185 amino acids at the the N-terminus form 
the extracellular domain, 26 amino acids span the membrane as 
a transmembrane segment and the 117 amino acids at the C- 
terminus form the cytoplasmic domain, rich in proline and 
basic residues. Murine CD2 is 51% identical overall with the 
human CD2, it shows a higher degree of similarity with human 
CD2 cytoplasmic domain (59%) than with its extracellular (47%) 
or transmembrane (44%) domains. The histidine-proline 
cytoplasmic region is conserved within the 3 species of CD2, 
The unglycosylated protein is 36.9 KDa (Sayre and Reinherz,
1988), it contains three potential N-linked glycosylation 
sites in the mature protein (Bierer et al., 1989) which has a
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relative molecular weight of approximately 45-55 KDa, as 
observed on SDS-PAGE.
Structurally, CD2 consists of two imunoglobulin superfamily 
domains (IgSF), the first one , denominated domain 1, includes 
residues 1 to 103 and domain 2, that exhibits two disulphide 
bonds, include;, residues 107 to 180 (Fig 1.3A). A soluble two 
domain CD2 molecule (Tllex2) of all 180 residues from 
the extracellular sequence and 2 residues of the transmembrane 
region has been produced in a baculovirus expression system 
(Sayre et al. 1989) . Papain digestion of this segment produced 
a single-domain CD2 immunoadhesion molecule (Tllpap), which was 
purified and characterized (Recny et al., 1990) . Circular 
dichroism analysis of both forms predicted the presence of a- 
helix in these segments, so a pattern of alternating a-helices 
and p-strands for the extracellular domains of CD2, suggesting 
that CD2 molecule should be included in an a-P protein folding 
class. Jones and colleagues (1992) reported the structure of 
the soluble extracellular region of CD2 (sCD2) determined at 
2.8 k resolution (Fig 1.3B). It consists of two antiparallel 
b-barrels with immunoglobulin folds, domain 1 has a similar 
topology to immunoglobulin variable (v) domain and domain 2 
has both V-like and C-like features. These conclusion based 
on three dimensional data confirmed early comparisons based 
on primary sequence homologies of CD2 with immunoglobulin K -  
chain variable region hypervariable sequences (Peterson and 
Seed, 1987), human CD4 domain I and IV (Williams et al., 1987) 
and other nonimmunoglobulin members of the immunoglobulin gene 
superfamily (William and Barclay, 1988) . As is the case of 
LFA-3, BCM-1 (Kil ,en et al., 1988) and CEA (Oikawa et al.,
1987) the first domain lacks the disulphide bond.
Expression of CD2 initiated in the thymus, and is found 
expressed on nearly all resting or activated human T
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Figure 1.3A - A. Schematic structural diagram of native CD2
molecule. B. Diagram of CD2 gene, exon 1 corresponds to CD2
amino acids -24 to -5, exon 2 to residues -4 to 103, exon 3 to
residues 104 to 180, exon 4 to residues 181 to 221 and exon 5
to residues 222 to 327 ( according to Sayre and Reinherz,
1988).
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MOLECULAR STRUCTURE of HUMAN CD2
Structure of domains 1 & 2 is 
based on 2.8 angstrom 
structure of rat CD2 (Jones 
et al 1992, Nature 360:232- 
239). The representation of 
the leader, Tm and 
cytoplasmic domains is 
notional. Residue numbers 
count from the start of the 
mature polypeptide (TNAL..).
Domain 1
A 3- 9
B 13 -17
C 27-34
C : 39-45
C *: 50 - 53
D 57-60
E 64-67
F 76-84
G 89-100
Domain 2
A: 107-111
B: 116-120
C: 128-133
C': 136-140 
E: 144-148
F: 157-163 
G: 166-172
cvs-cvs bonds 
119-159 (B-F) 
112-176 (A/B-G/Tm
Figure 1.3B - Schematic diagram of CD2 external and
transmembrane domain according to structure of the soluble, 
extracellular domain of rat CD2 (sCD2) described in Jones et 
al., 1992).
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lymphocytes. One of its function is to allow thymocytes and 
mature T cells to adhere to thymic epithelium targetting
cells through another cell surface protein, CD58 or LFA-3, a 
ligand for CD2 on human cells (Selvaraj et al., 1987: Dustin 
et al., 1989) that is widely distributed on endothelial cells, 
thymic epithelial cells and most of blood cells including
erythrocytes (Krensky et al., 1983; Seed, 1987; Volger et al.,
1987) . This interaction, CD2/LFA-3, activated the thymocytes, 
promoting their differentiation. A second physiological ligand 
for CD2 was identified, CD59, a glycoprotein with complement- 
inhibitory function by monoclonal antibody inhibition studies 
(Deckert et al., 1992; Hahn et al., 1992a). By single amino 
acid substitution in region I and II, it was demonstrated that 
the binding site on CD2 for LFA-3 and CD59 are overlapping but 
not identical (Hahn et al, 1992a). The immunoadhesion 
functions of the CD2 molecule are likely to reside within the 
domain 1. Peterson and Seed (1987) by saturation mutagenesis
studies, SRBC rosetting assays and using 16 anti-CD2 
monoclonal antibodies, identified the epitope^ for this 
antibodies related with three distinct regions on the 
extracellular domain. In domain 1, region I is centred about 
Lys48 and it is involved in T-cell activation and adhesion 
function; region II is situated around Gly90 and it is involved 
in adhesion. In domain 2, region III is situated around Tyr135- 
Gln136 and is related with T-cell activation. CD48 is a related 
cell surface glycoprotein with a similar tissue distribution 
in rats to that of LFA-3 in humans, van der Merwe and 
colleagues (1993) shown that the rat CD 48 is a ligand for rat 
CD2 and that the N-terminal domain of the latter one binds CD48 
with a lower affinity tean CD2-LFA-3 interaction. The binding is 
independent of glycosylation, once the fusion SCD48-CD4 
(extracellular domain of CD48 and domains 3 and 4 of rat CD4) 
binds in solution soluble forms of rat CD2 (domain 1 of CD2) 
expressed in bacteria.
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CD2 also plays a role in the T cell activation pathway. The 
interdependence of CD3-Ti and CD2 molecules in the activation 
pathway of human T lymphocytes was demonstrated by induction 
of IL-2 gene and measurement of cytosolic Ca^+ in mutants 
which selectively express either CD3-Ti or CD2 on cell surface 
(Alcover et al.,1988). Brown and colleagues (1989) observed 
that cell surface CD2 molecules can be specifically co­
precipitated in association with the CD3-Ti complex, 
suggesting that they are physically associated. The histidine 
and proline rich, 117 amino acids long cytoplasmic region of 
CD2 is required for T cell activation, deletions in this 
segment (Chang et al., 1989/ He et al., 1988/ Hahn et al., 
1992b) and chimaeric constructs from rat CD2 cytoplasmic 
domain and rat CD4 extracellular and transmembrane sequences 
(Beyers et al., 1991) support this idea.
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CHAPTER 2 
MATERIAL AND METHODS
2.1 General material and methods 
Bacterial strains
The bacterial strains used in these studies were derivatives 
of Escherichia coli K-12
DS941 
MC1061/P3
JM109
BMH71-18 mutS 
NOVABLUE
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supE44, recF143, LacZ M15, laclq derived from 
strain AB 1157.
F”, araD139, (ara-leu)7679, (lac)Y74, GalY,
GalK,hsr”,hsm+, Strr (Casadaban and Cohen, 1980)
P3 is a single copy stably maintained 57Kb 
epis ome. It is derived from the "P" group of 
plasmids ( Windass et al, 1980) . It specifies 
resitantce to Km and carries amber mutated Tet 
and Amp resistance genes.
endAl, recAl, gyrA96, thi, hsdR17 (rk-,mk+), 
relAl, supE44,AT, A(lac-proAB), [F',tradD36, 
proAB, lacqZAM15] (Hanahan, 1985) .
thi, supE, A (lac-proAB), [mutS::TnlO] 
[F',proA+B+, laqlqZAMl5](Kramer et al.,1984)
endAl, hsdR17 (rk”'mk+) , supe44, thi-1, gyrA96, 
relAl, lac,[F1,proAB, lacqZAM15, relAl,
TnlO (tetr) ] recAl
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Plasmids
pCDM8 is derived from the cDNA expression vector prcH3, which 
is derived from pjiSV (Little et al., 1983). It is a 4.4Kb
vector and it was constructed by inserting a synthetic
transcription unit between the supressor tRNA gene and the 
SV40 origin. The transcription unit is a chimeric promoter, 
composed of the human cytomegalovirus (CMV) ADI69 immediate 
early enhancer sequence fused to the HIV long terminal repeat 
(LTR). Immediately downstream from the LTR, there is a
polylinker, and further downstream from this, the SV40 small 
tumour antigen and the splice and early region polyadenylation 
signals derived from pSV2 are located. The pCDM8 has no 
selectable markers for growth in E. coli, but it carries a 
supressor tRNA gene, supF. So , when it is transformed into 
MC10 61/P3, the supF complements the amber mutations and
confers Tet and Amp resistance to the cell.
pcDNAINeo (INVITROGEN) is an eukaryotic expression vector,
7.0 Kb long, derived from pcDNAI, which in turn is derived 
from pCDM8. Because it carries the neomycin resistance gene, 
it can be used for transient or stable expression of
recombinant proteins in mammalian cell. It also offer an 
enhancer/promoter sequence from the Rous sarcoma virus long 
terminal repeat (RSV LTR) for high level transcription.
pT7Blue (NOVAGEN) vector was designed for cloning of PCR 
products, based on two observations, that many thermostable
DNA polymerases, such as Taq DNA polymerase, leave single 3 1 
A-nucleotide overhangs on their reaction products (Clark, 1988) 
and these molecules can be ligated to a vector containing 
compatible single T-nucleotide overhangs (Marchuk et al, 
1990) . The vector was digested by EcoRV, generating two
blunted ends to which T-nucleotides were added creating T- 
nucleotide overhangs. This EcoRV belongs to a polylinker 
situated in the LacZ a-peptide, so disruption of this peptide
by the insert will produce white colonies containing the
recombinat plasmid.
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pAT153 plasmid vector(Twigg and Sherrat, 1980) is 3.6Kb long, 
it is a high copy variant of pBR322, because a Haell fragment 
from Col El was removed.
pSELECT-1 (PROMEGA) vector is a phagemid, defined as a 
chimeric plasmid containing the origin of a single-stranded 
DNA bacteriophage. It contains a multiple cloning site flanked 
by the SP6 and T7 RNA polymerase promoters and inserted into 
the lacZ a-peptide. Cloning of a DNA insert into this 
polylinker results in inactivation of the a-peptide, what 
facilitates the selection of recombinants. Although it carries 
gene sequences for both ampicilin and tetracycline resistance, 
it is ampicilin sensitive because a frameshift was introduced 
into this resistance gene by removing the Pstl site.
Microbial culture media
L-broth lOg tryptone, 5g yeast extract, 5g NaCl, lg
SOC medium 20g/l tryptone, 5g/l yeast extract, lOmM NaCl,
2.5 mM KC1, 10 mM MgCl2, lOmM MgSCU and 2mM 
glucose.
Antibiotics
L-agar
glucose and 20mg thiamine, made up to 1 litre in 
distilled water and adjusteito ph 7.0 with NaOH.
As L-broth, but containing 15g/l and no glucose.
Stock
solution
Solvent working
concentration
Ampicilin
Kanamycin
Tetracycline
G418
100.Omg/ml 
25.Omg/ml 
12.5mg/ml 
80.Omg/ml
Water 
50% ETOH 
Water
Water 100. 0p.g/ml 
50. 0|ig/ml 
12. 5|ig/ml 
400. Op-g/ml
45
Chapter 2 Material and Methods
Buffer solutions
TE lOmM Tris/HCl, lmM EDTA, pH 8.0
lOx TBE 0.90M Tris/borate, 0.20M EDTA pH 8.3
lOx TAE 0.40M Tris/acetate, 0.05M EDTA pH 8.3
Organic solvents
Phenol
Chloroform
Phenol was equilibrated to pH 7.6 by extracting 
with 1M Tris/HCl pH 9.5 for several times until 
the 1M Tris/HCl solution reaches pH 7.6. 
8-hydroxyquinoline (0.1%) was added as an anti­
oxidant and aliquots of phenol were stored at 
-20°C, under 0.1M Tris/HCl pH7.6.
Analytical grade chloroform was mixed with iso 
amyl alcohol (24:1 v/v) and stored protected 
from light at RT.
Ethanol Analytical grade ethanol and 70% ethanol used 
for DNA precipitation, were stored at 4°C.
Other solvents like , methanol, acetic acid, 
dimethylformamide, DMSO and isopropanol were of analytical 
grade, so they were stored at RT temperature and used 
directly.
Sterilization conditions
All growth media were sterilized by autoclaving at 120°C for 15 
min. Supplements, buffer solutions and calcium chloride were 
autoclaved at 108°C for 10 min. Heat-labile reagents were 
sterilized by filtration through disposable 0.2|im filter 
units (COSTAR). Plasticware was sterilized by autoclaving at 
120°C for 90 min and glassware underwent dry sterilization.
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Microbial growth conditions
Liquid culture of bacteria, for transformation and DNA 
isolation, were grown in L-broth at 37°C with vigorous shaking. 
Plates cultures were incubated overnight at 37°C, antibiotics, 
X-gal and IPTG were added as required. Stocks of the bacterial 
strains were made by making the liquid cultures (1 ml) 15% 
(v/v) with respect to glycerol and storing in a tightly sealed 
vial at -70°C.
2.2 Preparation of plasmid DNA 
Mini preparations of plasmid DNA
This preparation was used for characterization and subcloning, 
it was performed according to the lysis alkaline method, a 
modification of that described by Birnboim and Doly (1979).An 
overnight culture of 1.5 ml with plasmid containing clone in 
selective L-broth, was harvested by centrifugation (bench 
microfuge, 13Krpm, 40 sec, RT). The pellet was re suspended in 
GTE buffer and the cells were lysed by a treatment with a 
NaOH/SDS solution followed by 3.5M KAc. Chromosomal DNA and 
cell debris were precipitated by centrifugation (bench 
microfuge, 13Krpm,15min, RT). Contaminating proteins were 
removed by phenol extraction, the DNA was recovered by ethanol 
precipitation and further centrifugation ( bench centrifuge, 
13Krpm, 30min, 4°C) .
Solutions
GET
25mM Tris/HCL, pH8.0 
50mM Glucose 
lOmM EDTA pH8.0
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NaOH/SDS 3.5M KAc
0.2M NaOH 60ml 5M KAc
1% SDS 11.5ml Glacial acetic acid
28.8ml distilled water
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Large scale preparations of plasmid DNA
The DNA from this preparation was used for subcloning, double 
stranded DNA sequencing, as template for PCR reactions and in 
transfection experiments. This procedure is based on the 
modified alkaline lysis (mentioned above) combined with the
use of QIAGEN resin columns to purificate plasmid DNA (Joanne 
Crowe, 1992) . An overnight culture of 100ml L-broth with the 
required plasmid and selection, was pelletelby centrifugation ( 
Beckman centrifuge, 5Krpm, 5min, 4°C). The pellet was
ressuspended in buffer PI and the cells were lysed using 
buffers P2 and P3. After centrifugation, to remove cell 
debris and denatured protein, the supernatant was added to the 
column, which has been previously equilibrated with buffer
QBT. The contaminants of the preparation were discarded by 
washing the column with buffer QC. The DNA was eluted with
buffer QF, a phenol extraction was included at this step. The 
DNA was recovered by precipitation with 0.7 volumes of 
isopropanol and centrifugation at 4°C for 30min. The pellet was 
washed with 70% ethanol and re suspended in TE pH 8.0.
Buffers
100|ig/ml RNase A 
50mM Tris/HCl 
lOmM EDTA pH 8.0
PI P2
200mM NaOH 
1% SDS
P3
3.0M KAc pH5.5
QBT (pH 7.0)
750mM NaCl 
50mM MOPS 
15% ethanol 
0.15% Triton X-100
QC (pH 7.0) 
1.0M NaCL 
50mM MOPS 
15% ethanol
QF (pH 8.5) 
1.25M NaCl
50mM Tris/HCl 
15% ethanol
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2.3 Transformation of Escherichia coli 
Preparation of competent cells using CaCl2 method
50 ml of L-broth were inoculated with 1 ml of an overnight
"the.
culture and incubated with vigorous shaking until OD600 reached 
0.7. The 50 ml culture was put on ice for 10 min. The cells 
were harvested by centrifugation (Beckman centrifuge, 4Krpm, 5 
min, 4°C) . The pellet was resuspended on 20 ml of 50 mM CaCl2, 
left on ice for 20 min and centrifuged again at the same 
conditions. At this stage, the pellet was resuspended on 2 ml 
of 50 mM CaCl2 and 1 ml of 50% glycerol/CaCl2, it was aliquoted 
and freezed immediately on dry ice. An aliquot of 300 jxl was 
used in each transformation.
Transformation of DNA into competent cells
Vector DNA (20ng in 20^1)was added to an aliquot of competent 
cells, gently mixed and maintained on ice for 30 min. 
Following this, the cells were heat sh5ked at 42°C for 2 min 
and placed on ice for another 2 min. L-broth (1 ml) was added 
to the cells and incubation continued at 37°C for 1 hour. The 
cells were plated on selective L-agar plates and incubated 
overnight at 37°C. A selection of transformants from these 
plates were picked for DNA isolation and anal/sys.
In the case of NOVABLUE competent cells there was some 
modifications on this transformation procedures because they 
are high efficiency competent cells. An aliquot of 20^1 of 
cells was used per transformation, they were heat shocked for 
only 40 sec and 80p,l of SOC buffer was added to each aliquot. 
After 1 hour incubation at 37°C, another 300|ll of SOC buffer 
was added, the cells were pla ted on selective L-agar plates 
with IPTG and X-gal indicators and incubated overnight at 37°C.
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2.4 DNA purification procedures
Phenol/chloroform extraction to remove proteins from DNA 
samples
Contaminating proteins were removed from DNA samples by 
sequential extrition with phenol/chloroform (1:1 v/v) and 
chloroform/isoamyl alcohol (24:1 v/v). The DNA samples were 
mixed with equal volumes of these solvents by vigorous 
vortexing. Phase separation was enhanced by centrifugation in 
a bench microfuge for 15 min. Protein separated into the 
phenol phase while the DNA remains in the aqueous phase. 
Residual phenol was reextracted by chloroform and residual 
organic solvents dissolved in the aqueous phase were removed 
during ethanol or isopropanol precipitation.
Ethanol precipitation
This procedure was used in order to remove salts from the DNA 
and to concentrated the samples after preparation of plasmid 
DNA. A l/10th volume of 2.5M sodium acetate pH 5.2 was added 
to the DNA sample, followed by two volumes of absolute 
ethanol. The mixture was stored at -20°C for 30 min and 
centrifuged for 15 to 30 min at 4°C (bench microfuge, 13Krpm). 
The excess salt was removed by repeatedly washing the pellet 
with 70% ethanol. The DNA pellets were vacuum desiccated and 
resuspended in TE pH 8.0.
Isopropanol precipitation
In this procedure no salt is required to induce precipitation, 
provided the DNA concentration exceeds 70|ig/ml. Because^has 
the advantage of precipitating the DNA in a smaller final 
volume (0.6 vol), it is commonly used to concentrate DNA 
after large scale preparation of plasmid DNA, although it also 
precipitates proteins with higher efficiency. Isopropanol was 
added, at the required volume, to the DNA sample. The mixture
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was vortexed and allow to stand at RT for 10 min, followed by 
centrifugation (bench microfuge, 13Krpm, RT, 15min). The DNA 
pellet was washed with 70% ethanol, to remove any trace of 
isopropanol and facilitate rapid dessication of the pellet.
2.5 DNA gel electrophoresis 
Agarose gel electrophoresis
Agarose gels electrophoresis was used to separate and analyse 
DNA fragments. Electrophoretic mobility of linear double­
stranded DNA is inversely proportional to logio of the number 
of base pairs. Because there is a relationship between the 
logarithm of the electrophoretic mobility of DNA and the gel 
concentration, it is possible to resolve a wide size range of 
DNA molecules by using gels of diferent concentrations. The 
molecular weights of DNA fragments were estimated by 
comparison with DNA standard, of known molecular weight, 
electrophoresed on the same gel.
Depending on the size of the fragments being separated and the 
degree of resolution required, agarose gels of diferent sizes, 
concentrations and applied voltage were used. The agarose was 
dissolved by boiling in IX running buffer and EtBr (lOmg/ml) 
was added to a final concentration of 0.5|ig/ml. The DNA 
samples were mixed with l/10th vol of 6X loading buffer prior 
to loading and electrophoresis.
6X Loading dye
0.25% bromophenol blue 
0.25% xylene cyanol FF 
30% glycerol in water
51
Chapter 2 Material and Methods
Visualisation and photography of the gels
DNA fragments were visualised by UV-induced fluorescence of 
ethidium bromide on short (254nm), or medium (302nm) or 
long(366nm) wavelength transilluminators. Gels were 
photografed using a polaroid camera loaded with polaroid 545 
or 667 type lan film and fitted with a Kodak Wratten filter 
n9.
2.6 Isolation of DNA fragments from agarose gel
Purified DNA fragments were used for enzymatic
manipulations and in PCR reactions. The success. of
these reactions depend very much on the quality of these
fragments and in order to minimize the presence of impurities, 
ultra pure agarose was used and all gels were formed and run
in TAE buffers, as the presence of residual borate ions from
gels run in TBE can inhibit the efficiency of enzy.natic
reactions.
Electroelution
The digested DNA was run on a TAE gel and the required
fragment was sliced from the gel under long wavelength UV
light (to reduce photo-nicking of the DNA). The gel slice was
placed in a buffer-filled (200^1)dialysis tubing, clamped and
subject to electrophoresis at 100V for 30 min. By using a
hand-held long wavelength UV light, it was possible to follow
thw DNA migration out of the gel slice. When the DNA was
observed to have migrated to the buffer, the gel slice was
removed.from the dialysis tubing, wvmgH was resealed, placed
back in the gel tank and electrophoresis ' carried out for 2
min under reverse polarity to detach the DNA from the
dialysis tubing. The DNA solution was transfered to an 
-tote
Eppendorf, extracted with phenol chloroform to remove any 
residual agarose and ethanol precipitated to concentrate the 
sample. The pellet was resuspended in the appropriate volume
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of sterile water and an aliquot was run on a gel to check 
^concentration.
Isolation of DNA fragments by glass wool method
This glass wool method (Gannon et al., 1990) is recomended for 
fragments in the range 0.1Kb to 3.0Kb tat the recovery can be 
lower for fragments above this size. Initial amounts of DNA 
can be as low as 20ng and the recovery yields a small volume of 
eluate containing purified DNA . The DNA fragment required was 
sliced from the gel (TAE) and transferred to a punctured 
Eppendorf microcentrifuge tube that had., been plugged with 2-3 
mm of siliconized sterile glass wool. This is placed on the 
top of other Eppendorf tube in a two tiered system and 
centrifuged for 10 min at 6Krpm in a bench microfuge. The 
eluate containing the DNA fragment was collected in the bottom 
tube, the recovery of the fragment could be verified by 
examining its fluorescence under UV illumination. In order to 
purify the fragment from any possible agarose, the eluate was 
extracted by phenol/chloroform followed by an ethanol 
precipitation to concentrate the sample.
QIAEX agarose gel extraction
The DNA fragment was excised from the gel in a minimum size 
gel slice and its size was determined by weighing. The gel 
slice was solubilazed by adding buffer QX1 (300p,l/100mg of 
gel) . The QIAEX resin was added and mixture by vortexing. To 
solubilize the agarose, it was incubated at 50°C for 10 min, 
vortexing it briefly every 2 min. The sample was centrifuged 
and the pellet was washed two times with buffer QX2, and once 
with buffer QX3. The pellet was dried and he DNA was eluated 
from the pellet by resuspending it in TE, After 
centrifugation the supernatant was collected and ethanol 
precipitated to concentrate the sample.
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2.7 DNA manipulations
Digestion of DNA with restriction enzymes
Single digestions were performed using 0.2-5p.g of DNA, 5 units 
of enzyme per l|ig of DNA , compatible react buffer at l/10th 
of the reaction final volume. Normally they were carried out 
in a final volume of 20 |il at 37°C for 2 hours, unless 
otherwise stated. Multiple enzymatic digestions were carried 
out in the react buffer in which each enzyme retained at least 
50% of its activity. If no compatible react buffer was found, 
it was digested for one enzyme, followed by a ethanol 
precipitation prior to the second digestion. The volume of 
restriction endonuclease added should be kept to less than 
l/10th of the volume of the final reaction mixture, because 
the glycerol present in the enzyme storage buffer might have 
an inhibitory effect on the enzymatic digestion of DNA.
Ligation of DNA fragments
T4 DNA ligase catalyzes the formation of phosphodiester bonds 
between adjacent 3'-hydroxil and 5 'phosphate termini in DNA. 
It is able to join fragments with either blunt or compatible
cohesive ends. Theoretically, maximal ligation efficiency
theshould result when reaction contains equimolar concentration 
of the ends. However, cohesive end ligations require; a molar 
excess of the insert (3:1), and blunt end ligations, being 
less efficient require five-fold molar excess of insert. The 
molar ratios were adjusted according to the molecular size of 
the vector and insert. Ligation reactions were carried out in 
a final volume of 10 jxl, the total DNA concentration was 
0. 2jJ.g/|il, 1 unit of ligase (BRL system) , 2 |il of ligation
buffer (BRL system) and l|ll of lOmM ATP were added. They were 
incubated at the appropriate time and temperature depending 
of the nature of the fragments. Although its activity is 
optimal at 30°C, ligations between cohesive ends were carried 
out at 16°C, Whidr\ should allow adequate annealing of the DNA. 
Blunt ended ligations were carried out at 4°C -and it is
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considerably less efficient than cohesive end ligations. AfterWar^ 
l/10th of the ligation mixture was transformed irifcothe 
required cell strain and pla- ted onto selective L-agar plates.
Dephosphorilation of vector fragments
The vector was digested to completion withanexcess of the 
required restriction enzyme. The digested plasmid was run on a
gel and isolated by glass wool method, in order to avoid any
uncut DNA. The fragment was treated with CIP (Calf intestine 
phosphatase) to remove the phosphate groups and avoid 
religation of the vector. The sample (l(lg) was incubated at
37°C for 30 min, with 1 unit of CIP and 2 p.1 of CIP react
buffer, in a final volume of 20|ll. Another l|il of CIP was
added, followed by another incubation at 37°C for 30 min. To 
terminate the reaction the mixture was extracted with 
phenol/chloroform, then ethanol precipitated and res uspended 
in an appropriated volume of sterile water.
Filling recessed 3'ends of double stranded DNA
Filling of 3' recessed ends following digestion of DNA with 
restriction enzymes does not require either the inactivation
of the enzyme or altering the buffer. A completed digest, 
of DNA was incubated with l|il of 0.5mM dNTP mix and 1 unit of
Klenow polymerase, for 30 min at RT. The reaction was
terminated by addition of l|il of 0.5M EDTA and followed by 
phenol/chloroform extraction and ethanol precipitation.
2.8 PCR procedures 
Oligonucleotides
The oligonucleotides were synthesised on an Applied Biosystem 
PCR Mate.
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Oligo C 297721 - CD2 18 TM
5 1 ATA TGT GGA GGA GGC AGC CTC GTT TTC TAT ATC 3 1 
Oligo C 298696 - CD2 14TM
5 1 ATT GGC ATA TGT GGA GGA TTC TAT ATC ACC 3 1 
Oligo G 259949 - CD2 12TM
5 1 ATT GGC ATA TGT GGA TAT ATC ACC AAA AGG 3 ’
Oligo A 276056 - CD2 8 TM - Primer b
5' ATA TAT CCG ATG AGA TAG ATG TCC A 3'
Oligo G 248334 - CD2 8TM - Primer c
5 1 ATC TCA TCG GAT ATA TCA CCA AAA G 3 1 
Oligo A 298772 - CD2 10 TM - Primer b
5 1 ATA TAT CCG CCA ATG ATG AGA TAG A 3'
Oligo G 260354 - CD2 10 TM -Primer c
5 ’TCA TTG GCG GAT ATA TCA CCA AAA G 3 ’
Oligo A 276166 - CD2 +VE - Primer b
5' ACT CCT CTG TTG CTG TTG CTG GGT GAT ATA 3'
Oligo T 237916 - CD2 +VE - Primer c
5' TAT ATC ACC CAG CAA CAG CAA CAG AGG AGT 3'
Oligo T 257155 Primer d  ( pcDNAINeo, 2380 - 2397) 
5' AA ATC TCT GTA GGT AGT 3'
Oligo G 288024 Primer a (pcDNAINeo, 2070 - 2086)
5 1 ATT GAC GCA AAT GGG CG 3 1
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Oligo CD2B7 CD2 (556-551)
5 1 CCA CCA GCC TGA GTG 3'
Oligo 234920 CD2 (817-833)
5' TCA ACC CCT CAG AAT CC3'
Purification of oligonucleotides
This procedure gives high yields of de-salted oligonucleotide 
longer than 20 bases in a quantity greater than 0.1 OD. To 
360|ll oligonucleotide in ammonium hydroxyde, 40 p.1 of 3M
sodium acetate solution was added, to give 400^ .1 of 0.3M 
sodium acetate solution containing oligo and 1.2 ml of 
absolute ethanol. It was mixed by inverting the tube, left at 
-70°C for 30 min and centrifugated at 4°C for 30min (13Krpm) . 
The supernatant was removed as much as possible and the 
pellet was washed three times with 70% ethanol. The pellet 
was vacuum dried, resuspended in 100|ll of water and stored at 
-20°C.
PCR reaction conditions
The PCR reactions were carried out in IX react buffer, 0.2 mM 
dNTPs, ljig of template, 1|1M of each primer and 0.05 units of 
Taq polymerase in a final volume of 50|ll. Otherwise specified 
in the text, the conditions described below were used 
to obtain the PCR products. The PCR reactions were 
performed in a Hybaid "Omnigene".
Denaturing 94°C 1:30 min 1 cycle
Annealing 50°C
Extension 72°C
Denaturing 91°C
Annealing 50°C
Extension 72°C
0:30 min
1:30 min 30 cycles
1:00 min
0:30 min 1 cycle
15:00 min
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2.9 Mutagenesis experiments
A.Altered sites™ in vitro mutagenesis system (PR0ME6A)
This system consists of a mutagenesis vector pSELECT™-l and
"th€- , of
a procedure for selection oligonucleotide-directed mutants 
based on the use of a second mutagenic oligonucleotide that 
restores ampicilin resistance to the mutant DNA during 
the mutagenesis reaction. Both mutagenic oligos are annealed to 
the ssDNA template at the same time, followed, by synthesis of the 
mutant strand with T4 DNA polymerase and its ligation, linking 
the two. Afterwards, the mutant DNA is transformed into a 
repair minus strain of E. coli (BMH71-18 mutS), the cells are 
grown in the presence of ampicillin and a second 
transformation in JM109 ensures proper segregation of the 
mutant and wild type plasmid (Fig 2.1)
Preparation of phagemid single-strand DNA
The DNA fragment to be mutated was ligated to pSELECT-1. The 
ligation mixture was transformed into JM109 and plated on 
blue/white selective L-agar plates containing 15|ig/ml 
tetracycline, 0.5mM IPTG and 40jig/ml X-GAL. White colonies 
from the recombinant phagemid and the control vector (it had 
the lacZ gene disrupted by removing the Pst-1 site within the 
polylinker) were grown overnight in 2ml of L-broth, containing 
15|ig/ml tetracycline. The next morning 5 ml of L-broth 
(15|ig/ml tetracycline) were inoculated with 100^ .1 of the 
overnight culture. After 30 min of vigorously shaking at 37°C, 
the culture were infected with 40 p,l of helper phage R408, the 
incubation with shaking continued for another 6 hours. The 
supernantant were harvested 'centrifugation, twice at 12Krpm 
for 15 min, and precipitated with 0.25 volume of phage 
precipitation solution. The mixture was left on ice for 30 min 
and centrifuged for 15 min at 12Krpm. The supernatant .was 
aspirated and the pellet was resuspended in 400|il of TE. To 
lyse the phage, a chloroform/isoamyl alcohol extraction .was 
carried out, followed by several phenol/chloroform extractions
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Figure 2.1 
(PROMEGA)
mutagenic 
oligo
Recombinant ssONA 
template (Amps, Tetr)
1. Anneal ampicillin repair 
oligo and mutagenic oligo.
2. Synthesize mutant strand 
with T4 DNA polymerase 
and ligate.
Amp
3. Transform BMH 71-18 
mut S. Grow in media + 
ampicillin.
4. Prepare mini-prep DNA.
5. Transform JM109. Select 
mutants on ampiallin plates.
Screen for mutants by 
direct sequencing.
Diagram of Altered sites in vitro mutagenesis
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until the interface was clear. The upper aqueous phase was 
precipitated by adding 0.5 volume of ammonium acetate plus 2 
volumes of absolute ethanol. The mixture was centrifuged at 
12Krpm for 15 min, the pellet was washed with 70% ethanol and 
resuspended in 20|il of water.
5T Phosphorylation of oligonucleotides
The required oligonucleotide (lOOpmol), IX kinase buffer and 
T4 polynucleotide kinase (0.2 units/|il) were mixed to a final 
volume of 25|il and incubated at 37°C for 30 min. To inactivate 
the kinase the reaction was incubated at 70°C for 30 min, the 
products were stored at -20°C.
Mutagenesis procedures
The mutagenesis annealing reaction were performed with lOOng 
of ssDNA(0.05pmol), 2.2ng(0.25pmol) of ampicilin repair
oligonucleotide, 1.25pmol of phosphorilated mutagenic 
oligonucleotide and IX annealing buffer in a final volume of 
20p.l. In the control reaction the mutagenic oligonucleotide 
was substituted by 10.8ng of lacZ control oligonucleotide, 
which was used to repair the lacZ gene function disrupted at 
the pSELECT-1 control vector. Both reactions were heated to 
70°C for 5 min and allowed to cool slowly to RT. Subsequently, 
the annealing mixture was placed on ice and T4 DNA polymerase 
(10 units) and T4 DNA ligase (2 units) plus synthesis buffer 
was added to a final volume of 30|ll. The reaction was 
incubated at 37°C for 90 min and transformed into BMH71-18 
mutS, the cells recovered after 1 hour at 37°C, ampicillin to a 
final concentration of 125|ig/ml was added followed by 
incubation at 37°C for another 14 hours.
An alkaline-lysis mini preparation of plasmid DNA was carried 
out with 2.0 ml of the overnight culture. The final pellet was 
resuspended in 50|il and half of this was transformed into 
JM109. The cells were plated on L-agar plates containing 
125|ig/ml ampicillin and incubated at 37°C for 16 hours.
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Colonies were picked randomly, mini plasmid preparation and 
sequencing of mutants were carried out.
Phage precipitation solution 10X Kinase buffer
3.75M ammonium acetate, pH7.5 500mM Tris/HCl pH7.5
20% PEG-8,000 lOOmM MgCl2
50mM DTT
ImM spermidine 
lOmM ATP
10X synthesis buffer 
lOOmM Tris/HCl pH7.5 
5mM dNTPs 
lOmM ATP 
20mM DTT
B.Site-directed mutagenesis by overlap extension using the PCR
It consists in using complementary oligo primers that 
generate, by PCR, two fragments with overlapping ends (Ho et 
al., 1989). These fragments can be fused by denaturing and 
annealing, and reamplified by futher PCR reactions. As it is 
possible to generate mutations by incorporating changes into 
complementary oligos, the product from the second PCR 
reaction will be the mutated DNA fragment. The external 
primers ( referred as primers a and d in the text) hybridizes 
at one end of the required sequence, and the internal primers 
( referred as primers b and c) hybridizes at the site of the 
mutated sequence and contains the mismatched bases (Fig 2.2).
The first PCR products AB (using primers a and b) and CD 
(using primers C and D) were obtained following the 
conditions described before for PCR reactions. The whole 
sample (50|il) was run on a gel and band purified.by QIAEX 
method. The second round of PCR was carried out using 500ng 
of each first product as template and primers a and d, in 
order to purify the whole mutant fragment, the other reagents
10X Annealing buffer 
200mM Tris/HCl pH7.5 
lOOmM MgCl2 
500mM NaCl
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I
AD d e l e t i o n  p ro d u c t
Figure 2.2 - Schematic representation of site- directed
mutagenesis by overlap extension using PCR.
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were kept at the same concentration. The AD product were band 
purified by QIAEX method and used for further ligations to 
the required plasmid.
Screening bacterial colonies by PCR
10|il from an overnight culture was diluted With. 100|ll of
sterile water and boiled for 5 minutes to lyse the cells and
denature DNases. The mixture was centrifuged for 1 min
(microfuge, 12Krpm) . An aliquot of 10pl from the superna *ant
was used as a template in 50|il PCR reaction, the conditions
as
of the reaction were the same described before.
2.10 Double strand DNA sequencing
This was carried out using the Sequenase Version 2.0 system
(purchased from USB), described by Tabor and Richardson 
(1987) . The system is based on the chain termination DNA 
sequencing method, which involves the synthesis of a DNA 
strand by a DNA polymerase in vitro using a single stranded 
DNA template. The full method and reagents utilized are 
describemtheSequenase Version 2.0 protocols book.
Double strand«iDNA (5|ig) was denatured by incubating it with
denaturing buffer (0.2M NaOH, 0.2mM EDTA) for 30 min at 37°C.
The mixture was neutralized by adding 0.1 volumes of 3M sodium
acetate followed by an ethanol precipitation. The pellet was
resuspended in 7 |ll of water, 2|il of reaction buffer and l|ll
of required primer (1 pmol) . The annealing step was done at
65°C for 2 min, the mixture was left to cool slowly to nearly
30°C. Once it has reached the right temperature, the labeling
reaction was carried out by adding 1 |il of 0.1M DTT, 2 p.1
of diluted labeling mix (1:5), 0.5|ll of [a35S]dATP and 2jll of
diluted Sequenase(1:8) to the annealing mixture and it was
left at RT for 3 min. This labeling mixture was aliquoted to 4 
eaoW
tubes containing each 2.5|il of termination mix, a
solution of diferent dideoxynucleotides (ddNTPs). The
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reaction was stopped by adding 4|il of the stop solution to 
each termination reaction tube.
Analysis of the sequencing reactions was done on 
polyacrylamide gels (6%), run in IX sequencing TBE at
1500V. The samples were heated to 100°C for 2 min before 
loading, and because of the two dyes(bromophenol blue and 
xylene cyanol) of the stop solution it was possible to monitor 
the electrophoresis. Usually the gel was run until the 
bromophenol blue band reached the bottom of the gel. The 
plates were dismantled, the gel fixed in 5% methanol/5% acetic 
acid for 15 min and dried under vacuum for 1 hour. The dried 
gel was placed in a cassete adjacent to a sheet of Fuji RX 100 
film and exposed for 48 hours, at RT.
10X sequencing TBE buffer 1M Tris, 0.89M boric acid, 0.02M
EDTA, pH8.3.
Acrylamide stock 40% (w/v)acrylamide/bisacrylamide
(19:1)
Polyacrylamide gel 6% 15ml of 40% acrylamide, 50g of
UREA, 10ml 10X sequencing TBE, 
lml of 10% APS, 20p.l TEMED and 35 
ml of water to complete 100 ml.
2.11 Mammalian cell culture 
Cell lines
COS-7, derived from CV-1, transformed by an origin defective 
mutant of SV40, supports the growth of recombinant SV40
virus (Gluzman, 1981)
CHO.A2H, Chinese hamster ovary cells
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Cell culture media
For maintenance of the cells and transfections experiments, 
GMEM (Glasgow Modified Eagles Medium) medium was used. It was 
made from a 10X stock and the following supplements were added 
to 400ml of IX media:
300.0ml ddH20 
40.0ml 10X GMEM
13.4ml sodium bicarbonate (7.5% w/v)
4.0ml sodium pyruvate (lOmM)
4.0ml non-essential amino acids (100X)
4.0ml Penicillin/Streptomycin (10000 units/10000|ig/ml)
4.0ml L-Glutammine (200mM)(for COS-7 cells media)
Proline (for A2H.CHO media)
40.0ml FCS (Fetal Calf Serum) heat treated for 1 hour at 65°C
Non-essential amino acids (100X liquid)
g/i
L-Alanine 0.89
L-Asparagine 1.50
L-Glutamic acid 1.33
Glycine 0.75
L-Proline 1.15
L-Serine 1.05
The media was always filter sterilized to remove large protein 
and lipid precipitates, prior to use.
Cell culture conditions
All the cells were grown as monolayers in plastic tissue 
culture flasks (base area 25cm2) under 10ml of GMEM at 37°C in 
an atmosphere containing 5% carbon dioxide. When confluence 
was reached, the cells were diluted. The medium was aspirated, 
the monolayers were washed with 1XPBSA and the cells were 
detached by treating with IX Trypsin/EDTA (Gibco BRL) for 1 
min at 37°C. The cells were dislodged by tapping the flask, the 
trypsin was blocked by adding fresh medium to the flask.
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Several dilutions (1:10, 1:20 and 1:50) were made from the
cell suspension in 10ml of media and incubated at the usual 
grown conditions.
PBSA
8.0 gr of NaCl 
0.2 gr of KC1 
1.44 gr of Na2P04 
0.24 gr of KH2PO4 
1000 ml of dH20
Transfection of mammalian cells using CaP04 method
This method is described by (Davis et al., 1986) and used only 
for stable transfection of A2H.CHO. Basically, the DNA is 
presented as a calcium-phosphate DNA coprecipitate to the 
cell. The cells were plated, 24 hours before transfection, at 
3xl05 cells per dish (6mm), prior to transfection the media was 
changed. The coprecipitate is formed by mixing plasmid DNA 
(10|ig), 0.125M CaCl2 and IX HBS in a final volume of 1ml, the 
mixture was left at RT for 30 min, to allow the precipitate 
to form. The precipitated was mixed by pippeting up and down 
once and added slowly to the cells. After 48 hours, the cells 
were trypsinized, plated in another two tissue culture dishes 
and G418 selection started.
2X HBS buffer
1.5 mM Na2HP04 
lOmM KCL 
280mM NaCl 
12mM glucose 
50mM HEPES, pH7.0
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Transfection of mammalian cells using DOTAP method
This method consists in combine the plasmid DNA with the
cationic lipid N- [1-(2,3-Dioleoyloxy) propyl]-N,N,N-trimetyl- 
amoniummthylsulfate (DOTAP), in order to form a stable complex
that will adhere to the cell surface, fuse with the cell
"th©membrane and release the DNA into cytoplasm. The system used 
was purchased from Boehringer Mannheim Biochemica.
The cells were plated on 60mm tissue culture dish 24 hours
before transfection at 105 cells/ml per dish (6mm). The DOTAP 
solution was diluted to 5|ig/ml in HBS and added to 5|lg of 
plasmid DNA resuspended in 100|il of HBS. The mixture was left 
at RT for 10 min and applied gently to the cells, which were 
incubated for 16 hours. Afterwards the mediiun was replaced by 
freshw ^'A*wand after 72 hours the cell5 were harvested (in the 
case of transient transfection) or put under G418 selection to 
obtairi stable transfectants.
HBS buffer pH 7.4 
20mM Hepes 
150mM NaCl
Selection of stable transfectants
The mechanism of selection is based upon the cells sensitivity
to the aminoglycoside antibiotic G418. The resistance genes
are^Lomin^ and are located on both Transposons Tn601 (903) and
Tn5# ^^a^fects the function of 80S ribosomes and protein
£ resistance,
synthesis. When the coding sequences for gene are
arranged in a mammalian transcription unit to allow efficient 
expression and cointegrated with a desired gene, this chimeric 
gene confers resistance to G418 selecting for stable 
integration and expression of this desired gene, once it is 
stably integrated after transfection. The amount of G418 
needed for selection was established by a cytotoxicityassay. 
Cells were plated in a multiwell plate (103 cells/well) and 
diferent concentrations of G418 (200|ig/ml, 400|ig/ml, 600|ig/ml,
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800|lg/ml and 1000|ig/ml) were tested. After 10 days, the cells 
were stained with Trypan Blue (0.4% solution) and the
percentage of survival was calculated. For CHO the
optimal concentration was 800^ig/ml.
Stable transfection was performed on CHO cells, COS-7 cells 
are not appropriate ' for this purpose because they are. 
transformed with an origen defective SV40 genome, wKich 
increases the efficiency of replication overproducing foreign 
DNA sequences ^ iVtafc-.. is poison^to the cells, vy/hioto can not
tolerate high levels of extrachromosomally replication DNA. 
Because of this COS-7 cells were preferentially
used in transient transfection, wWre they can produce high 
levels of foreign DNA in a short time. After 10 days of
r\
selection of* transfected cells, . clones were lifted using
to-cloning rings and trypsin, and plated to multiwell plates were 
theyW grown until^reached . ' confluence. o They were
-ttan passed to tissue culture flasks (25cm2) and analysed. The 
frequency of transformed clone was calculated by the following 
formula:
% Frequency of = number of colonies after selection xlOO 
transformed clones number of cells plated for transfection
2.12 Panning experiments
This method was based on the protocol described by Wysocki and 
Sato (1978).
Preparation of panning plates
Falcon bacteriological plates (100mm) were coated with 
affinity purified Goat anti mouse IgG (Seralab, lmg/ml). The 
diluted antibody (10 ml of a solution of 3n.g/ml in Tris/HCl, 
pH 9.5) was added to each plate and allowed to bind for 5 
hours at RT. The plates were washed (3x) with 5ml of 0.15M 
NaCl, to remove the unbound antibody, and incubated overnight
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a
at RT with 5ml of lmg/ml solution of BSA/PBS, to reduce non 
specific binding. Next day, the BSA/PBS solution was 
aspirated, the plates were sealed in plastic bags and stored 
at -20°C.
Panning cells
cell
Transfected cells were harvestedwith PEA, the suspension was 
transferred to a falcon tube and pellete<3(MSE minor S benchtop 
centrifuge, setting 3.5 for 4 min). The cells were resuspended 
in PEA/5%FCS in a concentration of 2xl06 cells/ml and antibody 
added (1:10 dilution for anti-CD2 and 1:50 for anti-W632). The 
tube was agitated gently and incubated on ice for 30 min* To 
prevent cells from settling, it was periodically agitated. In 
order to remove the unbound antibody, the cell suspe^ion was 
submitted to a Ficoll density gradient. An equal volume of PEA 
was added to the cell suspension wVck . was layered on an 
equal volume of a PEA/2%Ficoll solution. The cells were 
centrifuged at the same conditions and the supernatant 
containing the unbound antibody was removed by aspiration. The 
pellet was resuspended in: 1ml of PEA and pipetted onto the 
panning plate containing 5ml of PEA/5%FCS. The plate was 
swirled gently to obtain an even spread of cells and left at 
RT for 3 hours. The unbound cells were washed with PBSA/5%FCS 
and the plates were analysed under a inverted microscope.
PEA 0.5mM EDTA
0 .02% sodium azide 
made up in PBSA
2.13 Resetting experiments
Transfected cells were haversted with PEA, centrifug. ,ed and 
res uspended in 250 |ll of PBSA/2% FCS. Sheep blood red cells 
(SBRC) were washed 2 times in PBS and incubated for one hour 
at 37°C with neuraminidase (0.2 unit/ml). The neuraminidase 
greatly enhances the SRBC specific binding and rosette
67
Chapter 2 Material and Methods
formation. After incubation the red cells were washed again 3 
times with PBS and 250 .^1 of a 0.5% suspension (v/v) was added 
to the cells. Firstly the mixture was incubated for 5 minutes 
at 37°C, centrifuged for 5 minutes (bench centrifuge, lOOOrpm), 
so the cell membranes were tightly together, and incubated for 
one hour at 4°C. The pellet was gently re.suspended and fixed 
with 3% glutaraldehyde for 20 minutes on ice. The tubes were 
ftlld.with water, inverted several times and centrifuged for 5 
minutes (1000 rpm). The cells were stained with 0.4% Trypan 
Blue solution, mounted on slides and analysed on a inverted 
microscope ^
2.14 Immunostaining of transfected cells 
Preparation of the cells
Transfected cells were grown in slide-flasks. After 24 hours 
they were washed in PBS, the slide-flasks were dismantled and 
the cells fixed in PBS/acetone (3:2) for 5 minutes at 4°C, 
followed by several washings in PBS to remove any excess of 
acetone and left to dry at RT.
Immunofluorescent staining
The slides were placed in a humid slide box and wetted with 
TBS/BSA . The appropriate dilution of the respective primary 
antibody was made in TBS/BSA (listed below). The slides were 
drained and the diluted primary antibody was added 
(100[il/slide), followed by a incubation of 30 min at RT. 
Thereafter, the slides were washed three times in a 
circulating bath of TBS. The slides were drained and the 
second antibody conjugated to FITC, previously diluted in 
TBS/BSA , was added (100|il/slide) . They were incubated for 15 
minutes at RT, washed and dried as described before. A cover 
slip was put over the cells with a 50% glycerol/TBS (v/v), 0.1% 
propidium iodide solution. The propidium iodide was added to 
help visualize the nucleus and damage cells. The slides were
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analised under a fluorescent microscope (Leitz).
Photomicrographs were obtained with a standard camera
attachment and EKTAR 1000 ASA film. The transfection
efficiency was calculated at this step, by counting the mean 
number of fluorescent green cells in a random field of view 
(minimum size of n=5) and expressing this as a percentage of 
total cell number, determined by the number of fluorescent red 
nuclei.
% efficiency = number of FITC stained cells (green) x 100 
total number of cells (red nuclei)
TBS
9.5g NaCl
50ml 1M Tris/HCl pH 7.5
q.s to 1 litre with distilled water
TBS/BSA 
3mg/ml BSA 
1XTBS
Primary antibodies used
Antibody Comments Dilution
W632 (Seralab) monoclonal antibody 
against HLA-A, -B, -C. 
IgG2a (mouse)
1:50
CD2RFT11 
(Brown et al., 
1987)
linear antibody 
used for immuno- 
staining and 
Western Blotting
1:10
CD2 (Seralab) IgGl (mouse) 1:10
CD2GT2 (Huet et al., 
1986)
IgGl (mouse) 1:100
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Secondary antibody used
Antibody Comment Dilution
Goat FITC anti-mouse conjugated 1:100
(Seralab) polyvalent
2.15 Western blotting analysis 
SDS-polyacrilamide gel electrophoresis
SDS-PAGE gels were performed on discontinues Laemli gels. The
cL'
resolving gel (10%) made up from 30% stock of acrylamide
(acrylamide:bis ratio is 30:0.8) diluted in 0.575M TRIS pH
8.8/0.1% SDS and polymerised by the addition of 0.1% APS and
0.05% of TEMED. A solution of 0.1% SDS was overlaid to avoid 
entry of oxygen (inhibitor of polymerisation) . Once this gel 
had polymerized, the SDS solution was removed from the 
surface, which was washed several times with water to remove 
any trace of SDS. The stacking gel (5%) was prepared by 
diluting acrylamide (30% stock solution) in 0.126M TRIS pH
6.8/0.1%SDS and also polymerized by addition of 0.1% APS and 
0.5% TEMED, and poured on the top of the resolving gel. The 
samples were diluted in final sample buffer (1:2) and heated 
at 100°C for 10 minutes, prior to loading. In the case of
'the, analysis of antibodies the non reducing-final sample buffer 
was used. The gels were always run on TRIS/Glycine buffer at1 .moLeu>,Lar
40mA for at least 30 minutes (depending on the weight of the 
protein). A marker of known molecular weights (Prestained SDS- 
PAGE Standard Solution, Sigma) were loaded at the same gel.
Electroblotting
The electroblotting procedures were carried out according to 
Towbin et al.(1979), with some modifications. After 
electrophoresis, the gel aparatus was disassembled and the gel 
was placed in a tray with BEB (Blotting electrode buffer). The 
gel and nitrocellulose were sandwiched between 3MM Whatman
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paper and placed in the electroblotting apparatus, w. ith the 
nitrocellulose side facing the anode, as proteins from 
reducing gels are negatively charged and migrate towards the 
anode. The electroblotting reaction were carried out in BEB at 
250mA with cooling  ^ and stirring for 1 hour. The
sandwich was the disassembled, the nitrocellulose washed twice
oin TBS/Tween and the gel stained with comassie blue to 
determine the efficiency of transfer.
Blotting electrode buffer (BEB)
25mM Tris/HCL 
192mM Glycine 
20%(v/v) methanol
Co%assie blue staining
After electrophoresis the gel were stained in a solution of 
0.1% Coomassie blue (1 hour to overnight, depending on the
concentration of the protein) and destained by washing the gel
in a solution of 40% methanol/10% acetic acid, until the 
background had cleared.
Coomassie blue stain 
0.1% Coomassie blue R-250 
made up in destain
Immunodetection of the proteins
The nitrocellulose membrane was incubated for 15 minutes at
RT in a solution of 5% dried milk/TBS-Tween to block the non­
specific protein binding sites. It was rinsed in three changes 
of TBS/Tween. The primary antibody (CD2 RFT11) was diluted in 
TBS/Tween (1:10) and added to the membrane in a plastic bag. 
The bag was sealed and incubated with gentle shaking for 1 
hour at RT. Following this, the membrane was washed as before, 
transferred to another plastic bag and incubated with the 
second antibody (alkaline phosphatase conjugated in 1:5000 
dilution) for 15 minutes, shaking as before. After this 
incubation, the membrane was once more washed in TBS/Tween.In 
order to develop the blots, the blots the membrane was
/
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10% acetic acid
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incubated with AP (alkaline phosphatase) color development 
solution for 3-5 minutes, until the bands appeared. The 
membrane was immediately placeiin the stop solution to avoid 
background.
AP color development solution 
10ml AP buffer
66|il NBT (nitroblue tetrazolium) (50mg/ml, 8% methanol)
33|ll BCIP (5-bromo-4-chloro-3-indolyl phosphate) (50mg/ml)
AP buffer Stop solution TBS/Tween
lOOmM Tris/HCl pH9.5 20mM Tris pH8.0 140 mM NaCl
lOOmM NaCl 5mM EDTA lOmM Tris
5mM MgCl2 0.1% Tween 20
2.16 Lateral mobility and fluorescence quantitation analysis 
Preparation of F(ab)2 fragment from CD2 MAb
This method is according to Harlow and Lane (1988), with some 
modifications because of the small quantity of antibody used. 
First the antibody was diluted with 20mM Na2PO4/10mM 
cysteine/lOmM EDTA pH 6.2 buffer to a final concentration of 
0.2mg/2ml and dialysed overnight against the same buffer. Next
day, the dialysed antibody was incubated with immobilised
papain (prewashed in the same buffer metioned before) for 5 
hours at 37°C with rocking. After that, lOmM Tris/HCl pH 7.5 
was added, the mixture was centrifuged and the supernatant was 
applied to a 5ml imobilised protein A column (previously 
equilibrated with 10 mM Tris/HCl pH 7.5). The column was 
washed with 1 ml of lOmM Tris/HCl pH 7.5, the eluted protein 
was the Fab fragment, To remove the Fc fragment and indigested 
IgG, the column was washed once more with 0. 1M Glycine/HCl pH 
2 .8 .
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Labeling of F(ab)2 fragment with FITC
The eluate was concentrated by freeze drying it, until l/10th 
of the volume (0.1ml), the concentration was calculated by 
measuring the absorbance, 1 OD28o of IgG is equal to 1.35mg/ml, 
and it was dialysed overnight in carbonate buffer pH 9.0. 
Fluorochrome isothiocyanate (FITC)/DMSO solution was added to 
a final concentration of 0.05mg/mg of antibody and incubated 
overnight at 4°C with rocking . The solution was dialysed for 2 
days at 4°C in PBS, in order to remove the excess of unbound 
FITC.
Ammonium sulphate precipitation
This method is described by Harlow and Lane (1988), with some 
alterations. The antibody was diluted in saline, 1:2 (v/v)
dilution. A saturated solution of ammonium sulfate pH 7.2 was 
added to bring the final concentration 45% saturation. The 
mixture was left stirring for 30 minutes and centrifuged for 
15 minutes at 5000rpm, 4°C. The precipitate was washed with
0.5ml of ammonium sulphate 45% saturated solution and 
centrifuged again at the same conditions. The precipitate was 
re suspended in 0.5ml of PBSA and reprecipitated with 40%
Swrnoniurvx 5u-iphate
saturated solution. After centrifuged and washed the 
precipitate was re.supended in 0.1ml of PBS and dialysed 
against 5 changes of PBSk . overnight at 4°C. The integrity of 
the antibody was checked by running 10ml of the dialysed 
solution on a SDS-PAGE gel under non reducim^ conditions. The 
concentration of antibody recovered was given by absorbance 
measurements at 280nm using a uv spectrophotometer, 1 OD28o f°r 
mouse IgG is equivalent to 1.35mg/ml. The FITC labeling was 
carried out as described before.
Preparation of the cells and staining
Stable transfected CHO cells were transfered to slideflasks 
(3X103 cells/flask) 24 ' hours before the experiment and
grown in media depleted of FCS. The slideflask was
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dismantled, the cells were washed with warm media without FCS, 
the required antibody was diluted (1:10) in the same media, 
applied to the cells and left for 60 minutes. The slide was 
washed 4 times with warm media with FCS and mounted with 100ml 
of media.
For control measurements the slides were stainedwith succinyl 
concanavalin A FITC conjugated, that is a probe specific to 
mannose and glucose. The cells were treated with 1:10 dilution 
of 200|ig/ml stock solution in PBS, and left for 30 minutes 
at 37°C. The cells were washed and the slide mounted as 
described before. Inhibitions assays with 0.2M Glucose and 
0.2M Mannose solutions were performed to confirm the 
specificity of the probe. Cells were treated with these 
solutions and labeled with succinyl Concanavalin A as before. 
To monitor the damage due to handling of the cells during 
staining and washing processes, the cells were labeled with 
Hoescht probe and propidium iodide.
Fluorescence quantitation
The Leitz MPV compact consists of a photomultiplier tube and 
control panel which allows quantitation of fluorescence from a 
defined area, which was fixed at 400^im2. For each group of 
readings an average background reading from a non fluorescence 
region of the slide was subtracted. The voltage across the 
photomultiplier was fixed at 500V and the mains current held 
constant by a Leitz steady current power pack.
Fluorescence Recovery After Photobleaching (FRAP) analysis
The biophysical technique of fluorescence recovery after 
photobleaching (FRAP) is used extensively in the study of 
lateral diffusion of plasma membrane components (Wolf, 1988). 
Fluorescence recovery after photobleaching (FRAP) denotes a 
method for measuring two-dimensional lateral mobility of 
fluorescently labeled molecules in regions of approximately 
10|im2 of a single cell. It is assumed that the molecules are in
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constant movement within the lipid bilayer. A small spot 
(1.5jim radius) of the cell surface containing fluorescent 
molecules is photobleached, causing the movement of the 
molecules out from this spot. As the fluorophore is 
photobleached at a wavelength which does not destroy the 
molecule, the rate of recovery of fluorescence and lateral 
mobility which results from transport of the fluorophore into 
the bleached region, can be monitored and measured. In FRAP, 
the molecule whose diffusion is to be measured must be
fluorescently labelled directly or indirectly in a non cross
linking manner. A laser bean is focussed using a modified 
fluorescence microscope to a small spot (approximately 1.2|im 
in radius) on the sample. The fluorescent molecules within 
this spot were excited, the fluorescence was detected by a
photomultiplier tube and the signal recorded. The laser bean
was briefly unattenuated for approximately 70ms which served
to increase the laser power by 104 fold and provide a bleach
pulse. As a result of this pulse a proportion of the
fluorophores (30-70%) in the spot were irreversibly bleached. 
This produced a reduced fluorescence intensity when examined, 
immediately after the bleach, with the attenuated laser bean. 
If there is no freedom of motion of molecules in and out of 
the spot, the fluorescence intensity will remain at this level 
ad infinitum, which is the condition of no diffusibility. If, 
however, there is complete freedom to diffuse in and out of 
the spot, the fluorescence intensity will return to the
prebleach level. The diffusion coefficient is obtained by 
fitting the recovery data to diffusion theory (Axelrod et al., 
1976). FRAP thus provides two measures of diffusibility: the 
fraction or percent of the molecules free to diffuse (%R or 
the percentage of recovery), and the diffusion coefficient of 
that fraction (D).
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Instrumentation used in FRAP (Fig 2.3)
The laser (light amplification by stimulated emission of 
radiation)
A 1.0W LEXEL MODEL 85 Argon ion laser was used (Lexel Corp, 
Palo Alto, Calif.), with a tap water cooling system, and 
adjusted for maximal first order diffraction at 488 or 514.5 
nm. Argon ion lasers produce the highest visible power levels 
and have up to ten lasing wavelengths in the blue and green 
portion of the spectrum. In addition to being monochromatic, 
laser light has a very defined mode structure. The fundamental 
mode, referred to as the TEMoo mode, is Gaussian in intensity 
profile.
The bean attenuator
The bleaching and measuring beam intensities are controlled by 
a method which uses a digital acoust-optic modulator (Model 
304D, Coherent Associates, Danbury, Connecticut) to attenuate 
the average intensity of the laser beam by variation of the 
on-off duty cicle. For example, to achieve an attenuation of 
104 the measuring beam is delivered as 10 |is pulses at 10Hz, 
whereas bleaching is achieved by an uninterrupted pulse of 
O.l-lOs (Garland, 1981).
Spatial filter
The spatial filter was obtained from Photon control, 
Cambridge, U.K. Spatial filtering is simply an opto-mechanical 
method of separating the wanted beam from the undesirable 
noise, and then mechanically blocking the unwanted noise.
Fluorescence microscope
The Leitz microscope (Ortholux), contains two secondary image 
planes. The first of these being where the objective focusses 
the specimen to a real image. This is usually about 170 mm 
above the objective in an upright microscope. A second 
secondary image plane is located also about 170 mm beyond the 
objective, only along the imaginary path of a ray reflectd 
back by the dichroic mirror. If the laser beam is focussed
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Fluorescence Recovery after Photobleaching 
Layout of apparatus Glasgow 1987
Oscilloscope
A.O.M.2
Laser Control Unit 
R 2 T  FrequencyI 
®  Width 9  *
Spatial
Curve
7. Pinhole To disc
1 1. COMPUTER
4. Microscope
MMflmazaaa 5. Heated Stage
1 . LEXEL MODEL 85 Argon ion laser HERTS. U.K.
2 . Acousto Optic Modulator 304D COHERENT U.K.
3 . Spatial Filter PHOTON CONTROL , CAMBRIDGE U.K.
4 Microscope LEITZ (Ortholux) , LUTON, BEDS. U.K
5 . Heated Stage LEITZ.
6 . Filters Leitz K530 , k590 .
7 , Pinhole 0.5mm Dept Nat. Phil. Workshop Glasgow Univ.
8 . PMT Photomultiplier tube Model 9924b THORN EMI U.K.
9 . Control Unit Dept. Electronic engineering Glasgow Univ.
1 0 Oscilloscope DIGITAL STORAGE MODEL 4035 GOULD U.K.
1 1 . Computer Hewlett Packard Model 82927A
Figure 2.3 - Schematic representation of the FRAP apparatus
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onto this image plane, it will also be in focus on the object 
plane.
Optical components
The complete FRAP apparatus is arranged on an optical table 
(Photon Control, Cambridge). Optical compnents are all mounted 
on optical rails (Oriel standard rails). Adjustable mirror 
mounts(Oriel model 1450) are used to align and direct the 
laser beam.
Control eletronics
The FRAP laser controller GUED 729 was designed and 
constructed by the Department of Eletronic Engineering, 
Glasgow University. The photomultiplier tube (P.M.T.) model 
9924b was obtained from Thorn E.M.I., UK, and powered by a 
Brandenburg P.M.T. power supply. The signal from the P.M.T. 
was collected by a Coherent P.M.T. signal collector model 304. 
A Gould digital storage oscilloscope type 4035 was used to 
"capture" the signal which produces the FRAP curve. A Hewlett 
Packard Integral Personal computer model 82927A, and plotter 
model 7470A (supplied by Electroplan) were used to retreive 
the relevant information about the FRAP curve, using a Fortran 
program which was supplied by Dr John Birmingham.
Measuring the beam radius (spot size)
A variety of methods exists for performing these measurements, 
and the method of Thompson and colleagues (1980) was used. The 
photobleaching experiment is carried out on FITC-labelled BSA 
suspended in 95% glycerol at room temperature. A typical FRAP 
curve for FITC-BSA in 90% glycerol is shown in figure 2.4. The 
theoretical value for the diffusion of albumin in solution is 
6 x 10-7 cm2s_1 (Proudfoot, 1991) . By taking this theoretical 
value and the viscosity of glycerol at 37°C, the predicted 
diffusion coeficient was estimated. This value was calculated 
to be 7.5 X 10"9cm2s-1. This value was inserted into the 
diffusion equation:
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A random scatter of the residuals and their autocorrelation 
function around zero indicates a satisfactory fit of the 
calculated curve to the observations.
Figure 2.4 - FRAP curve for FITC-BSA in 90% glycerol.
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Dl = (w2/4t0.5)Y
Where y and t0.s can be obtained from the recovery curve and w 
is the required beam radius.
Lateral diffusion coefficient (D) and mobile fraction (%R) 
measurements
Lateral diffusion and mobile fraction were measured by 
fluorescence photobleaching and percentage of recovery. The 
apparatus used, preparation of the cells and antibodies were 
described before. All measurements were made at room 
temperature within 120 minutes of staining and with the 
following conditions:
Pulse frequency : 384 Hz
Pulse width : 10 |is
Bleach pulse : 70 ms
Pulse time : 25 ms
The quality of the fluorescence staining of the cells was 
verified under UV microscope. The photobleaching experiment 
was carried out in a modified fluorescence microscope, where 
the fluorescence field was restricted to the laser spot. The 
cells and points in the membrane were chosen under normal 
light. After, the light source was covered and the spot could 
be visualized. Due to these limitations, the membrane points 
that would suffer bleachi^had to be choosen randomly, without 
selection for intensity of fluorescence. An average of 4 
measurements per cell were taken. The data was stored on a 
disk and subsequently transferred to a Dec 10 main-frame for 
running the curve-fitting programe in Fortran. The data that 
could not be fitted into a curve was discarded by the 
computer. Such data should be due to movement of the cell 
while receiving bleaching. For each mutant, the mean and 
standard deviation was calculated. As the values of D.L. and 
%R are not a typical normal distribution, the means were
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compared by a non parametric Wilcoxon's rank signed test and a 
parametric student t-test.
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CHAPTER 3
RESULTS
3.1 Introduction
Leading from the discussion in Chapter I, the experiments 
were to confirm observations on the minimal length -of a Tm 
region is consistent with stable association with the cell 
membrane. Deletions in the CD2 TM region were therefore 
made, shortening it from 26 amino acids to 18, 14 , 12 , 10
and 8 aminoacids (Fig 3.1). The positively charged sequence, 
KRKKQR, at the beginning of the cytoplasmic domain of CD2, 
may play a role in anchoring the protein in the cell 
membrane. These amino acids were mutated to something less 
positive, QQQQQR, in order to demonstrate the importance of 
this segment in stabilizing the protein insertion into the 
cell membrane (Fig. 3.1). The construct CD2B7 (Hundal, 1991) 
was included in the experiments related with conformation of 
the external domain. It is an in-frame fusion of the external 
domain of CD2 to a foreign TM sequence (HLA-B7, 17 amino 
acids long), it has a "stalk" of 25 amino acids situated just 
before the TM region and a deletion of the last 8 amino acids 
from the CD2 external domain (Fig 3.1).
The mutagenesis was done by the altered sitestm in vitro 
mutagenesis system from Promega and site-directed mutagenesis 
based on overlap extension using PCR. Cells were transfected 
with the plasmid constructs to verify the cellular 
expression, possible targeting, changes in conformation and
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CD2 Transmembrane region 26 amino acids long (CD2 WT)
FPV^i-PRKaT.rtTYLIIGICr^GSLLMVFVALLVFYITlKRKKQRSRRNDEE
CD2 Transmembrane region 18 amino acids long (CD2 18TM)
FPVSrPFKGLDIYLIIGICGGGSLVFYimRKKQRSRRNDEE
CD2 Transmembrane region 14 aminoacids long (CD2 14 TM)
F. PVR CPF KGLClI YLIIGICGGFYI TlKRKKQR S RRNDE E
CD2 Transmembrane region 12 aminoacids long(CD2 12TM)
EPVSCPEKGLDIYLIIGICGYITKRKKQRSRRNDEE
CD2 Transmembrane region 10 aminoacids long(CD2 10TM)
EPVSCPEKGLDIYLIIGGYITKRKKQRSRRNDEE
CD2 Transmembrane region 8 aminoacids long(CD2 8 TM)
EPVSC PE KGLDtEYLIGYITKRKKQRS RRNDE E
CD2 with mutated positively charges (CD2+VE)
E PVSCPEKGLEgYLIIGICGGGSLLMVFVALLVFYIT QQQQ QRS RRNDE E
CD237 fusion
E P VRE F PVWP S GE E QRYTC HVQHE GL P KP L TL iGIJEPSSQ GAWAAV MClRRK 
(3 D2 S ta lk  o t 2 6 amino a c ids  TH
e x te rn a l domain
Figure 3.1 - Amino acid sequence of CD2 wild type and mutants 
with Tm region deleted from 26 amino acids to 18, 14, 12, 10 
and 8 amino acids respectively, mutant with cytoplasmic 
positively charged stretch (KRKKQR) substituted (QQQQQR) and 
CD2B7 construct
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mobility within the cell membrane of the CD2 mutant forms. 
The first approach was to verify surface expression of the 
mutants on transfected cells by panning experiments. Once 
this was established, the cellular localization of the mutant 
protein needed to be determined. Therefore, staining of the 
transfected cells with antibodies against CD2 and Western 
blotting were carried out. In order to show any alteration in 
the conformation of the external domain of CD2, the cells 
were stained with antibodies against different epitopes on 
the external domain. Also because this domain is related with 
the adhesion function of CD2, rosetting experiments were done 
to check the structure of the adhesion domain. The stability 
of the association of the mutants with the cell membrane was 
examined by photobleaching studies, where the lateral 
mobility and the mobile fraction of the molecule were 
analysed.
3.2 Construction of CD2 mutants
The CD2 mutants with Tm region 18, 14 and 12 aminoacids long
were made by The Altered Sites tm in vitro mutagenesis system
from Promega. CD2 full length cDNA fragment was obtained by 
digesting pCDM8CD2 (Hundal, 1991) with PstI and Xbal. The
1.5 fragment was band purified by electroelution and then 
ligated to pSelect digested with PstI and Xbal. The ligation
was transformed into E. coli (JM109) by CaCl2 method. The
recombinants were selected on tetracyclin plates with 
white/blue selection. Xbal and PstI digestions were carried 
out to confirm the presence of insert ( Fig 3.2) . Single 
strand DNA from the recombinant pSelect plasmid were 
prepared, and oligonucleotide primers were used to 
synthesize the mutant double strand DNA (Fig 3.3).
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CDM8
H I I I  / 
Xbal
/  Xbal 
f PstI
H I I I
P s t IX L  a l
H I I I
1600  b p
A
B
E I I I
B a i o H I ' H I I I
pSelect
Figure 3.2 - Cloning of CD2 wild type fragment into pSelect. 
A - Schematic representation of CD2 fragment excised from the 
construction CD2CDM8. B - Schematic representation of CD2 wild 
type cloned into pSelect by Xba-l/Pst-1 digestion. C 
Diagnostic digestion of pSelectCD2 wild type with Xba-1 and 
Pst-1 to confirm cloning. Lanes 1 to 10 showed 5.6 Kb and 
1.6 Kb fragments that corresponds to pSelect and CD2 wild 
type respectively. Lanes 11 and 12 represents the linearized 
pSelect (5.6 Kb) and lane 13, the uncut pSelect plasmid. Lane 
14 and 15 represents CD2CDM8 digested with Xba-l/Pst-1 and 
uncut CD2CDM8 plasmid respectively.
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CD2 18TM
OLIGO CD2 18TM
5' 3 *
CD2WT TM ATATGTGGAGGAGGCAGCCTC...................... GTTTTCTATATCACC
RTrTaTrTr&TrATTGGraTATGTGGAGGAGGCAGCCTCTTGATGGTCTTTGTGGCACTGCTCGTTTTCTATATCACCAAAAGG
deletion site
CD2 14TM
OLIGO CD2 14TM
5* 31
CD2WT TM ATTGGCATATGTGGAGGA.................................TTCTATATCACC
ATCTATCTCATCATTGGCATATGTGGAGGAGGCAGCCTCTTGATGGTCTTTGTGGCACTGCTCGTTTTCTATATCACCAAAAGG
deletion site
CD2 12TM
OLIGO CD2 12TM
5' 3'
CD2WT TM ATTGGCATATGTGGA...................................... TATATCACCAAAAGG
ATCTATCTCATCATTGGCATATGTGGAGGAGGCAGCCTCTTGATGGTCTTTGTGGCACTGCTCGTTTTCTATATCACCAAAAGG
deletion site
Figure 3.3 - Schematic representation of Altered Sites in
vitro mutagenesis . The template used in the 3 mutagenesis 
reactions was ssDNA from the pSelectCD2 construct. The oligos 
described before in Material and Methods are positioned as in 
the annelling reaction. The deleted fragment for each mutant 
is underlined. The dotted line represents the continuity of 
the primer.
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The mutagenesis annealing mixture was ligated and transformed 
in E. coli (BMH-71-18 mut S), a repair deficient strain. 
Plasmid DNA were prepared and transformed again into E . coli 
(JM109). Colonies were picked randomly and screened by 
sequencing using CD2B7 as a sequencing primer (Fig. 3.4). 
Further sequencing was carried out using primer C234 920, to 
check if point mutations "haGl occurred during the mutagenesis 
reaction, a fragment of 430bp (from PvuII to Ncol sites) was 
checked. The mutants were designated CD2 18TM, CD2 14TM and 
CD2 12TM, according to the deletions. The mutation frequency 
was respectively 0%, 33% and 9.09%. Due to the restoration 
of the ampicilin resistance to the mutant DNA, almost 90% of 
mutants were expected, ■ but because factors such as incomplete 
in vitro polymerization, primer displacement by the DNA 
polymerase used and in vivo host-directed mismatch repair 
mechanisms which favor repair of the unmethylated newly 
synthesized DNA strand, this observed low frequency can be 
explained. The failing in CD2 18TM mutagenesis can be 
explained by a possible mismatch in the oligo that prevent 
the annealing , so the mutant double strand could not be 
synthesized.
The relative low CD2 14TM and CD2 12TM mutation frequency 
resulted in extensive sequencing to find- the mutants. I 
therefore changed to a system of site-directed mutagenesis 
based on overlap extension using the PCR, another pair of 
oligos for each mutant was synthesized (Fig. 3.5). At the 
first PCR reaction, primers a/b and c/d were used to produce 
the fragments AB and CD, respectively, for each mutant (Fig 
3.6a and 3.6b). The fragments were isolated from the gel by 
glass wool method and used as a template for the second PCR 
reaction, at least 500ng of each was used per reaction. The 
annealing temperature used in the second PCR reaction was
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A C G T
T ACC 
I ATC
V  TAT
V  GTT 
L  CTC 
L  CTG 
A GCA
V  GTT 
C TTT
V  GTC 
M ATG
L 
L 
S 
G 
G 
G
. I
TTG
CTC
AGC
GGC
GGA
GGA
^  TGT 
I ATA 
G GGC 
I ATT 
I ATC 
L  CTC 
Y TAT 
I ATC _
•>“
ft
m
__ '
m T  ACC —  
I ATC
Y TAT 
F rr:
G GGA 
G GGA 
C TGT 
I ATA 
G GGC 
I ATT 
I ATC 
L  CTC
Y  TAT
ATC
1I
I ATT 
I ATC 
L  CTC 
Y TAT 
I ATC
B
Figure 3.4 - Plasmid sequence of CD2 mutants in PSelect
generated by Altered sites in vitro mutagenesis, usin CD2B7 as 
a sequencing primer. A - CD2 wild type (CD2 WT) Tm region. B - 
CD2 14TM mutant. C - CD2 12TM mutant.
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CD2 10 TM
Primer a Primer c
5' 3' 5* 3'
ATTGACGCAAATGGGCG.....................................TCATTGGC.............GGATATATCACCAAAAG
ATTGACGCAAATGGGCG---ATCTATCTCATCATTGGCATATGTGGATATATCACCAAAAGG--- ACTACCTACAGAGATTT
TAACTGCGTTTACCCGC---TAGATAGAGTAGTAACCGTATACACCTATATAGTGGTTTTCC--- TGATGGATGTCTCTAAA
pcDNAINeoCD2 12TM.... AGATAGAGTASTAACCG.... CCTATATA TGATGGATGTCTCTAAA
3' 5' 3' 5'
Primer b Primer d
CD2 8 TM
Primer a Primer c
5' 3* 5' 3*
ATTGACGCAAATGGGCG ATCTCATC......... GGATATATC AC C AAAAG
ATTGACGCAAATGGGCG— TGGACATCTATCTATCTCATCATTGGCATATGTGGATATATCACCAAAAGG-- ACTACCTACAGAGATTT
TAACTGCGTTTACCCGC— ACCTGTAGATAGATAGAGTAGTAACCGTATACACCTATATAGTGGTTTTCC-- TGATGGATGTCTCTAAA
pcDNAINeoCD2 12TM ACC TG T AG AT AG ATAGAGTAG..........CCTATATA TGATGGATGTCTCTAAA
3' 5' 3' 5'
Primer b Primer d
CD2 +VE
Primer a Primer c
5' 3' 5' , 3'
ATTGACGCAAATGGGCG TATATCACCCAGCAACAGCAACAGAGGAGT
ATTGACGCAAATGGGCG— ATCTATCTCATCATT-- TATATCACCAAAAGGAAAAAACAGAGGAGT--ACTACCTACAGAGATTT
TAACTGCGTTTACCCGC— TAGATAGAGTAGTAA-- ATATAGTGGTTTTCCTTTTTTGTCTCCTCA--TGATGGATGTCTCTAAA
pcDNAINeoCD2WT ATATAGTGGGTCGTTGTCGTTGTCTCCTCA TGATGGATGTCTCTAAA
3' 5' 3' 5'
Primer b Primer d
Figure 3.5 - Schematic representation of site directed
mutagenesis by overlap extension using PCR for CD2 10TM, CD2
8TM and CD2+VE. The template DNA used for CD2 10TM and CD2 
8TM mutagenesis reaction was pcDNAINeoCD2 12TM and for CD2+VE, 
it was pcDNAINeoCD2 WT. Primers a and d hybridises with 
pcDNAINeo, primers b and c hybridises with CD2 12TM sequence. 
The dotted line represents continuity of the primer and the 
line, continuity of the plasmid.
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CD2 +ve
HIII
• A TG
pcBNAINeo CD2UT 
 1
PvuII
iwi'cwIvwa;
130 bp |_
730 bp
AB product (8 60 bp)
HIII PvuII
A TG
CD2+VE TM
AB product (1839 bp)
HIII PvuII
A T G
CD2+VE TM
CD2+VE
Ncol HIII Xhol 
H
TAA
BamHI Xbal
190 bp
789 bp
CD product (979 bp; 
Ncol HIII xhol
— — -44--- -(-) i
BamHI 3 d aI
Ncol HIII xhol
^  TA A
BamHI Xbal
CD2 lOTM and CD2 8Til
HIII
a
_ A
A TG
PvuII L_
,v,----.^ J„V
pcDNAIMeo CD212TM TM b
130 bp h
665 bp \-
AB product (795 bp)
HIII
I A TG
pcDNAIMeo CD2 10TM 
STM
PvuII
Ncol HIII Xhol
TA A H H-
BamHI Xbal
190 bp
785 bp
CD product ( 975 bp) 
Ncol HIII xhol
"hrsr BamHI Xbal
AD product (1770 bp)
HIII PvuII
• A TG
pcDNAINeo CD2 10TH 
STM
Ncol HIII xhol
 I I
TA A
BamHI Xbal
Figure 3.6a - Schematic representation of AB, CD and AD PCR 
products from the PCR mutagenesis reaction for CD2+VE, CD2 
10TM and CD2 8TM.
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3 4 5 6 (Kb)
Figure 3.6b - AB and CD PCR 
products after glass wool 
extraction from agarose gels 
Lane 1 - CD2 8TM AB product
Lane 2 - CD2 8TM CD product
Lane 3 - CD2 10TM AB product
Lane 4 - CD2 10TM CD product
Lane 5 - CD2+VE AB product 
Lane 6 - CD2+ve CD product
( K b )
2.0
1.6
1.0
Figure 3.6c - AD products 
from second PCR reaction.
Lanes 1 and 2 - CD2 10TM AD
Lanes 3 and 4 - CD2 8TM AD
Lanes 5 and 6 - CD2+VE AD
Lane 7 - control CD2 WT AD
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initially set at 50°C, but did not yield the AD PCR product, 
This product was obtained when the annealing temperature was 
changed to 45°C (Fig 3.6a and 3.6c),
The a d external primers were designed to yield an AD 
product with Hind III sites approximately lOObp away from 
both ends. The first idea was to digest this 1.8 kb fragment 
with Hind III, yielding two small fragments of 130 bp and 
190bp, respectively, and a 1.5 kb fragment , which would 
correspond to CD2 mutant fragment (Fig 3.6a). This fragment 
would be cloned directly to pcDNAINeo digest with Hindlll and 
treat with calf intestine alkaline phosphatase (CIP). 
However, the AD product could not be completely digestei-by 
Hindlll, it always gave products of partial digestion (Fig
the.' .
3.7). Even when the 1.5 Kb fragment was band purif; by QIAEX 
method, it was not possible to cloned it into pcDNAINeo/Hind 
III. So the AD PCR product, for the three mutants, was 
ligated to pT7Blue vector into the modified EcoRV site. The 
ligation mix was transformed into NOVABLUE cells. The 
transformants were select into ampicilin and tetracyclin 
plates, with white/blue selection. The white colonies were
screened by PCR, using primers a and d (Fig. 3.8). Plasmid
the
DNA were made from the positive clones, using alkaline lysate 
method. The presence of insert and the orientation was 
checked by Hind III digestions (Fig. 3.9). The mutants were 
sequenced , using CD2B7 and C 234920 primers (Fig 3.10), 
once more the PvuII/NcoI fragment could be checked for 
possible point mutations created during PCR reactions.
In order to avoid mutations created during any of the
mutagenesis process, fragments from all five mutants, CD2
14TM, CD2 12TM, CD2 10TM, CD2 8TM and CD2+VE were lifted by 
PvuII / Ncol digestions, 410bp, 410bp, 362 bp, 356 bp and
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Figure 3.7 - Partial digestion of CD2 mutants AD PCR products 
by Hindlll digestion.
1.8 Kb fragment - uncut PCR product
1.6 or 1.7 fragment - PCR product partially cut by Hindlll
1.5 fragment - PCR product totally cut by Hindlll
Lane 1 - CD2 8TM AD product 
Lane 2 - CD2 10TM AD product 
Lane 3 - CD2 +ve AD product 
Lane 4 - CD2WT AD product
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1 2 3 4 5 6  7 8  9 10 11
Figure 3.8 - PCR screening of bacterial colonies containing AD 
fragment cloned into pT7Blue. The 1.8 fragment amplified with 
primers a and d corresponds to AD fragment of CD2 10TM (lanes 
1 to 3), CD2 8TM (lanes 4 to 7) and CD2+VE (lanes 8 to 11).
PvuI1 Ncol
J  HIIIHIII
PvuII
pT7BLUEPvuII
887 bp
1 2 3 4 5 6 7 8 9 (Kb)
B
A - right orientation
HIIIHIIlHwtV ___
-------- U  CD2r « * - - - - -
HIII HcarV
Xbal1
I--- 1
180 bp .
pT7BLUZ
1S00 bp
B - wrong orientation 
r2cjrV HIII
HIII
Xbalm
HIII KCJtu
1 3 -
140 bp
pT7BLUJ
1500 bp
Figure 3.9 - A -Schematic representation 
of AD PCR product cloned into pT7Blue by 
modified EcoRV site. B - Diagram of 
the two possible orientations of the 
insert (AD fragment) into the vector 
(pT7Blue) with the diagnostic Hindlll 
sites. C - Diagnostic Hindlll digestion 
of pT7Blue/AD fragment to check 
orientation of insert. Lanes 1 to 3 CD2 
10TM, lanes 4 to 6 CD2 8TM and lanes 7 
to 9 CD2+VE. The 180bp fragment observed 
in lanes 2,3,6 and 8 corresponds to the 
right orientation of the insert.
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A C G T
T A CC-i 
I ATC 
Y TAT 
G  GGA 
C TGT 
I ATA
ft GGC
I ATT 
I ATC 
L CTC 
Y TAT 
I ATC —
i  ATC 
{ TAT 
3 GGA 
G GGC 
I ATT 
I ATC 
Li CTC 
Y TAT
3
P. AGA —»
D   I
Ps. AGG
■  .sf ■
Q  CAG
T  ACC
Y TAT
A C G T
—  ; D
Figure 3.10 - Plasmid sequence of CD2 mutants in PT7Blue
generated PCR mutagenesis, using CD2B7 as a sequencing primer. 
A - CD2 12TM mutant. B - CD2 10TM mutant. C
CD2 8TM mutant. D - CD2-+VE mutant
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410bp fragments were obtained, respectively (Fig. 3.11b). 
Each of these fragments was cloned into wild type CE2 
(previously cloned into Hind III site of pAT153), digested 
with PvuII /Ncol (Fig. 3.11a). This constructions were 
denominated pATCD2WT, pATCD214TM, pATCD212TM, pATCD210TM, 
pATCD28TM and pATCD2+VE, respectively (Fig. 3.11b).
The CD2 fragment from pATCD2WT, pATCD14TM and pATCD212TM was 
cloned into pcDNAINeo digested with Hindlll and treated with 
calf intestine alkaline phosphatase (CIP). These 
constructions were called pcDNAINeoCD2WT, pcDNAINeoCD214TM 
and pcDNAINeoCD212TM (Fig 3.12). Because of difficulties 
like high background of religated vector and orientation of 
the insert, the cloning strategy was changed to eliminating 
the 3 1 end Hindlll site by doing a partial digestion with 
Hindlll enzyme. The digestion was done using buffer selected 
to yield a partial digestion and suitable amount of enzyme in 
20 ul reaction. Different aliquots were left for 60, 40, 30r 
20 and 15 minutes at 37°C. Immediately after, dNTPs in a finaL 
concentration of 2mM/ul and 1.0 ul of Klenow were added to 
each aliquot and the mix was left for 30 minutes at room 
temperature. The samples were run on a gel and the 5.1 kb 
fragment, that corresponded to the linearized one, was band 
purified by QIAEX method and religated (Fig. 3.13a). The 
ligation mix was transformed into DS941 cells and
transformants were screened on ampicilin plates. The
efficiency of the reaction was checked by digesting the DNA 
of some candidates with Hindlll, if the plasmid linearized, 
one of the Hindlll sites was eliminated. This plasmids were 
digested with Hindlll and BamHI, in order to confirm the 
orientation of the disrupted Hindlll site (Fig 3.13b). The 
CD2 fragment was lifted by Hindlll / BamHI from pATCD2 
constructs and ligated into pcDNAINeo Hindlll / BamHI. The 
ligated DNA was transformed into DS941 cells and
86
C h a p t e r  3 Results
Ncol
HIII
Xb£
HIII.
BamHI
pATCD2 
S.l Kb
Figure 3.11a - Diagram of 1.5 Kb CD2 WT 
fragment excised from CDM8 by HIII digestion.
(Kb)
4.5
24
1.7
1.1
1.0
0.8
- - S
Figure 3.11a - Diagnostic restrition of pAT153CD2 with Hindlll 
to verify cloning of CD2 fragment into pAT153. The 1.5 Kb 
fragment corresponds to CD2 wild type and the 3.6 fragment to 
pAT153.
(Kb)
1840 bp
Figure 3.11a - Diagnostic restriction with Xbal/BamHI to check 
orientation of the insert into pAT153. The 1846 bp fragment 
corresponds to Xbal/BamHI fragment at the right orientation 
and the 3.3Kb one corresponds to pAT153.
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410 bp
PvuI1 Ucol 73S bp70S bp
•PvuII
PvuII
pSelect 
5.6 Kb
3047 bp
22S4 bp
PvuII
1 2 3 4 5 6 7
5.0
2.0
1.5
1.3
0.9
0-8
0.5
0.3
Figure 3.11b - Top - Diagram of pSelect/CD2 14TM and CD2 12TM 
digested with PvuII/NcoI, showing the size of the expected 
fragments. Bottom - Digestion of pSelect/CD2 14TM, pSelect/CD2 
12TM and pATCD2 WT plasmids with PvuII/NcoI. Lane 1 and 2 
pSelectCD2 14TM and 12TM. Lane 3 and 4 - 410 bp fragment of 
CD2 14TM and CD2 12TM, respectively, band purified by glass 
wool method. Lane 5 - pATCD2 WT digested with PvuII/NcoI. Lane 
6 - The 4670 bp fragment band purified by glass wool method. 
CD2 14TM and CD2 12TM fragments were ligated to CD2 WT 4 670bp 
fragment.
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356 bp(CSZ 10/8TM; 
410 bp{CD2+ve)
865 bp
PvuII jjcoI
.J HIIIHIII
Xbal
PvuII
pT7ELUE 
2.8 Kb
PvuII
A B
3 56 bp(CVZ 10/STH)
410 bp<CI>24ve)
4.0 bp<CP2TiJT/ 14 / 12TIT)
Pvu;i Urol
HIII
H III
E a m H I
c D
Figure 3.11c - A - Diagram of pT7Blue/CD2 10TM, CD2 8TM and 
CD2+VE with the expected sizes of fragments generated by 
PvuII/NcoI digestion. B - PvuII/NcoI digestions of plasmid DNA 
from pT7Blue/CD2 mutants. Lane 1 and 2 pT7Blue CD2 8TM. Lane 3 
and 4 pT7Blue CD2 10TM. Lane 5 and 6 pT7Blue CD2+VE. The 356 
bp and 410bp fragments were band purified by glass wool method 
and ligated to pATCD2 WT 4 670 fragment. C  - Diagram of CD2 
mutants cloned into pATCD2. D  - PvuII/NcoI diagnostic 
restriction of pATCD2 mutants. Lanes 1 to 5 pATCD2 8TM, Lanes 
6 to 10 pATCD2 10TM and lanes 11 to 13 pATCD2+ve.
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A
HIII Xbal HIII BamHI
p A T C D 2
1500
PvuII Ncol
HIIIXiao I 
Xbal > 
HIII >> BamHI V  Xhol VXbal
B
1 2 3
1 2  3 4 (Kb)
5.0
I-1
1.0
0.9
r i ght or le nt at i c n 
HIII Xba.I Hill
B  aiuHI X I  3.1
CDZ
Xhc I Xhol
600 bp
r>cDHAI3J*2 0
wrong orientation
96 bp
HIII
- t
HIII
Xbal BanHI Xbal
CDZ
Xhol Xhol: pcDNAINeo
Figure 3.12 - Cloning of CD2 WT, CD2 14TM and CD2 12TM into 
pcDNAINeo. A - Diagram representing the 1.5Kb fragment excised 
from pATCD2 WT, 14TM and 12TM respectively, by Hindu 
digestion. B - Plasmid DNA from a mini prep digested with 
Hindlll, the 1.5 Kb fragment corresponds to CD2 fragment and 
the 7.1 one to pcDNAINeo. Lane 1 pcDNAINeo CD2 WT, lane
2 pcDNAINeo CD 2 14TM, lane 3 pcDNAINeo 12TM. C - Xbal
digestion of CD2 14TM and CD2 12TM to check orientation into 
pcDNAINeo. Lanes 1 and 2 corresponds to right orientation 
because of the 1.5 Kb fragment, in lanes 3 and 4 the plasmid 
linearized because of the wrong orientation.
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I— 1500 bp
PvuF ncoI
:h i i i
HIII 
: EcoRI-,>
BaiflHI
3600 bp 
5100 bp 
5100 bp
Figure 3.13a - Partial digestion of pATCD2 10TM, 8TM and +VE 
with Hindlll. Top - Diagram of the plasmid with Hindlll 
digestions showing the expected sizes for partial (5.1Kb) and 
complete digestion (3. 6Kb/1.5Kb) . Bottom - Hind III partial 
digestion of the plasmid DNA. Lane 1 to 5 pATCD2 10TM, lane 6 
to 10 pATCD2 8TM, lane 12 to 16 pATCD2+VE and lane 11 the 
plasmid digested with BamHI as a control to the 5.1 Kb 
linearized fragment.
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Figure 3.13b - The religated plasmic 
was digested with Hindlll to check 
the disruption of the 3' Hindlll sit 
The linearized plasmids corresponds 
the one3 with only one Hindlll site 
(lanes 2 ,  8, 11 and 14). Lanes 1 to 
CD2 1QTM, lanes 6 to 10 CD2 8TM and 
lanes 11 to 15 C D 2 + V E .
A - wrong orientation
S' 3'
_HIII BamHI
 4-rl CD2 =*
XbaIXhoI pATlS3I---- 1
346 bp
B - r i g h t  o r i e n t a t i o n
S' 3'
HIII Hill BamHI
 L-rH *- CC2
XbaIXhoI PAT1S3
I------------------- 1
1 8 4 6  bs>
Diagram representing the sizes 
of fragments resulting from 
Hindlll/BamHI digestion of the 
plasmid for right and wrong 
orientation of the disrupted 
Hindlll site.
Figure 3.13b - Plasmid DNA digested with HindiII/BamHI. Lanes 
1 to 5 CD2 10TM, lanes 6 to 10 CD2 8 TM and lanes 9 to 16 
CD2+VE. In lanes 5, 8 10 and 14 two fragments of 3.9Kb and
1.8Kb were observed, these corresponds to the right 
orientation of the disrupted Hindlll site at the 3 f end.
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transformants were screened on kanamycin plates. Plasmid DNA 
was made from the colonies,. and the presence of insert was 
checked by cutting it with Hindlll/BamHI (Fig. 3.14). These 
constructions were called pcDNAINeo CD28TM, pcDNAINeoCD210TM 
and pcDNAINeoCD2+VE. Once the CD2 mutants were cloned into 
pcDNAINeo, they were sequenced again in order to check any 
possible mistake during cloning. The fusion protein CD2B7CDM8 
was cloned into pcDNAINeo digested with HindIII/Not-1 (Fig 
3.15) .
3.3 Transfection of CD2 mutants into mammalian cells
Once the CD2 WT and mutants were cloned into the expressing 
vector pcDNAINeo, the plasmids were transfected into 
mammalian cells with the purpose of observing cell expression 
of the mutant proteins. The established system in the 
laboratory for transient transfection of COS-7 was DEAE- 
dextran. As DOTAP is a more straight forward method and the 
transfection efficiency (see Material and Methods) obtained 
was 3%-5%, that was satisfactory for the purposes of the
project, transient transfection into COS-7 cells was changed
the
to DOTAP system. Transfection of CD2 WT, CD2 14TM and CD2 
12TM into CHO for selection of stable cell lines were 
performed using the CaP04 system. Because the frequency of 
transfected clones(see Material and Methods) was very low 
(0.004%), the system was changed to DOTAP and the frequency 
increased to 0.6%. Consequently, CD2 10TM, CD2 8TM, CD2+VE 
and CD2B7 were transfected into CHO cells for selection of 
stable cell lines by using DOTAP.
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Figure 3 .14a - Digestion of pATCD2 lOTf 
8TM and +VE and pcDNAINeo with Hind III 
BamHI, the 1.8Kb and 7.1Kb fragments 
were band purified by QIAEX and ligated. 
Lanes 1 to 4 - pATCD2 10TM
Lanes 5 and 6 - pATCD2 8TM
Lanes 7 and 3 - pATCD2+VE
Lanes 9 to 12 - pcDNAINeo
HIII Xhol Kill BasaHI
. ’_____
Xbal p A T C D 2
:....  1 8 4 6  b p   :
pcDNAINeo 
7.1 Kb
Figure 3.14b - Diagram representing 
the excised fragment from pATCD2 
contructs and the cloning of these 
fragments into the expressing vector 
pcDNAINeo.
1 2 3 4 5  6 7 8 9  10
Figure 3.14c - Diagnostic restriction 
of the plasmid with Hindlll/BamHI to 
check if the vector (7.1 Kb) has the 
insert (1.8Kb).
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CDH8 
4.8 Kb
HIII
Xbal
HIII
1380 bp
Figure 3. 15a - Schematic representation 
of the 1380bp CD2B7 fragment excised frorr 
CDM8 by HindIII/Not-1 digestion.
1 2 3 4 5 6 7 8 9  1011 12 13 (Kb)
Figure 3.15b - Diagnostic digestior 
of plasmid DNA by HindIII/Not-1 to 
check presence of insert. Lanes 1,2 
3,7 and 11 show the 1380 bp band 
that corresponds to CD2B7, the 7.1 
band corresponds to pcDNAINeo.
Figure 3.15c - Schematic representation 
of CD2B7 cloning into pcDNAINeo.
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3.4 Cellular expression and distribution of CD2 mutants
Panning experiments were carried out to determine if CD2 
mutants could be expressed on the cell surface. COS-7 cells 
were transiently transfected by DOTAP with DNA encoding the 
wild type and mutant forms of CD2. After 72 hours of 
transfection the cells were harvested, labelled with mouse 
anti-CD2 MAb (SeraLab) and distributed into panning plates 
coated with goat anti-mouse IgG antibody. COS-7 cells 
untransfected labelled with W6/32 were included as a positive 
control and COS-7 untransfected and unlabelled, as a negative 
control. CD2 WT, CD2 +VE, CD2 14TM and CD2 12TM transfected 
cells attached to the panning plates, indicating cell surface 
expression of CD2. On the other hand, CD2 10TM and CD2 8TM 
showed negative result for this experiment. These results 
were confirmed by panning CHO stable cell lines of CD2 
mutants with RFT11 and GT2 antibodies (Table 3.1).
Table 3.1 - Panning results for the 3 antibodies tested on 
transient transfected COS-7 cells and CHO stable cell lines 
of CD2 wild type (WT) and mutants (14TM, 12TM, 10TM, 8TM,
CD2+VE and CD2B7)
Anti-CD2 
Seralab (COS-7)
Anti-CD2 
RFT11 (CHO)
Anti-CD2 
GT2 (CHO)
COS-7/CHO -VE -VE -VE
CD 2 WT +VE +VE +VE
CD2 14TM +VE +VE +VE
CD2 12TM +VE +VE +VE
CD2 10TM -VE -VE -VE
CD2 8TM -VE -VE -VE
CD 2 +VE +VE +VE +VE
CD2B7 +VE +VE +VE
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Once some of the CD2 mutants exhibited cell surface 
expression and others not, indirect immunofluorescence 
microscopy experiments were performed to find out their 
distribution in the cell. Transient transfected COS-7 cells 
were passed to slides flasks 48 hours after transfection, 
they then adhered to it and were fixed after further 24 
hours. First, cells were stained with mouse anti-CD2 MAb from 
Seralab (1:10 dilution) and anti-mouse FITC second antibody 
(1:100 dilution). As a positive control untransfected cells 
were stained with mouse W6/32 MAb (1:50 dilution) and anti­
mouse FITC . The mutants CD2 10TM and CD2 8TM did not show 
cell surface labelling, as CD2 WT and other mutants and it 
was not possible to observe internal staining (Fig 3.16). So, 
immunostaining with a anti-CD2 antibody (RFT11) that is able 
to bind both the native and denatured conformation of CD2 
external domain, were carried out. CD2 WT and other mutants 
were included as a control for surface staining. An internal 
staining pattern were observed for both CD2 10TM and CD2 
8TM, and surface staining for CD2WT, CD214TM, CD212TM, 
CD210TM, CD28TM and CD2 +VE (Fig 3.17). This result indicates 
that the truncated forms of CD2 are not folding correctly, 
once the epitope for the first antibody (Seralab CD2) was not 
recognized.
Western blotting experiments were performed in order to 
estimate sites of post-translational modification and 
elucidate about the intracellular localization. Protein were 
extracted from CHO stable cell lines of each mutant with FSB. 
The lysate were run on a 12% SDS-PAGE gels and 
electroblotted. The blot was hybridized with RFT11 at room 
temperature and developed with Protoblot alkaline phosphatase 
AP system (Promega) . The CD2 WT, CD2 14TM, CD2 12TM and 
CD2+ve cells produced multiple bands ranging from 45kDa to 
55kDa (Fig 3.18), that correlates with the sizes described in
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Figure 3.16 - Staining of COS-7 cells transiently transfected 
with CD2 wild type and mutants, with anti-CD2 from SeraLab. A 
- No DNA, B - CD2WT, C - CD2 14TM, D - CD2 12TM, E - CD2 10TM, 
F - CD2 8TM, G - CD2 +VE and H - COS-7 cell stained with W632.
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Figure 3.17 - Staining of COS-7 cells transiently transfected 
with CD2 wild type and mutants, with RFT11 anti-CD2. A - No 
DNA, B - CD2WT, C - CD2 14TM, D - CD2 12TM, E - CD2 10TM, F - 
CD2 8TM, G - CD2 +VE and H - COS-7 cell stained with W632.
C h a p t e r  3 Results
Figure 3.18 - Western blotting of CD2 wt and mutants. The
protein was extracted from CHO cells and blot with RFT11
anti-CD2.
Lane 1 - CD2 WT
Lane 2 - CHO cells (negative control)
Lane 3 - CD2 14TM
Lane 4 - CD2 12TM
Lane 5 - CD2 +VE
Lane 6 - CHO cells (negative control)
Lane 7 - CD2 8TM
Lane 8 _ CD2 10TM
Lane 9 - CD2 +VE
Molecular weight of the 
unglycosylated form
CD2 WT 36.96 KDa
CD2 14TM 35.56 KDa
CD2 12TM 35.29 KDa
CD2 10TM 35.03 KDa
CD2 8TM 34.03 KDa
CD2 +VE 36.96 KDa
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the literature (50, 53 and 55kDa, Sayre et al., 1987). These 
various bands observed should correspond to differential 
glycosylation products, since the protein possesses three 
putative N-terminal Asn-linked glycosylation sites. CD2 10TM 
and CD2 8TM produced a single band around 35-38kDa (Fig 
3.18) .
3.5 Further studies of epitope presentation in CD2 external 
domain
Once CD2 WT, CD2 14TM, CD2 12TM, CD 2 +VE and CD2B7
(Hundal,1991) have shown cell surface expression by panning
and immunofluorescence microscopy, the external domain
conformation of these mutants was analysed. This was done by
immunostaining with antibodies to different epitopes of CD2, 
situated in domain 1 and domain 2, according to Peterson and 
Seed (1987) (Fig 3.19) .
COS-7 cells 48 hours after transfection were passed to slides 
flasks, after 24 hours they were fixed and stained with anti- 
CD2 GT2, specific to domain 2 and anti-mouse FITC second 
antibody (Fig 3.20). The wild type, +VE, 14TM, 12TM and 
CD2B7 mutants were positive for surface staining with anti- 
CD2 for domain 2. The antibody used in previous staining 
anti-CD2 from Seralab ( clone F923All)is specific to epitope 
in region II of domain 1 . As observed before CD2 WT, 14TM, 
12TM, CD 2 +VE (Fig 3.16) and CD2B7 (Hundal, 1991) showed 
surface staining with this antibody. These results indicate 
that there is no change in the conformation of the external 
domains of CD2.
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Figure 3.19 - Schematic representation of CD2 molecule with 
the epitope regions of the extracellular domain.
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Figure 3.20 - Staining of COS-7 cells transiently transfected
with CD2 wild type and mutants, with anti-CD2 GT2. A - No DNA, 
B - CD2WT, C - CD2 14TM, D - CD2 12TM, E - CD2 10TM, F - CD2 
8TM, G - CD2 +VE and H - CD2B7.
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3.6 Function of CD2 external domain
As mentioned before the first domain of CD2 carries the E 
rosetting receptor. In order to determine if the mutations 
had affected the adhesion function of the molecule, rosetting 
experiments with SRBC were carried out. Stable CHO cell 
lines of CD2 mutants were harvested and treated with SRBC. 
The mutants that had showed surface expression (CD2 WT, CD2 
+VE, CD2B7, CD2 14TM and CD2 12TM ) formed rosettes with 
SRBC, on the other hand CD2 10TM and CD2 8TM were negative 
for rosetting (Fig 3.21). These results showed that the 
first domain exhibits the right conformation to bind red 
cells, when the TM is reduced to 12 amino acids.
3.7 Lateral mobility of CD2 mutants on CHO cells
Preparation of CD2 antibody for photobleaching
Normally in photobleaching experiments the cells are labelled 
with the F(ab) fragment of the required antibody, to avoid 
cross reactions, what will interfere with the measurements of 
lateral mobility. The F(ab) fragment from CD2 was prepared 
(Fig 3.22) and labelled with FITC as described, but the 
staining of the cells with this antibody was very poor and 
the signal was not enough to the photobleaching analysis. So 
it was decided to use the whole CD2 IgG molecule labelled 
with FITC. Because the FITC labelling can be inhibited by the 
presence of BSA in the storage buffer of the antibody, CD2 
MAb (Boehringer Mannheim) was purified by ammonium sulphate 
precipitation prior to FITC labelling (Fig 3.23) .
Staining of the cells and photobleaching experiment
The following experiment was designed to have an estimation 
of the general lateral mobility of membrane glycoproteins 
proteins on surface of CHO cells. Cell surface
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Figure 3.21 - Rosetting of CHO cells expressing CD2 wild type
and mutants with sheep red blood cells. A - CHO cells, B - CD2
WT, C - CD2 14TM, D - CD2 12TM, E - CD2 10TM, F - CD2 8TM, G -
CD2 +VE and H - CD2B7.
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Figure 3.22 - Preparation of F(ab)2 fragment from W632 and
anti-CD2. SDS PAGE blot with anti-mouse AP conjugated. Under 
reducing conditions IgG yields two bands, one about 50 KDa and
one at 25KDa; F(ab)2 yield a 
and Fc fragments yield one 
slower than F(ab)2 doublet. 
Lane 1 W6/32 IgG
Lane 2 CD2 F(ab)2 fragment 
Lane 3 CD2 Fc fragment
(KDa)
205 * W M *
doublet of bands at about 25KDa 
band at about 25KDa that runs
1 2
Figure 3.23 - Purification of anti-CD2 by ammonium sulphate. 
SDS PAGE , commassie blue staining , run under nonreducing 
conditions.
Lane 1 anti-CD2 
Lane 2 BSA
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carbohydrates were detected with succynyl concanavalin A 
(1:10 dilution), simultaneously the cells were stained with 
Hoescht probe (1:100) and propidium iodide (0.01%) to observe 
damage of the cells during the staining and washing process, 
(Fig 3.24) . The Hoescht probe is a nucleus Stainer and when 
there is a damage in the cellular membrane the inside 
structures will be also stained. If the cell membrane is 
damaged propidium iodide entries and stained the nucleus. 
Since photobleaching analysis has to be carried out on 
intact cells, propidium iodide was always used together with 
the FITC staining; red labelling of the nucleus is observed 
under the laser and those cells were discarded . The cells 
expressing the WT and CD2 mutants (14TM, 12TM and +ve) were 
stained with anti-CD2/FITC (1:10 dilution) (Fig 3.25) and the 
slides mounted on media containing propidium iodide. The
measurements were carried out within 2 hours after staining, 
an average of 4 pulses/cell was stored in the computer and 
the curve was analysed by a computer program as described
(Fig 3.26)
before. The quantitative fluorescence was measured for each 
cell chosen to receive the bleach pulse. The data of D.L.
coefficient, % of recovery and quantitative fluorescence for 
each mutant is summarized at Tables 3.2, 3.3, 3.4, 3.5 and
3.6. The mean, standard deviation (sd) and standard error 
of the mean (sem) from D.L. coefficient, % of recovery and 
quantitative fluorescence for each mutant and CHO labelled 
with concanavalin A was calculated (Table 3.7). To verify if 
the differences between the calculated means from CD2WT and 
mutants were significant or not, paired data for the wild 
type and mutants was analysed by Wilcoxon's signed rank and 
student* s t test and p < 0.05 was considered
significant(Table 3.9).
92
C h a p t e r  3 Results
A B C
Figure 3.24 - Staining of CHO cells with. 
A - Propidium Iodide 
B - Hoescht probe 
C - Succynyl Concanavalin A
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Figure 3.25 - Staining of CHO cell lines expressing CD2 wild 
type and mutants with anti-CD2 FITC from Boheringer Mannheim.
A. - CD2 WT, B - CD2 14TM, C - CD2 12TM and D - CD2 +VE.
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Figure 3.26 - FRAP curves for CHO cell stained with Succinyl 
ConA and CHO cell lines of CD2 wild type and mutants stained 
with anti-CD2. A - CHO, B - CD2 WT, C - CD2 14TM, D - CD2 12TM 
and E - CD2 +VE.
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Table 3.3 - Values of D.L,, % of recovery and quantitative 
fluorescence for CD2 WT stained with anti-CD2 (Boheringer 
Mannheim)
DL (xl0~9cm/s"1) % of recovery Quantitative
fluorescence
GE622 2.18 79.5 134.9434
GE653 1.59 82.4 174.5214
GE721 0.48 79.0 214.2305
GE134 1.29 51.4 123.5566
GE1313 2.18 35.1 141.5957
GE145 1.16 81.7 32.4453
GE147 0.93 64.2 94.7851
GE1410 0.82 52.2 109.5996
GE1412 0.60 70.2 60.8125
GE165 3.35 36.1 58.3886
GE1622 6.74 54.0 116.0895
GE1627 0.29 35.0 124.1171
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Table 3.2 - Values for D.L. and % recovery for CHO stained 
with Succynyl Concanavalin A.
D.L.(xlO-10cm2/s”l) % recovery
GE115 6.91 91.9
GE118 7.06 95.2
GE119 3.45 92.1
GE1110 6.82 79.9
GE1122 1.36 58.2
GE122 3.42 86.7
GE922 7.23 85.2
GE924 1.68 81.0
GE925 7.01 90.8
GE927 1.34 87.9
GE928 1.41 89.0
GE931 7.29 92.4
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Table 3.4 - Values of D.L., % of recovery and quantitative 
fluorescence for CD2 14TM stained with anti- CD2 (Boheringer 
Mannheim).
DL (xl0“10cm2s"1) % of recovery Quantitative
fluorescence
GE168 0.18 36.8 107.0605
GE1610 7.13 74.3 48.2597
GE1613 0.94 30.2 50.8808
GE1614 3.27 10.2 50.1660
GE1617 0.25 21.3 71.6523
GE1716 1.29 37.2 127.9238
GE1718 0.04 21.7 49.3027
GE171 3.54 79.6 30.7460
GE173 2.20 72.1 35.7539
GE175 0.40 78.0 128.3574
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Table 3.5 - Values of D.L., % of recovery and quantitative 
fluorescence for CD2 12TM stained with anti-CD2 (Boheringer 
Mannheim).
DL (xl0‘10cm2s"1) % of recovery Quantitative
fluorescence
GE812 1.23 94.5 202.0488
GE813 9.33 99.1 63.1015
GE819 7.54 98.9 91.6757
GE822 3.74 99.3 143.5253
GE1510 7.26 91.1 50.7167
GE1513 1.33 94.8 46.5566
GE1514 0.64 88.5 58.0078
GE1515 3.47 85.3 47.0117
GE1517 0.79 40.9 39.2500
GE177 3.53 95.1 198.5390
GE1710 0.73 70.3 54.3144
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Table 3.6 - Values of D.L., % of recovery and quantitative 
fluorescence for CD2 +VE stained with anti-CD2 (Boheringer 
Mannheim)
DL (xl0_10cm2s"1) % of recovery Quantitative
fluorescence
GE1637 6.45 50.4 81.1015
GE1638 1.61 21.6 110.3398
GE1640 0.11 38.3 142.3554
GE1714 2.11 69.6 127.9238
GE191 0.11 30.6 130.8378
GE192 0.04 18.4 141.2246
GE194 0.20 75.6 113.6308
GE195 6.84 72.9 149.6914
GE198 7.64 79.5 109.4179
GE1914 1.07 62.9 114.1210
GE1915 68.69 74.5 126.1562
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Table 3.7 - Means values and standard deviation (s) of D.L.
coefficient, % of recovery and quantitative fluorescence 
calculated for CHO - Con A, CD WT, CD2 14TM, CD2 12TM and CD2 
+ V E .
Cell line 
staining
D.L. coefficient
(10_1®cm2/s”1) 
mean (sd/sem)
% recovery 
(mobile fraction) 
mean (sd/sem)
Quantitative
fluorescence 
mean (sd/sem)
CHO - Con A 
(n - 12) 4.48 (2.58/0.84) 85.8 (10.3/3.1) nt
CD2WT CHO - CD2 
(n - 12) 1.80 (1.78/0.51) 60.0 (18.6/5.4) 115.4(50.5/14.5)
CD214TM CHO - CD2 
(n - 10) 1.93 (2.22/0.70) 46.1 (26.9/8.5) 70.0 (37.3/11.8)
CD212TM CHO - CD2 
(n - 11) 3.60 (3.12/0.94) 87.0 (17.4/5.3) 90.4 (61.7/18.6)
CD2+VE CHO - CD2 
(n - 11) 3.00 (3.20/0.97) 54.0 (23.1/6.9) 122.4(19.4/5.8)
Table 3.8 - Values of lateral difusion(D.L) and percentage of 
recovery (%R) for membrane proteins referred in the 
literature.
Protein D.L.(xl0"10cm2/s) 
(sd/sem)
% of recovery (R) Reference
Class -I MHC 
antigens
0.12 (0.16/0.32) 31 Edidin and 
Zuniga, 1984
EGF receptor 1.2(3.56/0.7) 61 (106.9/21) Livneh et al., 
1986
Class II MHC 
molecules
1.0(2.05/0.56) to 
3.0(2.42/0.67)
36 (25.9/8) to 
73(50.5/14)
Wade et al., 1989
Human insulin 
receptor
6.0(5.39/0.5) 51(81.36/12) Goncalves et al., 
1993
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Table 3.9 - Statistical analysis by Wilcoxon's rank signed 
test and student t-test of D.L. coefficient, % of recovery and 
quantitative fluorescence for paired data of CD2 WT, CD2 12TM, 
CD2 14TM and CD2 +VE.
D.L. coefficient % of recovery Quantitative
fluorescence
Wilcoxon's t'student Wilcoxon's t'student Wilcoxon's t'student
test test test test test test
CHO ConA/ 
WT
8.000' 
p < 0.025
2.989**
p < 0.01
1.000' 1 
p < 0.005
4.037*** 
p < 0.001
nt nt
CHO ConA/ 
14TM
8.000' 
p < 0.05
2.494*
p < 0.02
o.ooo'1
p < 0.005
4.537***
p < 0.001
nt nt
CHO ConA/ 
12TM
21.000 
p > 0.05
0.863
p > 0.2
14.500 
p > 0.05
0.211 
p > 0.5
nt nt
CHO ConA/ 
+VE
22.000 
p > 0.05
1.316
p > 0.1
5.000* 
p < 0.05
4.160***
p < 0.001
nt nt
WT/ 14TM 24.000 
p > 0.05
0.146 
p > 0.5
n.ooo1
p < 0.05
1.430 
p > 0.1
13.000 
p > 0.05
2.355* 
p < 0.05
WT/ 12TM 18.000 
p > 0.05
1.715
p > 0.1
7.000' 
p < 0.05
3.577*** 
p < 0.001
21.000 
p > 0.05
1.067 
p > 0.1
WT/ +VE 28.000 
p > 0.05
1.122 
p > 0.2
27.000 
p > 0.05
0.693 
p > 0.4
29.000 
p > 0.05
0.432 
p > 0.5
14TM/12TM 8.000 ' 
p < 0.05
1.400
p > 0.1
4.000' 1 
p < 0.01
4.173***
p < 0.001
13.000 
p > 0.05
0.906
p > 0.2
14TM/ +VE 25.000 
p > 0.05
0.884 
p > 0.2
22.000 
p > 0.05
0.722 
p > 0.4
5.000' 
p < 0.05
4.098***
p < 0.001
12TM/ +VE 26.000 
p > 0.05
0.442 
p > 0.5
7.000 ' 
p < 0.05
3.784** 
p < 0.01
20.000 
p > 0.05
1.641 
p > 0.1
* and ' - significant at 5%
** and 1' - significant at 1%
*** and 111 - significant at 0.1%
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Quantitative fluorescence analysis
The quantitative fluorescence data is a measure of the 
quantity of CD2 on the cell surface and the only difference 
observed was between CD2 14TM and CD2+ve. The low level of 
fluorescence with 14TM expressed in CHO cell line was 
confirmed by fluorescence microscopy. This is likely to 
reflect the copy number of the plasmid in CHO cels rather tahn 
an effect on the protein level. When COS-7 cells were 
transfected with CD2 14TM plasmid DNA and immunostained, no 
detectable difference could be observed by fluorescence 
microscopy between CD2 14TM and the other surface staining 
mutants.
Lateral mobility and percentage of recovery analysis
From the D.L. coefficient data, no significant difference was 
observed between the lateral mobility of the wild type and 
mutant proteins. When the mobile fraction was analysed, 
differences between CD2 WT/ CD2 12TM, CD2 14TM/ CD2 12TM and 
CD2+VE/CD2 12TM were considered significant. When the means 
for these coefficients were analysed (Table 3.10), it was 
noticed that CD2 12TM presents the higher percentage of 
recovery.
Distribution of photobleaching data
The means and standard deviations values of the present FRAP 
data show a scattered distribution. This is also observed in 
data from literature for membrane proteins (Table 3.8) and in 
lateral diffusion studies of lipid probes in the surface 
membrane of Schistosoma mansoni (John Kusel, personal 
communication).It is widely regarded that the scattered 
distribution of FRAP results is due to the photobleaching 
method which requires the analysis of repeat samples over
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several days. Different days of analysis, different samples 
and different levels of protein expression from cell to cell 
are just some of the factors which may contribute to the wide 
variation in the data.
101
Chapter 3 Results
Table 3.10 - Comparisons of means for % of recovery and 
quantitative fluorescence, that were statistically 
significant.
Cell line
D.L. coefficient 
(lO-^cm^/s-1) 
mean (s)
% recovery 
(mobile fraction) 
mean (s)
Quantitative
fluorescence 
mean (s)
CHO WT/14TM ns ns ns
CHO WT/12TM ns 60.0(18.6)/
87.0(17.4)
ns
CHO WT/+VE ns ns ns
CHO 14TM/12TM ns 46.1(26.9)/
87.0(17.4)
ns
CHO 14TM/+VE ns ns 70.0/122.0
CHO 12TM/+VE ns 87.0(17.4)/ 
54.0 (23.1)
ns
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CHAPTER 4
DISCUSSION
4.1 Background and present study
Previous experiments have been done to determine the minimal 
length TM which can anchor in the cell membrane. Davis and 
colleagues (1985), using a prokaryotic system, made a series 
of overlapping deletions in the TM region of bacteriophage fl 
gene III protein from 23 amino acids (wild type) to 22, 20, 
16, 11, 6 and 4 amino acids. The mutants were expressed on E. 
coli and because of the presence of the outer cell wall the 
anchoring properties could only be investigated by alkali 
fractionation. The mutant proteins with TM region 22 to 16 
amino acids long were still able to span the cell membrane. 
Mutants 11 to 6 exhibited a residual membrane association and 
the 4 amino acids long mutant lost the anchoring properties 
completely. Due to the indirect methodology used in these 
experiments to assay the membrane bound fraction of proteins, 
it was difficult to differentiate cell surface membrane 
signals.
Adams and Rose (1985b) created mutant forms of VSV G proteins 
with shortened TM domains to determine the structural 
requirements for a functional membrane spanning domain. The TM 
domain was deleted from 20 amino acids (wild type) to 18, 16, 
14, 12 and 8. The mutant proteins were expressed in COS cells. 
Cellular localization was verified by immunostaining. 
Transport through the secretory pathway was determined by 
acquisition of endoglycosidase H (endo H) resistance. Simple 
oligosaccharide units are added to the polypeptide in the ER,
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at this stage such units are susceptible to endo H digestion. 
After transport to the Golgi apparatus, these oligosaccharides 
are converted to a complex type which is resistant to endo H 
cleavage (Tarentino and Malley, 1974). The VSV G proteins with 
TM of 18, 16 and 14 amino acids were transported to the cell
surface and were resistant to endo H. The mutant protein with
12 amino acids was not detected at the cell surface and was 
only about 30% resistant to endo H, indicating that a
fraction of the protein reaches as far as the Golgi region. 
The 8 amino acid form was not detected at the cell surface and 
was not endo H resistant, indicating a failure in the 
transport to Golgi. These results demonstrated that in the 
case of VSV G protein, at least 14 amino acids become
necessary to permit expression on the cell surface.
Doyle and colleagues (1986) introduced translational 
termination codons at four sites of the HA transmembrane 
region (composed of 27 amino acids), producing truncate0^ forms 
that lack the entire cytoplasmic domain and with TM domains of 
17, 14 and 9 amino acids long. The mutants were expressed on 
CV-1 cells and by immunostaining, hemagglutination and 
acquisition of endo H resistance the cellular localization and 
transport rate were determined. When the protein had a normal 
TM (27 amino acids) but no cytoplasmic domain it was detected 
at the cell surface and exhibited erythrocyte binding as the 
wild type. A low percentage of the mutant protein with TM 17 
amino acids long was anchored at the cell surface at a 
concentration sufficient for erythrocyte binding. Some 
internal staining was also observed. The acquisition of 
resistance to endo H by this mutant was detectable only after 
4 hours of chase, while in the wild type it was detected after 
30 minutes. So the transport of the majority of these mutant 
protein between the endoplasmic reticulum and the medial Golgi 
is blocked or severely delayed. The 14 and 9 amino acids 
proteins exhibited intracellular immunofluorescent staining 
that was confirmed to be a ER region by endo H digestion. They
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were not able to bind erythrocytes. From these results it was 
possible to conclude that 17 hydrophobic amino acids are 
sufficient to anchor HA in the membrane. This association was 
not considered stable, maybe because this mutant also lacked 
the cytoplasmic domain. HA is a trimeric protein, and 
trimerization is a prerequisite for intracellular transport. 
Alterations in the cytoplasmic and transmembrane domains 
possibly interfere with this assembly process causing a 
delayed or failure in the transport to the cell surface.
-tVe-
In the present study human CD2 molecule was studied. This, is a 
eukaryotic membrane protein, that assembles in a monomeric 
form in the cell membrane and its structure has been
determined (Sayre and Reinherz, 1988). Crystallography studies
the*on rat CD2 extracellular domain contributed to better 
understanding of this- structure (Jones et al., 1992). A series 
of deletions were made on the TM domain shortening it from 26
amino acids (wild type) to 14, 12, 10 and 8 amino acids long.
The mutant proteins were expressed on mammalian cells (COS-7 
and CHO) . The CD2 14TM and 12TM mutants showed cell surface 
expression, as demonstrated by panning and immunostaining. 
Quantitative fluorescence measurements indicated that these 
two mutants are being expressed at the cell surface at the 
same level that the wild type. Rosetting with SBRC confirmed 
the integrity of the adhesion domain of CD2 14TM and CD2 12TM, 
corroborating the idea that these mutants were able to
span cellular membrane in a functional way. The mutant 
proteins were also detected on the cell surface by 
immunostaining with antibodies specific to domain 1 and domain 
2. In the case of CD2, it seems that the TM region has to be
at least 12 amino acids long to U-gnUiorti to the cell membrane in
a functional state.
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4. .2 Comparisons between CD2 and VSV 6 mutants
CD2 TM mutants (This study)
CD 2 WT
E17Z-PVSC176PEKGLD IYLIIGICGGGSLLMVFVALLVFYIT KRKKQRSRR217
CD2 14TM
E17^ PVSCPEKGLD IYLIIGICGGFYIT KRKKQRSRR
CD2 12TM
E17ZPVSCPEKGLD IYLIIGICGYIT KRKKQRSRR
CD2 10 TM
E172PVSCPEKGLD IYLIIGGYIT KRKKQRSRR
CD2 8TM
E172PVSCPEKGLD IYLIGYIT KRKKQRSRR
CD2B7
£172.PYREFPVWPSGEEORYTCHVOHEGLPKPLTL GWEPSSOGAWAAVMC RRKSS
CD2 HLAB7   TM
VSV G mutants (Adams and Rose, 1985b)
VSV G WT
e455gwfsswkssiasfffii472gliiglflvlrvgihlc489.iklkhtkkr498
TM
VSV G 18TM
E455GWFSSWK SSIASFFFIIGLGLFLVL RVGIHLCIKLKHTKKR
VSV G 16 TM
E455GWFSSWK SSIASFFFIIGLFLVL RVGIHLCIKLKHTKKR
VSV G 14TM
E455GWFSSWK SSIASFFFIIFLVL RVGIHLCIKLKHTKKR
VSV G 12TM
E455GWFSSWK SSIASFFFILVL RVGIHLCIKLKHTKKR
VSV G 8TM
E455GWFSSWK SSIAFLVL RVGIHLCIKLKHTKKR
The numbers indicate amino acids positions, the transmembrane domain is 
highlighted in bold. In CD2B7 construction, the CD2 sequence is underlined 
with a double line and HLAB7 with single line.
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Comparing the amino acids sequence of CD2 and VSV G protein 
mutants, it is noticeable that the hydrophobic domains from 
both are flanked by positively charged amino acids. Adams and 
Rose (1985b) suggested that an additional short hydrophobic 
stretch from the cytoplasmic domain could be buried into the 
lipid bilayer, to complete the enough length require to form 
an a-helix. This was verified when the mutants proteins were 
labelled with [3H] palmitic acid. Palmitic acid is esterified 
to the VSV G protein at Cys489 at the cytoplasmic domain and it 
is believed to occur just as the protein enters the Golgi. The 
12TM mutant showed a reduced level of labelling, which 
indicates that either the cysteine is not available or the 
mutant protein failedto reach the compartment where the 
palmitic acid is added. In the case of CD2, it is unlikely 
that additional residues could be incorporated into the 
membrane spanning region from the cytoplasmic domain, because 
they are so highly charged.
Amino acids from the external domain could be buried inside 
the lipid bilayer. The TM region of VSV G protein is preceded 
by a Lys residue at the extracellular domain, immediately 
before the TM region. CD2 molecule has a stalk of 11 amino 
acids that separates the external domain from the TM region 
(Glu172-Pro-Val-Ser-Cys176-Pro177-Glu-Lys-Gly-Leu-Asp) . The Tm 
domain is preceded by an Asp residue. The Cys176 together with 
C112- forms one of the disulphide bonds characteristic of CD2 
external domain, that brings the bulk of the molecule close to 
the C-terminal. The other dis ulphide bond between C119 and C159 
corresponds to the standard immunoglobulin di sulphide bond, 
both contribute to the tight conformation of CD2 external 
domain 2 (Jones et al.,1992). Such conformation did not suffer 
any change, as verified by immunostaining with antibody 
against domain 2. It seems unlikely that any of the residues 
from the stalk would be buried inside the lipid bilayer 
because they are mainly charged residues or weakly 
hydrophobic.At this step, the CD2B7 fusion mutant was
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included. It is composed of the external domain of CD2 up to 
Glu170, followed by The HLAB7 sequence which provided a long 
stalk before the B7 TM, which is 17 amino acids in length. The 
cytoplasmic domain was the wild type B7 domain. Cys174 residue 
from the CD2 stalk was deleted in this new construction, but 
another Cys 14 amino acids downstream from this site is 
present at the new 25 amino acid stalk. This may have 
contributed by forming a di. sulphide bond with C110 to maintain 
the conformation of CD2 external domain. However, it was not 
deleted to test whether it was essential for di sulphide bo nd 
function. Therefore, it seems that the foreign TM region and 
the 45 amino acids stalk does not interfere with CD2 insertion 
in the membrane, or even with a different conformation the 
adhesion domain and epitopes are still available.
4.3 Lateral diffusion studies of CD2 mutants with short TM
The lateral mobility for membrane proteins may differ by three 
orders of magnitude, 10*8 to 10"11 cm2/s (Chan et al., 1991). 
Membrane proteins are assumed to have a slow lateral mobility 
because of the interactions of the positively charged regions 
of the cytoplasmic domain with the acidic lipid head groups of 
the lipid bilayer. Interactions with other membrane proteins 
that are themselves anchored in the bilayer or interactions of 
of the molecule with cytoskeletal elements could also 
contribute to decrease the lateral mobility. Comparing 
previous observations of lateral diffusion in membrane 
proteins , the values vary from 0.12xl0~10 cm2/s to 6.4xl0_1° 
cm2/s, and the percentage of recovery, from 31% to 73% (Table 
4.1). The lateral diffusion of CD2 wild type in CHO cells is 
1.8xl0-10 cm2/s with 60.07% of mobile fraction, similar to the 
observed for membrane proteins.
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Table 4.1 - Values of lateral diffusion (D.L.) and percentage of 
recovery (%R) for membrane proteins referred in the literature.
Protein D.L.(xl0"1^cm2/s) 
(SEM)
% of recovery (R) Reference
Class -I 
antigens
MHC 0.12 (0.32) 31 Edidin 
Zuniga, 1984
and
EGF receptor 1.2 (0.7) 61 (21) Livneh et 
1986
al.,
Class II 
molecules
MHC 1.0 (0.56) to
3.0 (0.67)
36 (8) to 73(14) Wade et al., 1989
Human insulin 
receptor
6.0 (0.5) 51 (12) Goncalves et 
1993
al.,
There is no significant difference between the CD2 wild type and 
CD2 14TM, CD2 12TM mutants lateral mobility coefficients. This 
suggests that large deletions in this domain do not affect the 
lateral diffusion of the mutant proteins in the lipid bilayer. 
Glycine and proline residues are considered to be classical helix 
breakers. Goncalves and colleagues (1993) observed that when the 
residues Gly933 - Pro934 within the transmembrane domain of human 
insulin receptor are mutated to Ala, the lateral mobility 
increased 2 to 3 fold. These results suggests that in this case 
the lateral mobility is retarded by a kinked TM domain in the 
wild type receptor. Comparing CD2 12TM with CD2 WT, CD2+ve and 
14TM, the number of Gly residues has reduced by half, without 
significant effect on the lateral mobility. This implies that the 
interaction of the CD2 12TM transmembrane domain is not as stable 
as the wild type and other mutants, maybe due to an extension of 
the a-helix to accommodate the mutant form into the lipid 
bilayer. Although this seems to not interfere with the lateral 
mobility, it could play a role in the interaction of the mutant 
protein with the other membrane proteins or elements of the 
lipid bilayer. However, when the means for the mobile fraction 
are compared, there is no linear increase of such values from CD2 
wild type to CD2 12TM. These results could also reflect an 
artificial situation, where the recovery coefficient is altered 
because the protein has a TM region in a limit length to be 
detected in the cell surface.
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4.4 Intracellular localization of CD2 mutants with short TM
CD2 10TM and 8TM mutants fail to anchor the cell membrane and 
the immunostaining indicated an intracellular localization. It 
is not possible to differentiate by immunofluorescence 
microscopy the actual site of intracellular distribution of 
CD2 10TM and 8TM mutants. Poruchynsky and colleagues (1985) 
have shown by electron microscopy that in COS-7 cells the 
Golgi stacks in the juxtanuclear region are spatially 
interwined with an extensive endoplasmic reticulum region and 
the Golgi apparatus can surround concentrated elements of the 
ER. Human CD2 has three potential sites of N-linked 
glycosylation N62, N114 and N123 ( Bierer et al., 1989) which
give to the mature protein molecular weight of approximately 
45-55 KDa. On SDS-PAGE gels CD2 12TM and 14TM proteins showed 
patterns of bands similar to CD2 wild type,which is consistent 
with these mutant proteins being glycosylated and transported 
to cell surface through the Golgi apparatus. The mutants CD2 
10TM and 8TM exhibited single bands with higher molecular 
weight than the expected for unglycosylated forms. It is not 
clear whether these mutants reached the medial Golgi 
apparatus, where glycosylation is completed. Addition of 
oligosaccharide units to the polypeptide takes place in the ER 
and trimming of these units begins in the ER and is completed 
after the glycoprotein reaches the medial Golgi apparatus, 
whereupon the glycoproteins become endoglycosidase H 
sensitive. Without data about sensitivity to this enzyme we 
cannot be sure how far the 10TM and 8TM passed into the Golgi.
We only know they do not reach the surface in significant 
quantity.
It was observed that CD2 10TM and 8TM could be not stained 
with antibodies against epitopes localized on the 
extracellular domains 1 (Seralab) and 2 (GT2), the
intracellular staining pattern could be visualized only when 
the cells were stained with the antibody against the denatured-
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protein (RFT11). This indicates that such domains are in a 
different conformation and therefore, the epitopes are not 
available anymore. Mutants with short TM regions, like the VSV 
G protein 8 amino acids mutant (Adams and Rose, 1985b) and the 
HA 9 amino acids mutant (Doyle, 1986) were able to be 
transported until the Golgi apparatus (as observed by endo H 
digestion), although in a slow rate. Such observations suggest 
that even proteins with short TM domains are able to anchored 
cellular membranes, but their transport to cell surface is 
defective maybe due to failure in the folding process, causing 
their transport to a degradation pathway.
4.5 The role of positively charged residues
The positive inside rule suggests that membrane proteins 
orientate themselves with the most positively charged end in 
the cytoplasm. This charged residues cluster is related with 
orientation of the protein and not with translocation. Studies 
where the topology of integral membrane proteins were altered 
when this positive stretch was deleted, support this idea (von 
Heijne, 1989/ Parks and Lamb, 1991/ Nilsson and von Heijne, 
1990) . Cutler and Garoff (1986) created mutants of Semliki 
Forest Virus (SFV) p62 polypeptide by altering the two basic 
amino acid in the cytoplasmic domain adjacent to the TM 
region. The wild type charge cluster of Arg-Ser-Lys was 
changed to Gly-Ser-Met (hydrophobic) or to Gly-Ser-Glu (weakly 
hydrophobic). The mutants were expressed on COS-7 cells and 
showed membrane association in a functionally unaltered 
fashion. Cutler and colleagues (1986) demonstrated by 
carbonate extraction of the mutants from the membrane, that 
the stability of the mutants in the cell membrane was reduced. 
This raises the question of the role of the positive charges. 
The current dogma is probably inapplicable to membrane 
proteins with one spanning domain, when the leader sequence 
should orientate the rest of the protein across the membrane.
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We mutated the cytoplasmic positive cluster Lys-Arg-Lys-Lys, 
immediately adjacent to CD2 TM , to something less positive 
like Gln-Gln-Gln-Gln. The mutant reached the cell membrane in 
a functional state as observed by panning, immunostaining and 
western blotting. Rosetting experiments demonstrated that the 
extracellular domain did not exhibit any conformational change 
or signs of inverted topology. This implies that substituting 
these residues for something less positive does not alter the 
orientation of CD2 molecule in the lipid bilayer. This result 
could be also due to the other sequence of positively charged 
amino acid (Arg-Ser-Arg-Arg) situated immediately downstream 
this mutated sequence. This sequence was left behind because 
it was assumed that the positively charged amino acids (Lys- 
Arg-Lys-Lys) interact with the acidic heads of the lipid 
components of the membrane, contributing to stabilization of 
the molecule within the membrane. The substitution of these 
amino acids would disrupt this interaction, consequently even 
the Arg-Ser-Arg-Arg sequence left behind would not be in 
contact with the membrane anymore. It was also possible that 
removal of the further positively charged amino acids would 
disrupt the organization of the cytoplasmic domain, changing 
the behaviour of the molecule. We have disrupted the positive 
cluster without phenotypic effect. Therefore, to know if this 
downstream positively charged sequence is stabilizing the 
protein insertion into the membrane, further mutagenesis in 
this sequence should be done.
The CD2+VE mutant have not shown any significant difference as 
regards to lateral mobility and percentage of mobile fraction 
in comparison with the wild type CD2 protein. This lead us to 
deduce that there is a stable association of this mutant with 
the membrane even when the number of positively charged amino 
acids flanking the the TM domain at the cytoplasmic side was 
reduced. One of the reasons membrane proteins show a slow
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lateral diffusion is because interactions of the cytoplasmic 
domain with the lipid bilayer can retard the lateral mobility 
of the molecule (Jacobson et al., 1987). Large deletions in 
this domain do not affect the lateral mobility of epidermal 
growth factor (EGF) receptor (Livneh et al., 1986) and class I 
MHC antigen (Edidin and Zuniga, 1984), although in none of 
these cases the positive cluster situated at the cytoplasmic 
side of the TM domain was deleted. Wade and colleagues (1989) 
observed that deletion of all amino acids of the cytoplasmic 
domain of both a and |3 chains of the murine class II MHC 
antigen, resulted in a 10 fold increase of lateral mobility 
coefficient. This indicates that this domain is important in 
constraining the lateral mobility of these molecules. Wier and 
Edidin (1988) noticed that the loss of glycosylation of the 
glycoprotein Ld of the class I MHC increased the lateral 
mobility coefficient. This protein has three sites of 
glycosylation, and such results indicates that the external 
domains of cell surface glycoproteins also interact with other 
nearby molecules. Chang and cols (1989) in an attempt to 
demonstrated the role of the cytoplasmic domain of CD2 in 
signal transduction, created some mutants with deletions in 
this domain. A particular mutant with a cytoplasmic domain 
composed only by two  ^ residues Lys-Arg has shown an
unstable surface expression and functional analysis was not 
possible. This should be due to misfolding because of the 
short cytoplasmic domain, although VSV G proteins mutants with 
only three residues in the cytoplasmic domain (Arg-Val-Gln and 
Lys-Val-Lys) were still able to anchor the cell surface 
(Puddington et al., 1986).
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4.6 Hydrophobic and positively charged sequences within mature 
secreted proteins
The way a stop transfer signal halts the translocation of the 
polypetide across the membrane is related to its association 
with protein-conducting pore (channel) situated in the 
membrane. There are some hypothesis about the interaction of 
the protein with components of this pore (see Introduction, 
Lingappa, 1991/ Simon and Blobel, 1991) . The hydrophobic 
domain stop the translocation of the polypeptide chain, 
disrupting such structure. However, in the case of secreted 
proteins, the hydrophobic and positively charged stretches 
are passing across the pore without disruption. This implies 
that either the length of the hydrophobic stretch or the 
position of the positively charged residues should interfere 
with the translocation.
Computer searches was done in order to look for hydrophobic 
sequences and positively charged residues in secreted 
proteins. Hypothetical sequences of highly hydrophobic 18, 
16, 14, 12, 10 and 8 amino acids were created and matched
sequences in secreted proteins were searched in a data base. 
Hydrophobic sequences that vary from 7 to 8 amino acids long 
(excluding signal sequences) were found (Table 4.2). 
Hypothetical sequence of at least 4 positively charged amino 
acids (similar to the observed in CD2) was created and matched 
to sequences in the data base. Sequences varying from 4 to 6 
positively charged amino acids were found (Table 4.3).
114
Chapter 4 Discussion
Table 4.2 - Hydrophobic stretches (in bold) in secreted
proteins, excluding signal sequences.
Secretory glycoprotein gX (A=498) 
(Rea et al., 1985) V14 6L Q P  G L  Y E A S  G L Y I W L V F G J 2 I 1 A Y L 17 0
Serum albumin precursor - pig 
(Ap=605) (Weinstock and Baldwin, 
1988)
E 162 I A & R H P  Y F Y A P £ L L Y Y A I  I Y & H V F 18 6
Serum albumin precursor - human 
(A=558) (Eiffert et al., 1984) G 171E I E L H I Q G T G Q L L F S W I H E L E L  S 195
Secretory component - human (A=609) 
(Lawn et al., 1981)
£ 341N Y A £ L A m W L G M F L Y E Y A £ R H P n 364
Secretory component - human (A=693) 
(Krajci et al., 1989)
E  8 6N A £ Q £ R K G L  Y £ Q  I G L Y P V L V T H S  S 110
Beta lactoglobulin I - donkey 
(A=162) (Godovac et al., 1988)
A 94L H S H Y £ N Y L L F L C M K N A T P G Q S L V 118
Table 4.3 - Sequences of positively charged residues (in bold) 
in secreted proteins.
Human RD protein (A=382) 
(Speiser and White, 1989)
E11EALQKKFNKLKKKKKALLALKKQSS37
Human ovarium inhibins (A=426) 
(Mason et al., 1986)
E249SGASLVLLGKKKKKEEEGEKKKGG274
Human ovarium inhibins (A=426) 
(Mason et al., 1986)
R298QSEDHPHRRRRRGLECDGKVNICC322
Bovine interferon - gamma (A=166) 
(Cerreti et al., 1986)
N141DLSPKSNLRKRKRSQNLFRGRRAS165
Platelet - derived growth factor 
(A=211) (Betsholtz et al., 1986)
K72HVPEKRPLPIRRKRSIEEAVPAVCK97
Platelet - derived growth factor 
(A=211) (Betsholtz et al., 1986)
L184NPDYREEDTGRPRESGKKRKRKRL209
A represents the amino acid length of the protein and numbers represent the 
amino acids position.
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Comparing sequences of table 4.2 with CD2 8TM transmembrane 
region (EPVSCPEKGLDIYLIGYITKRKKQRSRRND, the bold represents 
the TM region) not much difference is observed, apart from the 
positively charged cluster immediately after the hydrophobic 
stretch. At the secretory glycoprotein gX, the hydrophobic 
sequence could be extended to 12 amino acids, flanked by Asp 
residues at both sides, and the sequence is similar to CD2 
12TM. In the case of the three mutants CD2 12TM, 10TM and 8TM, 
the positively charged sequence could be contributing to their 
membrane anchoring, since translocation of positively charged 
amino acids through the hydrophobic domain uses considerable 
free energy. Some of the secreted proteins exhibit the 
hydrophobic domain flanked by positive charge like serum 
albumin precursor (pig), human secretory component and beta 
lactoglobulin (donkey), it seems that one or two positive 
charges adjacent to a short hydrophobic domain does not have 
the same effect.
Table 4.3 highlights a further feature of the protein 
translocation apparatus, namely strings of positively charged 
sequences that can translocate the cell membrane, through the 
protein conducting pore. However, in the examples above the 
positive charges were not observed adjacent to hydrophobic 
domains. It may be that in the case of CD2 12TM, CD2 10TM and 
8TM, the positively charged sequence that follows the TM 
prevents the polypeptide from translocating through the pore. 
Consequently the pore structure would disassembled and the 
polypeptide chain will interact with the lipid bilayer with a 
transmembrane topology of a mature protein. Its subsequent 
fate (export or degradation) will then be influenced by 
conformational considerations in the flanking domains. This 
may help explain why hydrophobic runs of amino acids can be 
secreted (Table 4.2) unless they are present in membrane 
proteins. To determine if the positive cluster adjacent to the 
TM is influencing in the insertion of CD2 12TM or in the
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intracellular localization of CD2 10TM and 8TM, deletion or 
substitution of such positive sequence should be done.
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CHAPTER 5
CONCLUDING REMARKS
The topology of integral membrane proteins is determined in 
the early stages of the polypeptide translocation across the 
protein-conducting channel in the ER membrane. The
localization and structure of the signal peptide and
transmembrane domain contribute to this orientation, and
positively charged amino acids situated at the cytoplasmic 
side of the TM is more likely to be responsible by the 
stabilization of this interaction.
CD2 transmembrane domain has to be composed of at least 12
hydrophobic amino acids to span the lipid bilayer in a stable
association. Although it was not determined if 12 amino acids
are enough to stop translocation and disrupt the pore
structure. Maybe the positively charged amino acids situated
of .
immediately downstream this domain could be contributing to
this insertion. Mutants forms with shorter TM domains have
their transport to the cell surface blocked, and the truncate
forms should be degraded. It was assumed that the positive
cluster situated immediately after the TM region of mutants
CD2 10TM and 8TM, was also responsible for their intracellular
localization. It is unlikeVjthat the a-helix structure of the
TM of these mutants is halting the translocation of the
molecule across the cell membrane Additional
-the.
mutagenesis studies, where this positive cluster in CD2 12TM, 
10TM and 8TM cytoplasmic domain is either removed or 
substituted by something less positive would bring more 
information; about the transport of £Ke.seT mutants through the
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secretory pathway and the length of the hydrophobic sequence 
necessary to stop translocation across the protein-conducting 
pore. Further studies will be also necessary to establish the 
intracellular localization of the CD2 10TM and CD2 8TM. 
Electron microscopy of structure of the endoplasmic reticulum 
from cells expressing these two mutants should reveal more 
about their intracellular localization .
The lateral diffusion experiments suggested that larger 
deletions in the TM domain do not interfere with the lateral 
mobility of a membrane protein. CD2 12TM exhibited a higher 
percentage of molecules free for diffusion. This suggests 
that this molecule is not associated to the lipid bilayer in 
such stable way as CD2 wild type, 14TM and CD2+ve. Maybe due 
to an alteration of this structure to accommodate the molecule 
into the membrane in a functional state. Both ends of the 
transmembrane domain are marked by positively charged amino 
acids (a higher number is found at the cytoplasmic side) and 
it seems unlike that any of these would be buried inside the 
lipid bilayer as part of the transmembrane domain.
The common basic box situated in the cytoplasmic domain 
adjacent to the TM was disrupted. It was expected either 
changes in the orientation of this mutant within the membrane, 
or a less stable interaction of the molecule with the lipid 
bilayer. It is assumed that these positively charged amino 
acids will interact with the acidic heads of the lipid 
components of the membrane. The substitution of these amino 
acids should interfere with this interaction. The stable 
association of CD2+ve mutant with the cell membrane, revealed 
by lateral diffusion studies, lead us to two conclusions. The 
26 amino acids TM domain is enough to maintain a stable 
association with the lipid bilayer and the positive charged 
amino acids are not required-for this. The positive sequence
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left behind may still have been able to interact with the 
lipid bilayer, stabilizing this association. Further
deletions of the positively charged sequence left behind 
should also be carried out to verify if any change in the 
topology would occur.
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Appendix
APPENDIX
I - Abbreviations
Ab - Antibody
Amp - Ampicilin
APS - Ammonium persulphate
ATP - Adenosine triphosphate
Bis-aerylamyde - N,N’ methylene-bisacrvlamyde
BiP - H chain binding protein
BSA - Bovine serum albumin
CD2 - Cluster of differentiation molecule 2
cDNA - copy DNA
CIP - calf intestinal phosphatase
dH20 - distilled water
DMSO - Dimethyl sulfoxide
DNA - Deoxyribonucleic acid
dNTPs - Deoxynucleotides triphosphates
DTT - Dithiothreitol
EDTA - Ethylenediaminetetra acetic acid
ER - Endoplasmic reticulum
FRAP - Fluorescence recovery after
photobleaching 
FITC - Fluorescein isothiocynate
GT - Glucose transporter
HA - Hemagglutinin
HEPES - N-2- Hydroxyethylpiperazine-N-2-ethane
Sulphonic acid 
HLA - Human leukocyte antigen
Ig - Immunoglobulin
IgG - Immunoglobulin G
11-2 - Interleukine 2
IPTG - Isopropylthio-B-D-Galactoside
Km - Kanamycin
152
Appendix
LFA - Lymphocyte function associated
MAb - monoclonal antibody
MHC - Major histocompatibility complex
mRNA - messenger RNA
Page - Polyacrylamyde gel electrophoresis
PBS - Phosphate buffered saline
PCR - Polymerase chain reaction
RER - Rough endoplasmic reticulum
RNA - Ribonucleic acid
RNase - Ribonuclease
rRNA - Ribosomal RNA
RT - Room temperature
SDS - Sodium dodecyl sulphate
SRBC - Sheep blood red cells
SRP1 - Signal recognition particle
SV4 0 - Simian virus 4 0
TBS - Tris buffered saline
TCR - T cell receptor
TEMED - N,N,N’,N’ - tetramethylenediamine
Tet - Tetracycline
TM - Transmembrane
TRAM - Translocating chain-associating membrane
protein
TRAP - Translocating assembly protein
tRNA - Transfer RNA
T/E - Trypsin / EDTA
VSV G - Vesicular stomatitis virus G protein
Xgal - 5-bromo-4-chloro-3-inaolyl-p-
galactosidase
II Units
A - amps
mA - mi li amps
bp - base pair
Kb - Kilobase pair
Append ii'
°C - degrees centeqrade
Da - Daltons
KDa - Kilodaitons
0 - grammes
Kg - Kilogrammes
mg - milligrammes
uq - microgrammes
ng - nanogrammes
Hz - Hertz
1 T •-) v> r* c*-t X.L L-X c 5
ml - millilitres
llI - microlitres
m - metres
zm - centimetres
jllt: - micrometres
m m  - minutes
M - Molar
mK - mi H i  molar
uM - micromolar
pinoles - picomoles
sec - seconds
ms - miliseconds
us - microseconds
rpm - revolutions per minute
krpm - hi1orevo1utions per minute
III - Chemicals
General chemicals and solvents - EDH
Media — D^ hfco , Qxoid
Biochemicals - BDH, 5RL, Sigma
Agarose - ERL
Antibiotics - Gibco-BRL, Sigma
Restriction enzimes - BRL, Promega
DNA modifying enzymes - ERL, Promega, USB
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A n n  bodies - Fera Lab, Serotec,
Boehrmger Manheim 
The CD2GT2 antibody was kindly given by Prof. Alain Bernard 
Immunological reagen - Sigma, Promega
Tissue culture media - Gibco
Fetal Calf Serum - Gibco
IV Equipment 
C e n trifuo e s
Soectroohotometers
SoDencorf 5413, 5414 5 and 
5415, MSE microcer.trifu 
Beckman microfuqe E, MS 
minor S bench top centrifuge 
Beckman Du 50, LICE ultraspec
sequencing apparatus
\ o  p. 3
Protein gel kit 
Electroblotter 
Mi cr os cooes
IBI and BRL
LKB 2197 power supply
IBI
Bi or ac 
Biorad
yn uore?cent ~ L e 11 z 
phase contrast - Zeiss 
inverted - Leitz
Power supplies 
Balances 
Membranes 
Pipetmans 
X-rav film
Consort - Flowgen 
Sartcrius
Nitrocellulose - Kybaid
Finnpipettes
Kodak hvioer film
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